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Increased macrophage infiltration and extracellular matrix deposition in adipose tissue and 
skeletal muscle are observed in obesity and associated with insulin resistance. Daily calorie 
restriction (DR) and intermittent fasting (IF) are two dietary approaches to treat obesity. A 
handful of studies have compared the effects of DR versus IF on metabolic health in humans. 
However, the impact of these dietary interventions on adipose tissue and skeletal muscle 
remodelling are poorly investigated. This thesis focuses on the adipose tissue and skeletal 
muscle remodelling following 8-weeks of DR or IF in humans, and also examines metabolic 
characteristics and adipose tissue remodelling in lean and diet-induced obese mice following 
IF.  
 
The study reported in Chapter 3 is the first randomised controlled study to compare continuous 
and intermittent intake patterns at two energy levels (at energy balance, or 30% energy 
restriction). This study showed that IF induced greater reductions in body weight, fat mass, 
homeostatic model assessment of insulin resistance and total cholesterol. However, the mode 
of dietary restriction did not impact overall insulin sensitivity by the clamp method, and fasting 
for 24-hours induced transient insulin resistance. In Chapter 4, weight loss by DR and IF 
reduced fat cell size and stimulated markers of extracellular matrix remodelling, but did not 
reduce markers of inflammation. In contrast, IF transiently elevated markers of inflammation 
in adipose tissue and muscle, which was associated with increases in non-esterified fatty acids 
(NEFA).  
 
To further examine the metabolic profiles and adipose tissue remodelling in response to IF, 
C57BL/6J mice were fed chow or high-fat diet ad libitum for 8-weeks, then subjected to ad 
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libitum feeding or IF for another 8-weeks. The study in Chapter 5 suggests IF promoted fat 
mass loss and improved glucose tolerance in chow and high-fat diet fed mice, but decreased 
body weight, and visceral adipose tissue inflammation and fibrosis in high fat diet fed mice 
only. In contrast to humans, IF did not increase macrophages in adipose tissue in mice, despite 
marked increases in NEFA. 
 
The mechanisms underlining improved metabolic phenotype in chow and high fat diet fed mice 
following IF was documented in Chapter 6. Our data shows that IF increased energy 
expenditure and promoted subcutaneous and visceral adipose tissue browning in both chow 
and high fat diet fed mice. However in humans, eight weeks of IF did not alter mRNA levels 
of uncoupling protein 1, a marker of white adipose tissue browning. 
 
The adipose tissue and skeletal muscle remodelling in response to acute overfeeding was 
described in Chapter 7. This study suggests extracellular matrix remodelling in adipose tissue 
is an early event in response to over-nutrition, and occurs prior to altered insulin sensitivity by 
clamp. 
 
In conclusion, this research highlights that energy restricted intermittent fasting promotes 
greater weight and fat loss, but does not induce greater improvements in insulin sensitivity by 
clamp versus daily calorie restriction. This thesis also suggests intermittent fasting results in 
favourable adipose tissue remodelling in mice, and distinct tissue adaptations versus daily 
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Chapter 1:  Introduction 
  





Obesity is a condition in which abnormal or excessive adipose tissue accumulates in the body 
due to positive balance between energy intake and expenditure. Commonly, it is classified 
using body mass index (BMI), which is defined as a person’s body weight in kilograms divided 
by the square of his or her height in metres (kg/m2). According to the criteria from the World 
Health Organisation, for adults, obesity is a BMI greater than or equal to 30. A BMI less than 
30 but greater than or equal to 25 is classified as overweight (World Health Organisation, 2018, 
February 16). Recently, obesity has been recognised as a chronic and preventable disease 
(Hruby and Hu, 2015).  
 
1.1.2 Prevalence 
The prevalence of obesity and overweight has increased rapidly worldwide and in Australia. 
It was estimated that the worldwide prevalence of obesity nearly tripled between 1975 and 
2016. Globally, it was estimated that 39% of adults were overweight and about 13% of the 
world’s adult population were obese in 2016, with a proportion of 11% in men and 15% in 
women (World Health Organisation, 2018, February 16). If this global trends continue, 18% 
of men and 21% of women will be obese by 2025 (N. C. D. Risk Factor Collaboration, 2016). 
 
This situation is even more critical in Australia. The latest survey by the Australian Bureau of 
Statistics revealed that 63.4% of Australian adults were overweight or obese in 2014-2015, and 
the prevalence of obesity reached 27.9% (Australian Bureau of Statistics, 2015, December 8). 
A more recent study estimated that the prevalence of obesity for Australian adults would 
continue to climb, reaching 35% by 2025 (Hayes et al., 2017).  





The causes of obesity are multifactorial. These include excessive calorie intake, physical 
inactivity, inadequate sleep, socioeconomic status, nutritional insults during intra-uterine 
growth, and genetic factors (Caballero, 2007, Brisbois et al., 2012, Stettler and Iotova, 2010, 
Goldstone and Beales, 2008, Fall, 2011, Beccuti and Pannain, 2011). For example, people with 
high socioeconomic status in low-income areas are more likely to be obese, whilst in high-
income countries, those with high socioeconomic status are less likely to be obese (Pampel et 
al., 2012). Offspring from pregnant mothers who suffered from extreme food deficiency or 
who were obese have increased risk of adulthood obesity (Parlee and MacDougald, 2014, Liu 
et al., 2017c, Dabelea, 2007). Mutations in genes encoding factors regulating energy 
intake/expenditure such as leptin (LEP), leptin receptor (LEPR), proopiomelanocortin (POMC) 
and melanocortin-4 receptor (MC4R) are linked with severe early-onset obesity (Montague et 
al., 1997, Clément et al., 1998, Krude et al., 1998, Vaisse et al., 1998). 
 
1.1.4 Impact 
Obesity is linked with a number of health issues. Obesity increases the risks for coronary heart 
diseases, stroke, type 2 diabetes, pulmonary diseases, osteoarthritis and cancer etc., thus 
leading to increased all-cause mortality (Poirier et al., 2006, Katsiki et al., Zammit et al., 2010, 
Kahn et al., 2006, Basen-Engquist and Chang, 2011, Flegal et al., 2013). Additionally, obesity 
causes a significantly economic burden to the health system. It was estimated that obesity 
accounts for between 0.7% and 2.8% of a country’s expenditure in healthcare annually 
(Withrow and Alter, 2011). But the situation in Australia is more severe. The most recent report  
revealed that 7% of the total health burden in Australia was due to overweight and obesity 
(Australian Institute of Health and Welfare, 2017, April 13). In total, 25% of the coronary heart 
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disease burden, 22% of the stroke burden, 19% of the cancer burden and 53% of the diabetes 
burden were attributed to overweight and obesity (Australian Institute of Health and Welfare, 
2017, April 13). 
 
1.1.5 Lifestyle Management  
Lifestyle interventions remain the cornerstone of weight management. These interventions aim 
to modify eating behaviours and/or physical activity to achieve weight loss, improving health 
and quality of life (Heymsfield and Wadden, 2017, American College of Cardiology/American 
Heart Association Task Force on Practice Guidelines, 2014). The advantages of these 
interventions are low cost with no, or minimal side effects (Heymsfield and Wadden, 2017).  
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1.2 Calorie restriction 
Calorie restriction (CR) is a nutritional approach characterised by reducing nutrient intake 
without causing malnutrition. In 1935, McCay and colleagues for the first time demonstrated 
that long-term CR prolonged the maximum lifespan in rats (McCay et al., 1935). Since then, 
this lifespan extension effect of CR has been repeatedly confirmed in a large spectrum of 
species, including yeast, nematode, fruit flies, mice and rats (Kapahi et al., 2017, Ingram and 
de Cabo, 2017). In addition to prolonged lifespan, a growing number of studies in rodents, 
monkeys and preliminary data in humans have shown that moderate CR can prevent and 
reverse age-related chronic diseases, such as obesity, insulin resistance, diabetes, and chronic 
heart disease (Balasubramanian et al., 2017, Ingram and de Cabo, 2017, Kapahi et al., 2017, 
Most et al., 2017).  
 
1.2.1 Calorie restriction, lifespan and health-span in rodents 
Rodents in moderate CR displayed lifespan extension, the degree of which depends on the 
onset and duration of CR. Rodents that started CR at the age of weaning (3 to 6 weeks) 
manifested decreased weight gain and an approximately 30-60% increase in maximum lifespan 
(McCay et al., 1935), and showed a more youthful metabolic phenotype and immunologic 
responses than the age-matched control (Masoro et al., 1980, Weindruch et al., 1979). Mice of 
long-lived strains that were subjected to a restricted diet in late adulthood (12-13 months) 
increased average mean and maximum lifespan by 10-20% compared to ad libitum litter mates 
(Weindruch and Walford, 1982). Of note, initiation of CR at an older age for rodents may not 
extend, and may even reduce, lifespan. Forster et al. reported that CR (-40% energy) in 
C57BL/6N mice increased lifespan when it was introduced at 4-months of age, but reduced 
their lifespan when initiated at 24-months of age (Forster et al., 2003). Similar findings with 
shorter lifespan was observed when CR was implemented in 300 day old Sprague-Dawley rats 
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(Ross, 1977). Further, the impacts of CR on lifespan also depend on the genotype of the rodents. 
In a CR study (-40% energy) which included 41 recombinant inbred strains of mice, the lifespan 
for the majority of the strains was not extended, and notably, nearly 27% of the strains had 
shortened lifespan (Liao et al., 2010).  
 
CR also prevents the functional and structural changes in multiple organs and tissues, and 
improves health-span of rodents. CR inhibits spontaneous, chemical- and radiation-induced 
malignant tumours in several animal models of cancer (Longo and Fontana, 2010). CR can 
prevent or delay the incidence of chronic kidney disease and heart disease, as well as diabetes 
(Weindruch et al., 1986, Shimokawa et al., 1993, Masoro, 2005). Moreover, a variety of 
cytokines such as tumour necrosis factor α (TNFα) and leptin secreted by adipocytes were also 
reduced by CR (Barzilai and Gupta, 1999). Finally, neurodegenerative conditions such as 
Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and cerebral stroke in mouse 
models can be prevented by CR, via decreased neurodegeneration and β-amyloid deposition 
and increased neurogenesis in the central nervous system (Cohen et al., 2009, Mattson, 2005).  
 
It should be noted that CR may bring some detrimental effects on health-span. CR reduced the 
bone mineral content and bone mineral density in rodents independent of the age that CR was 
initiated (Huang and Ables, 2016). CR may also affect immune function causing increased risk 
of infection and retardation of wound healing (Gardner, 2005, Gardner et al., 2011, Ritz et al., 
2008, Clinthorne et al., 2010, Harrison and Archer, 1987, Reiser et al., 1995, Otranto et al., 
2009). 
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1.2.2 Calorie restriction, lifespan and health-span in non-human primates 
Currently, there are two groups exploring the long-term impact of calorie restriction in non-
human primates, one at the National Institute on Aging (NIA) (Lane et al., 1992), the other at 
the Wisconsin National Primate Research Centre (WNPRC) (Ramsey et al., 2000a). A large 
body of evidence shows that calorie restriction significantly improves health-span of non-
human primates (Colman et al., 2009, Kemnitz, 2011).  
 
Monkeys undergoing 30% food restriction showed lower body weight compared with ad 
libitum fed control monkeys, in parallel with a decrease of both subcutaneous and visceral 
adipose tissue measured by dual-energy x-ray absorptiometry or computer tomography 
(Mattison et al., 2003, Colman and Anderson, 2011, Colman et al., 1999, Ramsey et al., 2000b). 
Monkeys on a CR diet displayed decreased fasting insulin and glucose, improved glucose 
tolerance and ameliorated pancreatic β cell function (Mattison et al., 2012, Bodkin et al., 2003, 
Lane et al., 1995, Kemnitz et al., 1994, Anderson et al., 2009, Hansen and Bodkin, 1993, Gresl 
et al., 2001), suggesting that CR enhances both insulin secretion and peripheral insulin 
sensitivity and prevents the onset and development of diabetes in non-human primates. CR also 
reduces the risk of cardiovascular diseases in rhesus monkeys. Evidence shows that CR 
lowered blood pressure, total cholesterol and triglyceride, and improved the lipoprotein profiles 
by increasing high- density lipoprotein (HDL) and reducing very low-density lipoprotein 
(LDL) (Lane et al., 1999, Edwards et al., 1998, Rezzi et al., 2009, Verdery et al., 1997).  
 
As the beneficial effects of CR in rhesus monkeys are in line with findings in rodents, it is 
reasonable to speculate that CR may also prolong lifespan of non-human primates. However, 
whether CR extends lifespan in monkeys is still in debate. The NIA study (Mattison et al., 
2012)showed that after 20 years of intervention, CR did not improve survival outcomes in both 
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adult and aged monkeys. In contrast, the WNPRC study (Colman et al., 2014) reported that 
monkeys with long-term 30% CR showed significant improvements in age-related and age-
caused survival. The authors involved in these two studies compared the distinct outcomes 
from two groups and pointed out that differences in study design, the source of the monkeys in 
each study, the age at which CR was initiated, the implementation of the diet for control 
monkeys, diet composition and feeding time may help explain the divergence between two 
studies (Mattison et al., 2017, Colman et al., 2014). In the NIA study, Food allotments for the 
control monkeys were based on their age and body weight in accordance with National 
Research Council guidelines (Mattison et al., 2012). Monkeys in the WNPRC study however 
were fed ad libitum, which mirrored human feeding habits (Colman et al., 2014). In addition, 
the diet in the NIA study was lower in fat, and higher in protein and fibre compared to the diet 
used in the WNPRC study. Thus, control monkeys in the NIA study displayed lower body 
weight than those in the WNPRC study, which minimised the differences between the 
intervention and control groups in the NIA study.  
 
1.2.3 Calorie restriction in humans 
Since CR prolongs lifespan in rodents and in one study in monkeys, questions have been raised 
as to whether increased longevity in humans can be achieved. So far, the most convincing 
evidence is from the prevalence of centenarians on the island of Okinawa in Japan (Kagawa, 
1978). Okinawan adults had a 20% reduction of calorie intake along with extended life span 
compared to people living in mainland Japan (Suzuki et al., 2001, Japanese Ministry of Health, 
2005). The mortality rates caused by cerebral vascular disease, malignancy, and heart diseases 
on Okinawa were significantly lower than those for the rest of Japan (Mizushima and Yamori, 
1992).  
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The CALERIE study (Comprehensive Assessment of Long-term Effects of Reducing Intake of 
Energy) was the first randomised clinical trial to investigate the long-term impacts of CR in 
healthy humans. In the first step, CALERIE-1 study was conducted in three centres exploring 
the impacts of CR after 6-12 months. A series of publications from this programme suggest 
that CR promoted weight and fat mass loss, and reduced the risk for type 2 diabetes and 
cardiovascular diseases (Heilbronn et al., 2006, Larson-Meyer et al., 2006, Redman et al., 2007, 
Weiss et al., 2006, Fontana et al., 2007, Villareal et al., 2006, Das et al., 2007, Pittas et al., 
2006, Ahmed et al., 2009). More importantly, this study for the first time found that CR in 
humans reduced DNA and RNA damage in red blood cells, and increased mitochondrial DNA 
content in skeletal muscle (Civitarese et al., 2007, Heilbronn et al., 2006, Racette et al., 2006). 
 
Since many of the favourable adaptations occurring in rodents by CR which are considered to 
contribute to the extended lifespan were not seen in humans in the CALERIE-1 study, a 2-year 
CALERIE-2 study was launched in multiple research centres (Ravussin et al., 2015). Currently, 
this study is still ongoing. Preliminary data from this trial suggest that body weight was 
decreased by 11.5% after 12-months of intervention and maintained at the end of 2 years 
(10.4%) (Ravussin et al., 2015). Two years of CR significantly reduced circulating 
inflammatory factors including TNFα and C-reactive protein (CRP) (Ravussin et al., 2015). 
Additionally, risks for cardiovascular diseases including total cholesterol, total glycerides, 
mean blood pressure and homeostatic model assessment of insulin resistance (HONA-IR) were 
significantly decreased (Ravussin et al., 2015). 
 
There are also some non-randomised studies investigating the long-term effects of CR on 
human ageing. The participants in these studies were members from a Calorie Restriction 
Society who self-adopted a CR regimen believing this intervention would prolong their 
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lifespan. These individuals are very lean (BMI<20kg/m2) and stick to CR (approximate -30%)  
for an average length of 15 years (Fontana et al., 2004). Compared to age- and gender-matched 
control individuals, these members displayed a marked decrease in risk factors for type 2 
diabetes and cardiovascular diseases, including circulating levels of total cholesterol (TC), 
triglycerides (TC), LDL, blood pressure, carotid artery intima-media thickness, left ventricular 
diastolic dysfunction, glucose, insulin, HOMA-IR, CRP, TNFα and interleukin 6 (IL-6) 
(Fontana et al., 2004, Meyer et al., 2006, Fontana et al., 2010). However, similar to CALERIE 
study, circulating insulin-like growth factor 1 (IGF-1) levels, which is a key molecule linked 
with longevity and whose marked decrease was observed in rodent studies by CR (Sonntag et 
al., 1999),  were not affected in these participants who underwent very long-term CR (Fontana 
et al., 2008). 
 
There are some concerns about CR in humans, too. First, it is difficult to achieve and maintain 
the prescribed calorie intake, especially long-term. For example, in the CALERIE-1 study at 
Washington University, the achieved calorie restriction was only -11.5% after 12-months, 
which was far less than the prescribed -20% (Racette et al., 2006). Similarly, in the CALERIE-
2 study, averaged CR during the first 6-months was -19.5 ± 0.8%, and -9.1 ± 0.7% over the 
next 18 months, which were also less than the prescribed (-25%) (Ravussin et al., 2015). 
Second, CR causes significant reductions in resting metabolic rate which has been confirmed 
by doubly-labelled water (Redman et al., 2009), metabolic chamber (Heilbronn et al., 2006) 
and ventilated hood system (Martin et al., 2007). This decrease in energy expenditure will 
compromise the expected weight loss. Third, CR decreases bone mineral density in lumbar 
spine, total hip and femoral neck, which may increase the risk of bone fracture (Villareal et al., 
2016). 
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Overall, these studies show that CR improves health-span, but it is not feasible to perform a 
randomised controlled trial to test whether CR will prolong lifespan in humans.  
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1.3 Intermittent fasting 
Intermittent fasting (IF) is a dietary intervention characterised by alternating between periods 
of eating and fasting, typically in 24 hours. In 1946, it was first reported that rats placed onto 
IF diets displayed prolonged lifespan (Carlson and Hoelzel, 1946).  
 
1.3.1 Intermittent fasting, lifespan and health-span in rodents  
Since the first report of prolonged lifespan in IF rats, several following-up studies have 
confirmed this effect, both in rats and mice (Raffoul et al., 1999). Maximum lifespan was 
increased by 18-80% in rats, this was consistent with a significant body weight reduction (40% 
to 50%) compared to ad libitum controls, as these rats did not gorge (Goodrick et al., 1982, 
Goodrick et al., 1983a, Goodrick et al., 1983b, Beauchene et al., 1986). The reasons for such a 
fluctuation in lifespan extension is not clear, but this is very similar in comparison with CR 
studies (Weindruch et al., 1988), possibly due to the study design or strain differences. In mice, 
maximum lifespan is increased (range 11%-56%) (Talan and Ingram, 1985, Ingram and 
Reynolds, 1987), while body weight changes were not significant. Talan et al. (Talan and 
Ingram, 1985) examined IF in C57BL/6J and found that the mean and maximum lifespan of IF 
mice was increased by 11% over ad libitum fed control, with the mean lifespan 29.2 months in 
IF and 26.4 months in control, respectively. Goodrick et al. (Goodrick et al., 1990) examined 
the effect of IF started at different ages, and found that mean and maximum lifespan of 
C57BL/6J mice were extended when an IF regimen was started at 1.5 or 6 months of age. Both 
of these two studies confirmed a smaller weight gain in IF mice compared to ad libitum fed 
control. However, some other studies reported that body weight was not different between IF 
and ad libitum fed mice (Anson et al., 2003, Varady et al., 2010, Varady et al., 2008), as mice 
on IF can consume sufficient food on feeding days so that there is no net energy deficit (Anson 
et al., 2003, Soeters et al., 2009). This phenomenon makes IF quite distinct from CR, 
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suggesting that fasting per se, instead of weight loss, can lead to favourable effects on 
metabolism.   
 
In addition to lifespan, multiple effects of IF on health-span have been investigated in rodents. 
Similar to CR, IF delayed the onset of cancer in wild type as well as genetically modified mice 
which have an accelerated cancer death phenotype (Xie et al., 2017, Siegel et al., 1988). Rats 
bearing tumour cells that were subjected to IF displayed a longer survival period compared to 
ad libitum fed controls (Siegel et al., 1988). In addition, IF is effective to reduce the risk for 
diabetes. Animals subjected to an IF protocol displayed lower fasting insulin levels and glucose 
concentrations after administration of a glucose or insulin load (Anson et al., 2003, Xie et al., 
2017, Gotthardt et al., 2016, Joslin et al., 2017). The cardio-protective effects of IF have been 
investigated in animal models of myocardial infarction. Compared to control animals, IF 
reduced myocardial infarction size and apoptotic cells, improved the survival and recovery as 
well as cardiac function (Ahmet et al., 2005, Godar et al., 2015, Katare et al., 2009). Further, 
IF has been shown to improve the brain function in animal models with neurological disorders, 
such as Alzheimer’s disease and Parkinson’s disease (Mattson et al., 2017). 
 
To test whether 100% energy deprivation on fasting day is required for the benefits of IF in 
mice, modified fasting, which allows 25% food on fasting days has been tested. Modified IF 
resulted in similarly beneficial effects versus “true” IF that involves zero calorie intake during 
the fasting periods. Varady et al. (Varady et al., 2010, Varady et al., 2007b) found that, despite 
no significant weight changes, mice with 50% food restriction on fasting day for 4 weeks had 
reduced adipocyte size, while 75% restriction on a fasting day reduced the proportion of 
visceral adipose tissue and increased circulating adiponectin levels. These beneficial effects 
were further confirmed following human studies in which modified IF increased markers of 
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insulin sensitivity and decreased fat mass and blood lipids (Halberg et al., 2005, Varady et al., 
2009).  
 
Since I commenced my PhD, a number of studies have reported the effects of IF in diet induced 
obese mice (Gotthardt et al., 2016, Joslin et al., 2017, Liu et al., 2017b, Li et al., 2017, Kim et 
al., 2017). These studies are summarised in Table 1.1 and will be discussed in Chapter 5.  












Diet Group Trail length Fasting 
protocol 
Effect of IF in diet-induce obese mice 

















16-wks IF 2 fed days 
followed :1 
fast day 
 ↑ Fat mass ↓ 





Gonadal fat browning ↑ 
Liver size ↓ 
Liver steatosis ↓ 
 
 















ADF ↓ in male 
→ in female 
Not assessed ipGTT↑ 
ipITT→ 
in both sexes 
Beta cell survival ↑ 













30 days IF 
ADF ↓ 
 
Fat mass ↓ 
 
ipGTT ↑ Inguinal fat browning ↑ 
















Not assessed Insulin ↓ 
ipGTT↑ 
Leptin↓ 
Temperature (fast) ↓ 
























Abbreviations: Chow: rodent chow diet. HFD: high fat diet (% of calorie from fat). DIO: diet-induced obesity. ADF: alternate day fasting. ipGTT: 
intraperitoneal glucose tolerance test. ipITT: intraperitoneal insulin tolerance test. oGTT: oral glucose tolerance test. 
↑: increased versus HFD-AL; ↓: decreased versus HFD-AL; →: no significant change versus HFD-AL. 
   
 
  




















Effect of intermittent fasting 
Weight 
change 










ad libitum on feed day; 25% 
energy on fasting day 
↓3  (all groups) ↓3  FM and VAT 
( all groups) 
Unchanged  ↑3  LDL particle size;  
↓3  SBP only in ADF-SM 
(Varady et 









As above ↓2  ↓2  fat mass  Not measured ↑2 LDL particle size, 
plasma adiponection 










125% energy on feed day; 25% 
energy on fasting day;  
↓3  
 (all groups) 
Not measured Not measured ↑3 LDL particle size (all 









As above ↓3   
(all groups) 
Not measured Not measured ↑ adiponectin, ↓ leptin and 











No control; 3 days 
fasting/week 
25-30% energy on Mon, Wed, 
Sat); ad libitum on Friday; 1700-
1800 Kcal/d on the rest 3 days 
↓3   
 








No control group ad libitum on feed day; 25% 
energy on fasting day 
↓3   
 
Not measured Not measured ↑3  LDL particle size; 







No control group As above ↓3   ↓3  fat mass  Not measured ↑3  adiponectin, 
↓3  WC, LDL, TG, leptin 
and resistin 
(Varady et 












1. Control  
2. Fast for 20-hour  
Equal food intake in 2 groups None  Not measured Unchanged  ↓2 RMR 
(Halberg et 





No control group ad libitum on feed day; 20h fasting 
on fasting day 








No control group 200% energy on feed day; energy-
free food on fasting day 
↓3   
 
↓3  fat mass ↓3  fasting insulin, 
 
↑3 fat oxidation; 
↓3  RQ after  prolonged 
fasting  
Abbreviations : TC, total cholesterol;  LDL, low density lipoprotein; TG, triglyceride; CRP, C reactive protein; SBP, systolic blood pressure; DBP, 
diastolic blood pressure; RMR, resting metabolic rate; RQ, respiratory quotient;  FM, fat mass; VAT, visceral adipose tissue; WC, waist 
circumference. 
 






1ADF, alternate day fasting; HF, high fat diet (45% fat); LF, low fat diet (25%); ADF-L, meal at lunch time (12pm-2pm); ADF-D, meal at dinner 
time (6pm-8pm); ADF-SM, three small meals. 2P<0.05 versus control 3P<0.05 versus baseline
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1.3.2 Intermittent fasting in humans 
The limited data available examining IF in humans is summarised in Table 1.2. In 2005, 
Heilbronn et al. (Heilbronn et al., 2005b) showed that non-obese subjects that underwent a 24-
hour fast every other day for 22 days exhibited decreased body weight, as well as fat mass 
compared to baseline. In their study, a significant decrease in respiratory quotient was detected 
and both non-esterified fatty acids and blood ketones were elevated, suggesting increased fat 
oxidation. Meanwhile, they found that fasting insulin was also decreased compared with 
baseline, indicating improved insulin sensitivity in humans after IF (Heilbronn et al., 2005b). 
Very shortly after, Halberg et al. (Halberg et al., 2005) found that healthy men subjected to IF 
for 15 days had increased insulin-mediated glucose uptake rate, and increased lipolysis and 
plasma adiponectin, suggesting improved insulin sensitivity (Halberg et al., 2005). Unlike the 
fasting every other day protocol in Heilbronn’s study, participants in Halberg’s study were 
fasted for 20-hours on alternate days (started at 2200 and ended at 1800 the following day), 
thus individuals maintained their body weight (Halberg et al., 2005). Since then, several 
modified IF studies have been performed. Unlike the “true” IF conducted in most rodent 
studies, these experimental designs have allowed participants up to 25% of daily baseline 
energy intake on the fasting day. Modified IF resulted in significant weight loss in individuals 
with obesity and decreased TC, LDL, TG, leptin and resistin, and increased adiponectin 
(Varady et al., 2009, Bhutani et al., 2010). However, to our knowledge, there is no study 
examining insulin sensitivity with the gold standard method of hyperinsulinaemic-euglycaemic 
clamp. As long-term IF studies have not been performed, whether IF expands lifespan in 
humans is unknown. 
  
  Chapter 1 
19 
 
1.4 Studies comparing calorie restriction versus intermittent fasting 
To date, a number of mice studies have been performed comparing the effects of CR versus IF. 
In 1987, Ingram et al. (Ingram and Reynolds, 1987) examined mice undergoing CR or IF and 
found that IF produced greater increases in maximum lifespan (56% in IF and 36% in CR, 
respectively). Since then, several follow-up studies have further examined metabolic 
phenotypes in these two diet regimens. Anson et al. (Anson et al., 2003) randomised 9-week 
old mice to one of the following four groups: ad libitum (AL), CR (-40%), alternate day fasting 
(ADF) and ADF paired-fed (ADF-PF; daily food equal to the average daily intake of ADF). 
During the intervention, mice in ADF consumed a roughly equivalent amount of food in a 48-
hour cycle as AL mice, leading to a similar body weight compared to AL. Mice in CR had a 
49% smaller weight gain after 20 weeks intervention. Interestingly, both CR and ADF mice, 
but not ADF-PF displayed lower fasting glucose and insulin vs. AL, indicating that intermittent 
fasting, rather than restricted energy intake resulted in these beneficial effects. Varady et al. 
(Varady et al., 2007a, Varady et al., 2007b, Varady et al., 2008) compared CR vs. IF in mice 
and showed that CR and IF similarly reduced visceral fat mass, increased blood adiponectin, 
reduced the proliferation rates of T cells and prostate cells, and decreased blood IGF-1 levels. 
Of note, the “hunger hormone” ghrelin was only increased in mice following alternate day 
fasting. These studies, as well as modified IF mice studies are summarised in Table 1.3.  






Table 1-3: Animal studies comparing intermittent fasting vs. calorie restriction on metabolism1 




Effect of IF vs. IF 
Weight 
change 






Age 8 weeks 





↓3 in CR-25% ↑4 Subcutaneous fat  




Not measured ↑4 Adiponection, TG-glycerol synthesis 
and de novo lipogenesis 







Age 8 weeks 





↓3 in CR-25% Not measured Not measured ↓4 Cell proliferation in CR-25%, ADF-
85% and ADF-100%;  
↓4 IGF-1 in CR-25% and ADF-100% 
↑3 ghrelin  in ADF-100% 
(Varady et 




Age 8 weeks 
4 weeks  1. AL 
2. ADF-25% 
3. ADF-50% 
4. ADF-100%  
↓5 in ADF-
100% 




Not measured ↑3 Net lipolysis in ADF-100%  







Age 8 weeks 






Not measured Not measured ↓4 Proliferation rates of T-cells and 
prostate cells in ADF-50% and ADF-
100% 
↓3 IGF-1 in ADF-100% 












↓3 in CR-40% Not measured ↓6 glucose in CR and ADF 
↓7  insulin in CR and ADF 
↑4  IGF-1 in ADF and PF 
↓3 IGF-1in CR-40% 
↑3  β-HB in ADF 
↓3  β-HB in CR-40%  
1 DM, diabetes mellitus; FFA, free fatty acid; TG, triglyceride; IGF-1, insulin-like growth factor 1; β-HB, β-hydroxybutyrate. 
2 AL, ad libitum; ADF, alternate day fasting; CR-25%, 25% energy restriction; CR-40%, 40% energy restriction; ADF-25%,75% energy intake on 
fasting day; ADF-50%, 50% energy intake on fasting day; ADF-85%, 15% energy intake on fasting day; ADF-100%, no food intake on fasting 
day; PF, pair-fed mice (daily food allotment equal to IF);  
3 Post-intervention values of intervention groups significantly different from post-intervention values of control group, P<0.05. 
4 Post-intervention values of intervention groups significantly different from post-intervention values of control group, no difference between 
indicated intervention groups P<0.05. 
5 Post-intervention values of indicated group significantly different from post-intervention values of ADF-25% and ADF-50%,control group, no 
difference between indicated and control P<0.05. 
6Post-intervention values of intervention groups significantly different from post-intervention values of control group and PF, no significant 
difference between indicated intervention groups P<0.05. 






7 Post-intervention values of intervention groups significantly different from post-intervention values of control group, significant difference 
between ADF and IF groups P<0.05. 
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In humans, Harvie et al. compared an IF diet versus CR in two separate cohorts of women over 
3 or 6 months (Harvie et al., 2011, Harvie et al., 2013). The design of this diet was slightly 
different in that the 2 fasting days were prescribed consecutively, allowing 25% of energy 
requirements, followed by ad libitum consumption for 5 days per week. IF resulted in similar 
weight loss at 6-months vs. CR (Harvie et al., 2011). Of note, the IF group was assigned a meal 
replacement during the 2 days of severe energy restriction, whereas the CR group was 
prescribed a conventional food based diet. Meal replacements typically show better adherence 
and weight loss than conventional food based diets (Harvie et al., 2011). However, a 
subsequent 3-month study by this group implemented a food based program in both groups, 
and also reported similar weight loss following modified IF versus CR (6% vs 4%, P=0.1). A 
greater reduction in fat mass was observed in modified IF at 3 months, and this group continued 
to lose significantly more weight (-0.5kg) versus CR (-0.1kg) one month after cessation of the 
active weight loss phase. A slightly greater reduction in fasting insulin in the intermittent diet 
at 3 and 6 months was also observed (Harvie et al., 2011, Harvie et al., 2013).  
 
Two clinical trials comparing the effects of IF versus CR have been recently published since 
we conducted the human study. They are summarised in Table 1.4 and will be discussed in 
Chapter 3.  
 
It should be noted that none of these studies examined the metabolic adaptations on both fed 
and fasted days (Harvie et al., 2011, Harvie et al., 2013, Trepanowski et al., 2017, Catenacci et 
al., 2016). It is not clear whether energy restriction is necessary for intermittent fasting to have 
beneficial effects on health in humans.






Table 1-4: Human studies comparing intermittent fasting vs. calorie restriction 
Reference Participants  
(N, age, BMI) 
Study 
duration  
Group  Fasting protocol   Effects of IF vs. CR 
Adiposity  Diabetes risk CVD risk  Inflammation  
(Trepanowski 














Alternate day fasting; 
25% of energy requirement provided on fast 
day; 
125% of energy requirement on fast day; 




Glu, Ins and HOMA-
IR: ns 
HDL: ↑  
TG, LDL and 
TG: ns 
CRP: ns  
12-month 













Alternate day fasting; 
Zero food on fast day; 
Energy not prescribed on fed days 
8-weeks    
WL: ns 
FML: ns 
Glu and Ins: ns  TC, HDL, LDL 
and TG: ns 
not assessed  
32-week 
ns ns ns not assessed  















2 consecutive fasting days/week, 30% of 
energy requirement provided on fast day. 
Weekly energy matched with CR (-25%) 
 






Ins and HOMA-IR: ↑ 
not assessed not assessed  
4-month 
ns ns not assessed not assessed  
(Harvie et al., 
2011) 
107 women 
30-45 yrs  
24-40 kg/m2 
6-month IF CR 
IF 
2 consecutive fasting days per week 
 
25% food on fast day 
WL: ns 
FML: ns 
Glu: ns  
Ins and HOMA-IR: ↓  
TC, HDL, LDL 
and TG: ns 
CRP: ns  
Abbreviations: BMI: body mass index. CR: daily calorie restriction. IF: intermittent fasting. WL: weight loss. FML: fat mass loss. Glu: fasting 
glucose. Ins: fasting insulin. HOMA-IR: homeostatic model assessment of insulin resistance. CVD: cardiovascular diseases. TC: total cholesterol. 
LDL: low-density lipoprotein. HDL: high-density lipoprotein. TG: triglycerides. CRP: C-reactive protein. 
 
ns: no difference in the change between IF versus CR. ↑: greater increases in IF vs. CR. ↓greater reductions in IF vs. CR.  
 
  Chapter 1 
24 
 
1.5 Adipose tissue remodelling in obesity, calorie restriction and 
intermittent fasting. 
Adipose tissue is the main site of nutrient storage in the body and accounts for most of the 
weight gained during obesity. It consists of both cellular and non-cellular components. 
Adipocytes are the main cell type in adipose tissue to store energy in the form of lipid. Immune 
cells including macrophages, T cells and neutrophils infiltrate into adipose tissue, playing 
important roles in the regulation of adipocyte function and systemic metabolism. Additionally, 
extracellular matrix (ECM), which is a non-cellular structure provides mechanical and 
nutritional support to neighbouring cells.   
 
Adipose tissue displays great plasticity with a series of events occurring in response to nutrient 
availability, namely adipose tissue remodelling (Sun et al., 2011).  During chronic over-
nutrition, fat pads expand to store excess energy. This process is achieved through the 
enlargement of adipocyte size (hypertrophy) and/or new adipocyte generation (hyperplasia) 
(Martinez-Santibanez and Lumeng, 2014). Monocytes are rapidly recruited into adipose tissue 
and are polarised to classically activated M1-macrophages, which release pro-inflammatory 
molecules (e.g. TNFα, IL-6 and MCP1) contributing to the development of insulin resistance 
(Fujisaka et al., 2013, Lumeng et al., 2007a, Aron-Wisnewsky et al., 2009). Owing to the 
nutrient excess, the synthesis of ECM exceeds its degradation, leading to extra ECM deposition 
in adipose tissue (Martinez-Santibanez and Lumeng, 2014). This consequently restricts the 
expansion of adipocytes, causing lipid deposition in non-storage tissues such as liver and 
muscle, which in turn impairs insulin sensitivity (Khan et al., 2009, O'Hara et al., 2009, Li et 
al., 2010). Moreover, ECM may be also involved in the recruitment of macrophages into 
adipose tissue through ECM-macrophage crosstalk (Martinez-Santibanez and Lumeng, 2014). 
To catch up with the adipose tissue expansion, new blood vessels are generated to provide 
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nutritional support (Martinez-Santibanez and Lumeng, 2014). However, some evidence 
suggests this does not fully compensate the demand from adipose tissue leading to hypoxia and 
the activation of inflammatory cascades (Ye et al., 2007). The association between adipose 
tissue macrophages, extracellular matrix and insulin sensitivity will be reviewed in Chapter 2. 
 
Some studies have also examined the acute effects of weight gain by overfeeding on adipose 
tissue remodelling in humans. Current evidence pointed out that the weight gained by 4-8 
weeks of overfeeding led to impaired insulin sensitivity and increased ECM synthesis in 
adipose tissue, without altering macrophage accumulation in adipose tissue (Tam et al., 2010, 
Tam et al., 2014). However, it is not clear whether ECM remodelling in adipose tissue is an 
early contributor to, or a consequence of, insulin resistance in obesity. 
 
The effects of CR on adipose tissue have been extensively studied in both animals and humans. 
Moderate CR decreases fat mass as well as fat cell size in both mice and humans (Varady et 
al., 2007b, Larson-Meyer et al., 2006). However, it appears that the decrease in fat mass is 
mainly contributed by the decreased fat cell size, as some evidence suggests that fat cell number 
remains constant following marked weight loss (Spalding et al., 2008). The adaptation of 
macrophages in response to CR is dependent on its length and severity. For example, mice in 
the early stage of CR displayed increased macrophage accumulation in adipose tissue (Kosteli 
et al., 2010). This phenomenon was also observed in humans on a very low calorie diet (Capel 
et al., 2009). Following marked weight loss, macrophages in adipose tissue were significantly 
reduced (Magkos et al., 2016, Zamarron et al., 2017). Interestingly, some studies have 
suggested that this is accompanied by a phenotype switch from inflammatory M1- to anti-
inflammatory M2- profiles (Fabbiano et al., 2016). The responses in ECM are also somewhat 
controversial. A number of mouse and human studies have demonstrated that CR reduced the 
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mRNA levels of collagens and increased the mRNA of matrix metalloproteinase (MMPs) 
which degrade ECM (Zamarron et al., 2017, Magkos et al., 2016), however, most of these 
studies are limited to the measurement of gene expression. A clinical trial quantifying collagen 
content in subcutaneous adipose in participants following bariatric surgery showed that 
collagen deposition was actually increased after marked weight loss (Liu et al., 2016). 
 
The impacts of IF on adipose tissue remodelling are less investigated and mainly limited to 
mice studies. Varady et al reported that 4-weeks of IF decreased visceral fat mass as well as 
fat cell size, and this change was also observed in a modified IF approach (Varady et al., 2007b, 
Varady et al., 2010).  The effects of IF on adipose tissue inflammation is unclear. However, 
some studies showed that an acute 24-hour fast increased macrophage accumulation in adipose 
tissue in mice (Kosteli et al., 2010, Asterholm et al., 2012, Ding et al., 2016). This increase 
coincided with elevated NEFA levels and was proposed to buffer the lipids released from 
adipocytes(Kosteli et al., 2010). How IF affects ECM remodelling in adipose tissue is unclear. 
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1.6 Skeletal muscle remodelling in obesity, calorie restriction and 
intermittent fasting 
Skeletal muscle contains thousands of muscle fibres which are bundled together and 
surrounded by a layer of extracellular matrix (Tabebordbar et al., 2013). Immune cells, 
including macrophages and T cells reside in muscle fibres, secrete a number of cytokines which 
are associated with muscular contraction, repair and regeneration (Pillon et al., 2013). Recently, 
it has been suggested that skeletal muscle undergoes remodelling in obesity and in response to 
dietary interventions (Wu and Ballantyne, 2017, Martinez-Huenchullan et al., 2017).  
 
In mice, significant increases in macrophage and inflammation-associated markers, including 
Emr1, Cd11c, Tnfα and Ccl2 were detected in skeletal muscle after 1-week of high-fat diet 
feeding, and remained higher at 10-weeks, along with impaired glucose tolerance (Fink et al., 
2014). Of note, a follow up study confirmed this finding and pointed out that increased 
macrophages are predominantly located in extramyocellular adipose tissue, which is closely 
linked with insulin sensitivity (Khan et al., 2015).  
 
Obesity also affects muscle extracellular matrix remodelling through regulating its synthesis 
and degradation. Compared with lean mice, diet-induced obese mice displayed higher levels of 
collagen genes including Col1a1, Col1a2, Col3a1, Col6a1 and integrin which are key 
components of extracellular matrix (Kang et al., 2011, Inoue et al., 2013). Some evidence 
suggests obesity alters the expression and activity of MMPs, which belong to a zinc 
endopeptidase enzymatic superfamily and function to degrade extracellular matrix. Biga et al 
suggested that C57BL/6J mice fed a high fat diet (60%) for 6 weeks displayed increased mRNA 
levels and activity of MMP2 and MMP9 (Biga et al., 2013). In contrast, Kang et al 
demonstrated that 14-20 weeks of high fat diet feeding decreased MMP9 activity without 
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altering MMP2 (Kang et al., 2011). Discrepancy of these studies could be due to the diet or 
length of high fat diet feeding. But overall, these data suggest that obesity may cause a net 
increase in extracellular matrix deposition in skeletal muscle as revealed by histology (Kang et 
al., 2011). 
 
How obesity affects human muscle remodelling is less known and remains controversial. Some 
evidence suggests that macrophage accumulation in muscle is positively linked with obesity 
and insulin resistance (Patsouris et al., 2014, Varma et al., 2009, Fink et al., 2014). However, 
there are a growing number of studies showing that muscle macrophages are not associated 
with obesity and insulin sensitivity (Amouzou et al., 2016, Tam et al., 2012b), or are negatively 
correlated with obesity and insulin resistance (Fink et al., 2013, Liu et al., 2017a). Limited 
evidence suggests individuals with obesity display increased extracellular matrix deposition in 
skeletal muscle (Martinez-Huenchullan et al., 2017, Berria et al., 2006). 
 
Evidence that examined the impacts of CR on muscle remodelling is even scarcer. Kayo et al 
reported that 9-year CR in male rhesus monkeys down-regulated a number of genes in 
inflammatory responses including human leukocyte antigen DM, octamer transcription factor 
2 and iNOS in muscle (Kayo et al., 2001). Surprisingly, genes involved in ECM synthesis were 
up-regulated, such as COL1A1, COL1A2, COL3A1, COL6A3 and COL8A1 (Kayo et al., 2001).  
Yang et al assessed skeletal muscle adaptations in a group of lean adults (BMI 19.2±1.1kg/m2) 
from the Calorie Restriction Society who maintained a CR diet for 3-15 years (Yang et al., 
2016). They found that a CR diet significantly decreased a number of factors in inflammation 
pathways in muscle, including nuclear factor kappa B subunit 1 (NF-κB), TNFα, IL-6, IL-8, 
and iNOS compared to age-matched control adults (BMI 25.3±2.3kg/m2). However, the impact 
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of long-term CR on muscle extracellular matrix remodelling was not examined in this study. 
The impacts of IF on muscle remodelling is unknown. 
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1.7 Research questions 
The general aims of this thesis are to answer the following questions: 
1. Is energy restriction necessary for intermittent fasting to have beneficial effects on 
health in humans? 
2. Does intermittent fasting increase adipose tissue and skeletal muscle inflammation in 
mice and humans? 
3. Does intermittent fasting improve metabolic heath in chow and high fat diet fed mice? 
4. Does intermittent fasting reduce adipose tissue fibrosis in mice and humans? 
5. Does white adipose tissue browning contribute to improved health by intermittent 
fasting in mice and humans? 
6. Does short-term over-nutrition trigger adipose tissue and skeletal muscle remodelling 
in humans? 
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1.8 Specific Aims and hypotheses 
Study 1: Effects of intermittent versus continuous energy intakes on insulin sensitivity 
and metabolic risk in women who are overweight or obese 
Aims:    
1. To compare intermittent fasting versus continuous energy intakes at 100% or 70% of 
calculated energy requirements on peripheral insulin sensitivity, weight and body 
composition, and cardio-metabolic outcomes. 
2. To explore acute metabolic changes that occur when switching between a fed (i.e. after 
a 12-h overnight fast) and fasted (24-h fast) state. 
Hypotheses:  
1. Intermittent fasting without energy restriction will improve markers of metabolic 
health.  
2. Intermittent fasting with energy restriction may be more effective than daily calorie 
restriction to improve insulin sensitivity, promote weight and fat loss and reduce 
cardiovascular risk. 
3. The “metabolic switching” between the fed and fasted states that is characteristic of IF 
may underlie the observed health benefits of intermittent fasting. 
 
Study 2: Adipose tissue and skeletal muscle remodelling following eight-weeks of 
intermittent fasting or daily calorie restriction in women who are overweight or obese 
Aim: 
To compare the effects of intermittent fasting versus calorie restriction on adipose tissue 
and skeletal muscle remodelling. 
Hypothesis:  
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Intermittent fasting and calorie restriction may reduce fibrosis, but intermittent fasting 
may increase inflammation in adipose tissue and skeletal muscle. 
 
Study 3:  Does intermittent fasting improve metabolic health in chow and high fat diet 
fed mice?  
Aims:  
1. To examine the effects of intermittent fasting on body weight and glucose tolerance. 
2. To assess the effects of intermittent fasting on adipose tissue inflammation and fibrosis.  
Hypotheses:  
1. IF will improve glucose tolerance in chow fed mice without weight loss. 
2. IF will improve glucose tolerance and promote weight loss in high fat diet fed mice. 
3. IF will reduce adipose tissue fibrosis, but may increase adipose tissue inflammation.  
 
Study 4:  Does intermittent fasting promote white adipose tissue browning in mice and 
humans? 
Aims:  
1. To examine the effects of intermittent fasting on food intake and energy expenditure in 
chow and high fat diet fed mice.  
2. To assess markers of white adipose tissue browning in mice and humans undergoing 
intermittent fasting. 
Hypothesis:  
Intermittent fasting will increase energy expenditure and promote white adipose tissue 
browning in mice, and will promote white adipose tissue browning in humans. 
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Study 5: Adipose tissue and skeletal muscle remodelling in response to acute overfeeding 
in young adults. 
Aim: 
To examine adipose tissue and skeletal muscle remodelling in response to 3 days of 
overfeeding in young adults.  
Hypothesis:  
Markers involved in adipose tissue and skeletal muscle remodelling will be sensitive to 
3 days of overfeeding, and associated with markers of insulin resistance.  
 







Chapter 2:  Literature Review 
  
  Chapter 2 
35 
 
Do Adipose Tissue Macrophages Promote Insulin Resistance or 
Adipose Tissue Remodelling in Humans? 
 
 
Leonie K. Heilbronn 1,2,3 and Bo Liu 1,2 
 
1Discipline of Medicine, The University of Adelaide, Adelaide SA 
2Obesity and Metabolism Laboratory, SAHMRI; South Australian Health and Medical 
Research Institute, Adelaide, SA 
3Robinson Research Institute, School of Paediatrics and Reproductive Health, Adelaide, SA 
 
Address Correspondence to: 
A/Prof Leonie Heilbronn, SAHMRI, Level 7, North Terrace, Adelaide, SA, 5000, 
AUSTRALIA 
Email: leonie.heilbronn@adelaide.edu.au 













In diet induced and genetically obese rodent models, adipose tissue is associated with 
macrophage infiltration, which promotes a low grade inflammatory state and the development 
of insulin resistance. In humans, obesity is also closely linked with macrophage infiltration in 
adipose tissue, a pro-inflammatory phenotype and insulin resistance. However, whether 
macrophage infiltration is a direct contributor to the development of insulin resistance that 
occurs in response to weight gain, or is a later consequence of the obese state is unclear. There 
are a number of concomitant changes that occur during adipose tissue expansion, including the 
number and size of adipocytes, the vasculature and the extracellular matrix. In this review, we 
will examine evidence for and against the role of macrophage recruitment into adipose tissue 
in promoting the development of insulin resistance in rodents and humans, as well as discuss 
the emerging role of macrophages in mediating healthy adipose tissue expansion during periods 
of caloric excess. 
 
Key words: adipose tissue remodelling; inflammation; insulin resistance; macrophages; 
obesity 
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2.2 Obesity is a low grade inflammatory state 
The prevalence and severity of obesity is increasing rapidly in the majority of countries 
worldwide, and is highly associated with insulin resistance and an increased risk of developing 
type 2 diabetes, cardiovascular disease, and cancer. However, the precise mechanisms linking 
adipose tissue expansion and insulin resistance are unclear. Adipose tissue was originally 
considered an inert organ, whose sole function was the storage of lipid for energy. 
Metabolically, this is important and insufficient adipose storage has been linked to lipid storage 
in ectopic sites and insulin resistance (Heilbronn et al., 2004a). However, adipose tissue is now 
recognised to be an active endocrine organ that secretes numerous “adipokines”, which have 
remote actions in tissues including brain, skeletal muscle and liver, as well as paracrine and 
autocrine actions. Many of the cytokines that are secreted from adipose tissue are pro-
inflammatory, and obesity was first described as a low-grade inflammatory condition more 
than two decades ago. In this study, Hotamisligil et al. (Hotamisligil et al., 1993) showed that 
diet-induced obese rodents displayed elevations in circulating and adipose tissue levels of 
tumour necrosis factor alpha (TNFα). Since this seminal work, human and rodent obesity has 
been linked with altered secretion of many other inflammatory adipokines, including 
interleukin-6 (IL-6), plasminogen activated inhibitor (PAI-1), serum amyloid A (SAA), 
migration inhibitory factor (MIF), resistin, inducible nitric oxide synthase (iNOS), colony 
stimulating factor-1 (CSF1) and monocyte chemoattractant protein-1 (MCP-1).  
 
Diet and lifestyle interventions that result in weight loss and improvements in insulin sensitivity 
reduce the circulating and local expression of pro-inflammatory cytokines (Ryan and Nicklas, 
2004), which have been shown to directly inhibit the insulin signalling cascade (Krogh-Madsen 
et al., 2006, Lumeng et al., 2007c) via inhibitor kB Kinases (IKK), JUN N-terminal Kinase 
(JNK) and inhibitory serine phosphorylation of insulin receptor substrate-1 (IRS-1). In humans, 
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TNF infusion also reduced insulin-stimulated glucose uptake (Krogh-Madsen et al., 2006), 
whilst chronic exposure to IL-6 increased hepatic and peripheral insulin resistance in mouse 
(Klover et al., 2003) and mice lacking TNFα are protected from obesity-induced insulin 
resistance (Uysal et al., 1997).  
 
2.3 Adipose tissue macrophage infiltration and polarisation in obesity 
Adipose tissue obtained from obese humans and rodents is infiltrated by an increased number 
of macrophages (Weisberg et al., 2003, Xu et al., 2003). This was first shown by two groups 
in 2003 (Weisberg et al., 2003, Xu et al., 2003), where it was identified that the stromal vascular 
fraction was responsible for the majority of the pro-inflammatory phenotype that is observed 
in obesity. Their work suggested that this increase in macrophage number was limited to 
adipose tissue, although other studies have since described increases in inflammatory cells in 
other tissues (Stanton et al., 2011, Fink et al., 2014). Macrophages are mononuclear phagocytes 
involved in immunological and inflammatory processes, whose function is to provide an 
immediate defence against foreign organisms and to clear resultant cellular debris (Fain et al., 
2004, Maury et al., 2007). Macrophages can form crown-like structures (CLS) that completely 
surrounding necrotic adipocytes and fuse to form lipid containing giant multi-nucleated cells, 
that stain strongly for MAC2 (Cinti et al., 2005). Other immune cells are also present in adipose 
tissue, including neutrophils, mast cells, B-cells, T-cells and increased in obese animal and 
human models, although few T-cells were detected in subcutaneous adipose tissue collected 
from overweight and moderately obese individuals in our hands (Tam et al., 2010).  
 
Whilst, the total number of adipose tissue macrophages correlates strongly with the degree of 
obesity and insulin resistance (Cancello et al., 2005), it has been reported that there is also a 
change in the type of macrophage (Morris et al., 2011). “M1” macrophages are pro-
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inflammatory and release factors such as TNF, IL6, iNOS, CD40, CD11c and MCP1, whereas 
“M2” macrophages express an anti-inflammatory gene profile that is characterised by higher 
expression of TGFβ, Ym1, arginase 1, CD206 and Il10. Diet induced obese mice have increased 
expression of genes that are characteristic of M1 or "classically activated" macrophages 
(Fujisaka et al., 2013, Lumeng et al., 2007a). Increased M1 macrophages have also been 
detected in subcutaneous adipose tissue from morbidly obese vs. lean individuals (Aron-
Wisnewsky et al., 2009). Further, surgery-induced weight loss altered the M1/M2 ratio due to 
a concomitant decrease in M1 and increase in M2 macrophages, which was correlated with the 
change in insulin sensitivity (Aron-Wisnewsky et al., 2009). However, there is poor expression 
of many of these markers in humans, and some have shown that obesity is associated with 
increased M2, as well as M1 macrophages (Bourlier et al., 2008, Fjeldborg et al., 2014, Xu et 
al., 2013). This controversy highlights that simple classification into “M1” and “M2” 
macrophages is not entirely appropriate since macrophage phenotype spans a continuum in 
vivo. Recently, Kratz et al. (Kratz et al., 2014) reported that cell surface markers CD274, CD38 
and CD319 were classical M1 markers, since they were activated by lipopolysaccharide (LPS) 
and elevated in airway macrophages collected from patients with cystic fibrosis. In their hands, 
these cell surface markers were not elevated in subcutaneous or visceral adipose tissue 
collected from obese patients or rodents, even though these tissues displayed a pro-
inflammatory phenotype. Kratz et al. (Kratz et al., 2014) went on to show that treatment of 
macrophages in vitro with metabolic activators such as glucose, insulin, palmitate and visceral 
adipose tissue conditioned media, increased cell surface expression of markers ABCA1, CD36 
and PLIN2, but did not elevate CD274 and CD38 or M2-markers CD206 and TGF1b. This was 
mirrored in the subcutaneous and intraperitoneal adipose tissue depots obtained from obese 
mice and from obese humans. This study suggested that a distinct subset of macrophages may 
exist in adipose tissue, termed “metabolically activated macrophages, (MME)
”. Whether this 
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holds true in less obese populations, and if MME macrophages are differentially altered in 
response to weight loss or gain is currently unknown. 
 
What causes macrophage infiltration of adipose tissue? 
Numerous theories have been proposed that may explain macrophage recruitment into adipose 
tissue in the obese state, including increased adipose cell size and necrosis, local hypoxia and 
nutritional endotoxemia.  
 
Adipocyte size and necrosis 
Adipose tissue can expand through adipocyte hyperplasia or hypertrophy (Heilbronn et al., 
2004a). Adipocyte size is clearly increased in obesity, and displays a strong independent 
association with insulin resistance and progression to type 2 diabetes (Weyer et al., 2000, 
Dubois et al., 2006). Adipocyte hypertrophy is also a strong predictor of the number of 
macrophages in adipose tissue (Weisberg et al., 2003, Tchoukalova et al., 2007). Interestingly, 
adiponectin overexpressing transgenic ob/ob mice have increased fat mass, but reduced 
adipocyte size and are protected from macrophage infiltration and inflammation in adipose 
tissue, and have a healthy metabolic phenotype despite massive obesity (Kim et al., 2007).  The 
mechanisms underlying the potential relationship between adipocyte size and macrophage 
infiltration may be multifactorial. Larger adipocytes display an altered secretion of 
chemoattractant and immune-related genes that may promote macrophage infiltration (Jernas 
et al., 2006). Large adipocytes also have increased lipolysis (Laurencikiene et al., 2011, 
Michaud et al., 2014), which may stimulate macrophage infiltration as has been shown to occur 
in response to prolonged fasting, as well as pharmacologically (Kosteli et al., 2010). Finally, 
the rate of adipocyte death is also elevated in obesity (Cinti et al., 2005, Giordano et al., 2013). 
Immunohistochemistry shows that the CLS surround necrotic adipocytes and the phagocytic 
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ingestion of these adipocytes increases the lipid content of CLS, which protects against lipid 
leak (Altintas et al., 2011, Wu et al., 2011). This beneficial action of the macrophage may limit 
the continuation of the inflammatory response.   
 
Local adipocyte hypoxia  
Hypoxia occurs when oxygen availability does not match demand by the surrounding tissue. 
In rodent models of obesity, increased adipose tissue hypoxia is observed alongside increased 
expression of hypoxia-inducible factor-alpha (HIF1) and TNF (Ye et al., 2007). The 
hypoxic area in adipose tissue of obese animals coincides with macrophage infiltration (Rausch 
et al., 2008) and also induces M1 polarity of macrophages (Fujisaka et al., 2013). Adipocyte-
specific HIF1α knockout results in improved glucose tolerance, decreased macrophage 
infiltration, and reduced MCP-1 and TNFα expression in adipose tissue versus wild type 
(Kihira et al., 2014). Suppression of HIF1α by administration of antisense oligonucleotides 
results in weight loss, increased energy expenditure and decreased fasting blood glucose in 
diet-induced obese mice (Shin et al., 2012), although this study did not examine whether 
infiltration of macrophages and adipose tissue inflammation was altered. Together, these data 
suggest that hypoxia promotes macrophage infiltration into adipose tissue, and that HIF1α may 
mediate this, at least in part. However, whilst adipose tissue hypoxia is established in obese 
mouse models (Hosogai et al., 2007, Ye et al., 2007, Rausch et al., 2008), there is conflicting 
evidence as to whether adipose tissue hypoxia is a feature of human obesity (Pasarica et al., 
2009b, Goossens and Blaak, 2012). Pasarica et al (Pasarica et al., 2009b) showed that the partial 
pressure of oxygen was lower in adipose tissue from obese individuals versus lean individuals, 
and that this was in parallel with increased macrophage markers in adipose tissue and insulin 
resistance. However, Goosens et al. (Goossens and Blaak, 2012) noted that while there was 
low oxygen in adipose tissue, the metabolic demands of adipose tissue from obese individuals 
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was reduced and detected no net hypoxia in these individuals. The reason for this potential 
species difference is not clear, and more work is required to test whether adipose tissue in 
humans is hypoxic and whether localised hypoxia is a mechanism through which macrophages 
are recruited to adipose tissue.  
 
Nutritional endotoxaemia 
LPS activates and drives the M1 phenotype of macrophages via Toll-like receptor -4 (TLR4) 
and NF-κB, leading to transcription of pro-inflammatory cytokines (eg TNFα, IL-6, MCP-1) 
(Hoch et al., 2008, Leuwer et al., 2009). Numerous studies have examined the consequences 
of TLR4 deficiency, and with mixed results. Some studies have observed reductions in 
circulating inflammatory cytokines and macrophage infiltration of adipose tissue and improved 
insulin sensitivity (Shi et al., 2006, Suganami et al., 2007, Saberi et al., 2009), but this is not 
observed universally (Orr et al., 2012). Kratz et al. (Kratz et al., 2014) also recently showed 
that activation of “MME” macrophages was independent of TLR4. Thus, the role of TLR4 in 
mediating this relationship is still under debate. What is clear is that mice that are fed a high 
fat diet have higher LPS (Cani et al., 2007). This may be due to changes in gut microbiota, and 
increasing intestinal permeability by modulating the expression of genes coding for tight 
junction proteins (Cani et al., 2007, Cani et al., 2008, Lam et al., 2012). Interestingly, transfer 
of gut microbiota of obesity prone-rats increased adipose tissue macrophages, T-cell 
infiltration, TNFα, PAI1 and IL-6 versus transfer of gut microbiota from obesity-resistant rats 
(Duca et al., 2014). Treatment with antibiotics also reduced gut microbiota and activation of 
TLR4, and this was associated with reduced adipose tissue inflammation, as assessed by the 
numbers of CLS and F4/80+ macrophages (Cani et al., 2008, Carvalho et al., 2012). 
Interestingly, the mean size of adipocyte in antibiotic group was also reduced, suggesting there 
may be a role for gut in promoting adipose tissue remodelling (Cani et al., 2008). The 
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mechanisms underlying relationships between specific types of bacteria in the gut, obesity and 
inflammation is still in its infancy and little evidence is currently available in humans. 
Nonetheless, gut permeability may mediate some of the inflammatory response via TLR4 in 
intraperitoneal adipose tissue. 
 
Local proliferation 
Quite recent data suggests that tissue resident macrophages may also be capable of local 
proliferation (Jenkins et al., 2011, Hashimoto et al., 2013), and that the proliferating 
macrophages were M2-polarised (Bourlier et al., 2008). Haase et al (Haase et al., 2014) 
observed that the ki67+ positive proliferating macrophages were associated with CLS in human 
subcutaneous and visceral adipose tissue, although the absolute numbers were very low. 
Further work is required to understand whether local proliferation of macrophages contributes 
significantly to the total macrophage pool, and if this is altered in the obese state. 
 
2.4 Are adipose tissue macrophages responsible for obesity-induced 
insulin resistance?        
Genetic mouse models 
Many genetic approaches to reduce macrophage infiltration of adipose tissue prevent the 
deleterious consequences of obesity. For example, RIP140 mice that have been engineered to 
have a reduction in the circulating monocyte populations have an altered ATM profile in white 
adipose tissue, with a dramatic reduction in inflammatory M1 and an expansion 
in M2 macrophages, which was associated with improved insulin sensitivity (Liu et al., 2014). 
Whole body CCL2 knockouts similarly had reduced inflammation, decreased macrophage 
infiltration in adipose tissue and improved insulin sensitivity when exposed to high fat diet 
(Lumeng et al., 2007b) and transgenic adipose tissue specific overexpressing CCL2 mice 
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display increased macrophage infiltration and insulin resistance (Kamei et al., 2006). This 
suggests that reducing the inflammatory response improves insulin sensitivity in obese mice. 
However, this is not universally observed (Inouye et al., 2007) and studies examining knockout 
of C-C motif chemokine receptor-2 (CCR2, the receptor for CCL2) have also produced mixed 
outcomes in terms of protection from diet induced insulin resistance (Weisberg et al., 2006, 
Lumeng et al., 2007a, Gutierrez et al., 2011). On the other hand, ablation of CD11c+ cells 
increased insulin sensitivity in diet induced obese mice (Patsouris et al., 2008) and macrophage 
specific JNK1/2 knockouts were protected from macrophage infiltration of adipose tissue, and 
insulin resistance (Han et al., 2013). In summary, many studies using genetic manipulation to 
reduce macrophage infiltration of adipose tissue show an insulin sensitive phenotype. 
However, this is not universally observed. The reason for these discrepancies may be in the 
type of high fat diet imposed, the length of the overfeeding protocols and the genetic 
background of the mice under investigation.  
 
Diet and Lifestyle Interventions 
Substantial weight loss induced by bariatric surgery is insulin sensitising and significantly 
reduces the total number of macrophages in adipose tissue and induces a switch in macrophage 
polarisation towards an M2 phenotype, with increased staining for the anti-inflammatory 
cytokine IL10 and reduced expression of MCP1 and HIF1 (Cancello et al., 2005). Weight 
loss following a diet and lifestyle intervention also reduced adipose tissue expression of CD14, 
CD68, IL-6, IL-8, and TNF (Bruun et al., 2006). Both of these studies examined very large 
changes in adiposity in morbidly obese individuals, who have a range of co-morbidities. 
However, studies in less overweight individuals have shown similar results (Auerbach et al., 
2013). Exercise also significantly reduced circulating levels of LPS and TLR4 activation, 
lowered M1 macrophage infiltration, and improved insulin sensitivity in mice fed a high fat 
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diet (Kawanishi et al., 2013, Oliveira et al., 2013). The temporal response to caloric restriction 
in diet induced obese mice was recently examined (Kosteli et al., 2010). In this study, 
macrophage infiltration increased initially in response to caloric restriction, with the peak in 
adipose tissue macrophage numbers coinciding with the peak of circulating free fatty acids and 
adipose tissue lipolysis. Later time-points were associated with reduced macrophage 
infiltration. In humans, no change was observed in adipose tissue macrophage numbers after 4 
weeks of very low calorie diet in moderately obese females, whereas macrophages were 
significantly reduced following moderate calorie restriction and weight loss over the 
subsequent 4 months (Kovacikova et al., 2011). These data suggest that lifestyle interventions 
will reduce the inflammation and macrophage infiltration in adipose tissue in obese, but that 
this may not occur rapidly in response to caloric restriction.  
 
Therapeutic Interventions 
Treatment with thiazolidinediones, an agonist of PPARγ, reduced macrophage number in 
adipose tissue, in parallel with improved insulin sensitivity by triggering apoptosis of M1 
macrophages and increasing M2 macrophages (Bodles et al., 2006, Spencer et al., 2014). 
Administration of a recombinant adenovirus Glucagon-like peptide-1 (GLP-1) to diabetic 
ob/ob mice reduced fat mass, adipocyte size, M1 macrophages, and production of inflammatory 
cytokines (Lee et al., 2012).  Dipeptidyl peptidase-4 inhibitor, which acts by inhibiting the 
degradation of GLP-1 or glucose-dependent insulinotropic polypeptide also reduced total 
macrophage numbers and M1 macrophage staining in adipose tissue as well reduced mRNA 
expression of inflammatory cytokines, IL-6, TNFα (Kim et al., 2005, Dobrian et al., 2011, 
Shirakawa et al., 2011). Angiotensin type 1 receptor (AT1R) blocker, a classical anti-
hypertensive, decreased macrophage infiltration in adipose tissue of high fat diet-induced obese 
mice (Cole et al., 2010) and a similar response was observed in a randomised clinical trial in 
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humans (Goossens et al., 2012). Together, this data suggests that medications that target 
glucose regulation by either increasing insulin secretion and/or insulin sensitivity also reduce 
macrophage infiltration and inflammation in adipose tissue. 
 
Experimental Overfeeding  
There is conflicting evidence as to whether macrophage infiltration occurs early during weight 
gain, and thus could be responsible for the insulin resistant phenotype. A rapid induction of 
inflammatory gene expression was observed in adipose tissue in response to high fat diet (Chen 
et al., 2005, Brake et al., 2006), with significant increases in circulating levels of plasma MCP1 
detected after 4-weeks (Chen et al., 2005). However, Xu et al. (Xu et al., 2003) quantified 
macrophage numbers by histology and could only detect a significant increase in macrophage 
infiltration after 8 weeks of high fat diet. This preceded the rise in plasma insulin in their study, 
indicating that macrophage infiltration occurred prior to development of insulin resistance. One 
elegant study examined the temporal response to high fat diet, and observed that adipocyte 
hypertrophy and hypoxia preceded adipocyte necrosis and macrophage infiltration, which were 
elevated at 8 and 16 weeks (Strissel et al., 2007). In this study, the increase in macrophage 
infiltration coincided with impaired responsiveness to insulin tolerance test. However, gold 
standard measures of insulin sensitivity, the hyperinsulinemic clamp were not performed. 
Temporal investigation of diet induced insulin resistance shows that whole-body insulin 
resistance, as measured by hyperinsulinaemic-euglycaemic clamp, is detected after 1 week but 
that this is due to impaired hepatic insulin sensitivity. Adipose tissue is insulin resistant after 
1 week, while skeletal muscle displays insulin resistance by 3 weeks of high fat exposure 
(Turner et al., 2013).  
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Experimental overfeeding studies in humans show a much slower rate of weight gain, typically 
less than 2% per week (Bouchard et al., 1990). This is likely a very different stimulus to the 4-
5% weight gain that occurs when susceptible mice are exposed to overfeeding diets (Strissel et 
al., 2007). In our hands, overfeeding for 28 days resulted in less than 5% weight gain, with 
significant increases in total and abdominal fat mass and liver fat deposition (Samocha-Bonet 
et al., 2010). In parallel, increases were observed in fasting insulin and reductions were 
observed in peripheral insulin sensitivity by hyperinsulinaemic clamp. Importantly, this study 
showed that peripheral insulin resistance occurred, without significant changes in macrophage 
infiltration of subcutaneous adipose tissue as demonstrated using flow cytometry, 
immunohistochemistry and gene expression (Tam et al., 2010). Similarly, few changes were 
detected in circulating markers of inflammation, with the exception of the predominately liver 
derived cytokines CRP and Fetuin-A (Samocha-Bonet et al., 2014). We also observed no 
changes in adipocyte cell size, but it should be noted this was biopsied from subcutaneous 
abdominal adipose tissue. Similar results have since been reported following modest weight 
gains in other experimental overfeeding studies in humans that also induced insulin resistance 
(Alligier et al., 2012, Johannsen et al., 2014). This data suggest that low-grade systemic and 
subcutaneous adipose tissue inflammation, macrophage infiltration and immune activation 
likely occurs secondary to weight gain and peripheral insulin resistance, at least in humans. 
However, interpretation of these findings is limited to subcutaneous abdominal adipose tissue. 
Visceral adipose tissue contains more macrophages potentially contributing to the well 
described adverse effects of visceral adiposity (Cancello et al., 2006, Harman-Boehm et al., 
2007, Ortega Martinez de Victoria et al., 2009) and may be more important in this response. 
Tchoukalova et al. (Tchoukalova et al., 2010) also showed that multiple subcutaneous sites 
should be sampled since 4-weeks of overfeeding increased adipocyte size, but not adipocyte 
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number, in abdominal sites and increased adipocyte number without changes in adipocyte size 
in femoral sites.  
 
2.5 Does macrophage infiltration promote healthy adipose tissue 
expansion? 
Obesity and type 2 diabetes is associated with hypertrophic adipocytes and a reduced 
proportion of pre-adipocytes within adipose tissue (Tchoukalova et al., 2007). We, and others, 
have theorised that some individuals have reduced ability for adipogenesis, promoting 
adipocyte hypertrophy, ectopic lipid deposition and insulin resistance (Danforth, 2000, 
Heilbronn et al., 2004a). This theory however, was not supported in a recent human 
overfeeding study (Johannsen et al., 2014). Whilst some studies suggest that macrophages 
suppress adipogenesis, this evidence was produced in vitro (Constant et al., 2006, Hammarstedt 
et al., 2007). In vivo, the opposite response has been observed (Sadler et al., 2005, Wernstedt 
Asterholm et al., 2014). This difference may be because in vitro there is no need for 
angiogenesis or remodelling of the extracellular matrix (ECM) to accommodate the increasing 
adipocyte mass. Mice were recently engineered to express either a dominant negative (dn) 
version of TNFα or dnRIDα/β, which inhibits a number of inflammatory pathways (TLR4, 
TNFα and IL1-β), specifically in adipose tissue (Wernstedt Asterholm et al., 2014). Both 
models displayed reduced adipose tissue inflammation but were glucose intolerant, had 
increased fibrosis and hepatic steatosis when exposed to a high fat diet. Mice also displayed 
similar to larger adipocytes versus controls, despite having reduced fat pad weights. This 
suggests that blocking the inflammatory response specifically in adipose tissue impaired the 
ability of this tissue to expand, and led to ectopic lipid accumulation and the development of 
insulin resistance. Strissel et al. (Strissel et al., 2007) showed significant increases in 
adipogenesis following 20-weeks of exposure to high fat diet, which was subsequent to 
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macrophage infiltration at 8-16 weeks, providing indirect evidence to suggest that macrophage 
infiltration promotes adipogenesis in vivo. Wang et al. (Wang et al., 2013) examined 
adipogenesis in various adipose depots during high fat overfeeding. Epididymal fat pads were 
increased by 84% and subcutaneous fat pads were increased by 163% in response to 12-weeks 
exposure. After 7 days, very little adipogenesis was noted and there was no change in the size 
of the adipocyte. After 5-weeks, adipocyte hypertrophy was observed. Adipocyte hyperplasia 
was observed at 12 weeks in the epididimal fat pad but was still minimal in the subcutaneous 
fat pads at 12-weeks. This study did not extend to 20-weeks, and macrophage infiltration was 
not examined. 
 
Remodelling of adipose tissue involves not only changes to adipocyte, but also to the 
extracellular matrix and vasculature to accommodate the expanding mass. Morbidly obese 
individuals display reduced capacity for angiogenesis in subcutaneous adipose tissue versus 
lean (Gealekman et al., 2011), and this has been linked to impaired adipose tissue expandability 
(Rupnick et al., 2002, Nishimura et al., 2007). Vascular endothelial growth factor (VEGF) is a 
key factor in angiogenesis and is highly expressed in macrophage (Cursiefen et al., 2004, 
Walczak et al., 2004). Serum VEGF levels are increased in obesity, but capillarization in 
adipose tissue is reduced in obese humans. Recent studies utilising mouse models provide 
conflicting evidence as to whether VEGF-A prevents or accelerates metabolic dysfunction (Sun 
et al., 2012, Cao, 2013, Wu et al., 2014). In vitro, administration of anti-VEGF antibodies 
inhibited angiogenesis and the formation of adipogenic and angiogenic cell clusters, suggesting 
that this is essential for differentiation of adipocytes. Debels et al. (Debels et al., 2013) 
examined a murine tissue engineering model following addition of zymogen as an 
inflammatory agent, to a Matrigel matrix. In this context, macrophages were observed at 2-
weeks, along with immature new blood vessels. At 4-weeks, blood vessels had matured, and 
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immature adipocytes were observed, with mature adipocytes observed at 6-weeks. Importantly, 
knockout of macrophages reduced both angiogenesis and adipogenesis, suggesting that 
macrophages promote healthy adipose tissue expansion, at least in this type of environment.  
 
The extracellular matrix consists of structural and adhesion molecules such as collagens, 
glycoproteins and fibronectin that provide a structural lattice for cellular adherence, 
organisation and communication. Deposition and breakdown of the ECM is fundamental in the 
repair processes in response to inflammation, and is distinct from the abnormal deposition of 
ECM proteins, which is a process known as “fibrosis”. In obesity, fibrosis in adipose tissue and 
other organs is clearly increased (Henegar et al., 2008, Sun et al., 2013), and some studies have 
shown this can persist despite massive weight loss in subcutaneous adipose tissue (Henegar et 
al., 2008). It is unclear what contributes to excessive ECM accumulation in obesity. In vitro, 
pro-inflammatory macrophages have been identified as one such target, contributing to fibrosis 
development and maintenance (Keophiphath et al., 2009). In humans, Pasarica et al showed 
increased adipose tissue expression of COL6A3 mRNA, in parallel with increased CD68+ and 
CD163/MAC2+ macrophages and increased MIP and MCP1 expression (Pasarica et al., 
2009a). Further, obese subjects with expression of COL6A3 above median had increased 
visceral adipose tissue mass, increased MIP1 and MCP1, and fewer smaller adipocytes. Weight 
loss reduced the expression of ECM genes in adipose tissue (Kolehmainen et al., 2008) and 
overfeeding increased expression of COL6A3 in men, suggesting that rapid changes in the 
ECM are needed to accommodate the changing adipose mass (Pasarica et al., 2009b). 
Interestingly, diet induced obese mice lacking Col6A1 have an unrestricted expansion of 
adipocyte size, fewer crown like structures representing regions of adipocyte death and 
inflammation and improved glucose control (Khan et al., 2009), suggesting that fibrosis 
increases the rigidity of adipose tissue and restricts adipocyte expansion. Few studies have 
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examined the temporal response of ECM proteins to experimental overfeeding. Alligier et al. 
examined the effects of a moderate increase in energy intake at 14 and 56 days. Increases in 
lipid metabolism genes were observed at 14 days, followed by increases in ECM and genes 
related to adipogenesis and angiogenesis at 56 days, which was supported by histological 
examination (Alligier et al., 2012). Similarly Tam et al. reported significant increases in 
adipose tissue expression in collagens I and II and TGFβ after 10% weight gain, although no 
changes were noted in expression of inflammatory genes in either study suggesting ECM 
remodelling was independent of macrophage infiltration (Tam et al., 2014).  
 
2.6 Conclusions  
Obesity is clearly associated with an increase in the total number of macrophages in adipose 
tissue, and increased secretion of pro-inflammatory factors and chronic low grade 
inflammation, all of which may contribute to the development of insulin resistance. However, 
we and other have shown that macrophage infiltration is not an immediate response during 
experimental overfeeding in humans, despite expanding adipose mass and insulin resistance. 
Studies in mouse suggest that macrophage infiltration occurs about 8-16 weeks after initiation 
of high fat diet, which is typically after the development of insulin resistance. This disconnect 
between macrophage infiltration and insulin resistance, is also observed in many genetic 
manipulation studies in mice, and raises some questions as to whether macrophages are causal 
in the development of the insulin resistant phenotype. Studies investigating the temporal 
response to exposure to high fat diet suggest that macrophage infiltration during weight gain 
may be transitory, and promote healthy adipose tissue expansion, at least initially (Figure 2.1). 
Moreover, blocking this response may promote unhealthy adipose tissue expansion, and 
ectopic lipid deposition. Further work is required to ascertain whether we can selectively 
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activate macrophages to promote healthy adipose tissue expansion, and therefore potentially 
improve metabolic health. 
 
 
Figure 2-1: Macrophage infiltration in adipose tissue 
Macrophage infiltration in adipose tissue is a dynamic process that is reduced following energy 
restriction, and increased upon exposure to prolonged energy excess. During weight gain, 
adipocyte hypertrophy, necrosis and M1 macrophage infiltration occur. Macrophage 
infiltration may then promote healthy adipose tissue expansion, at least initially, via 
adipogenesis, angiogenesis, and remodelling of the extracellular matrix, improving the 
metabolic milieu of adipose tissue. Failure of this process leads to unhealthy adipose tissue 
expansion including pro-inflammatory activation of macrophages, adipocyte hypertrophy, 
adipocyte hypoxia, and fibrosis (Heilbronn and Liu, 2014).  
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What is already known about this subject? 
 Intermittent fasting with energy restriction produces similar reductions in body weight, 
and cardiovascular risk as daily energy restriction, and may have modest additional 
benefits to reduce markers of insulin resistance (e.g., HOMA-IR, fasting insulin). 
 The acute changes in metabolic parameters during fed and fasting states, have not been 
reported widely, nor in this population.  
 No studies to date have assessed changes in insulin sensitivity by hyperinsulinaemic-
euglycaemic clamp in response to intermittent fasting after both a fed, and fasted day. 
 
What does this study add?  
 This is the first randomised controlled study to compare continuous and intermittent 
intake patterns at two energy levels (at energy balance, or 30% energy restriction).  
 Intermittent fasting with energy restriction induced greater reductions in weight, fat 
mass losses, and greater reductions in total and LDL-cholesterol and non-esterified fatty 
acids (NEFA) compared with continuous daily restriction.  
 Intermittent fasting did not impact insulin sensitivity when examined in the fed state, 
but was transiently impaired following a 24-hour fast.  




Objective: To compare intermittent fasting (IF) versus continuous energy intakes at 100% or 
70% of calculated energy requirements on insulin sensitivity, cardiovascular risk, body weight 
and composition.  
 
Methods: Women with overweight (N=88; 50.2±0.9 years, BMI 32.3±0.5 kg/m2) were 
randomised to one of four diets (IF70, IF100, dietary restriction [DR70], or Control) in a 
2:2:2:1 ratio for 8 weeks. IF groups fasted for 24-h after breakfast on 3 non-consecutive 
days/week. All foods were provided and diets matched for macronutrient composition (35% 
fat, 15% protein, 50% carbohydrate). Insulin sensitivity by hyperinsulinaemic-euglycaemic 
clamp, weight, body composition and plasma markers were assessed following a “fed” day 
(12-h fast), and a 24-h fast (IF only).  
 
Results: The IF70 group displayed greater reductions in weight, fat mass, total- and low-
density lipoprotein-cholesterol (LDL-cholesterol) and non-esterified fatty acids compared with 
DR70 and IF100 (all P ≤0.05). IF100 lost more weight and fat than Control, however fasting 
insulin was increased. There were no differences in insulin sensitivity by clamp, however, a 
24-h fast transiently reduced insulin sensitivity. 
 
Conclusion: When prescribed at matched energy restriction, IF reduced weight and fat mass, 
and improved total and LDL-cholesterol more than DR. IF prescribed in energy balance failed 
to improve markers of metabolic health, despite modest weight loss. 
 
Key words: cardiovascular risk; continuous dietary restriction; insulin sensitivity; intermittent 
fasting; weight loss   
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3.2 Introduction  
Continuous dietary restriction (DR) remains the cornerstone lifestyle intervention to reduce the 
risk of developing type 2 diabetes and cardiovascular disease in individuals who are overweight 
(Neter et al., 2003, Look Ahead Research Group et al., 2007, Wing et al., 2011, Diabetes 
Prevention Program Research, 2015, Goodpaster et al., 1999). Due to the inherent difficulty 
associated with long-term adherence to DR (Scheen, 2008, Moreira et al., 2011), alternative 
approaches are being investigated.  
 
Intermittent fasting (IF) involves alternating periods of eating with fasting periods of up to 24 
hours, for 1-4 days/week. In mice, intermittent 24-hour fasting results in favourable 
redistribution of adipose tissue (Varady et al., 2010), reduced fasting glucose and insulin 
(Anson et al., 2003), and improved cardiovascular health (Mattson and Wan, 2005). In most of 
these studies, the metabolic health benefits were observed with minimal weight differences 
(Varady et al., 2010) or versus pair fed controls (Anson et al., 2003), suggesting that fasting 
may be the stimulus required to improve health.  
 
Studies in humans have shown that IF reduces weight and fat mass, total cholesterol, LDL-
cholesterol, triglycerides, postprandial lipemia and fasting insulin (Heilbronn et al., 2005b, 
Antoni et al., 2018, Varady et al., 2009, Hoddy et al., 2014, Varady et al., 2013), while others 
have shown no significant improvements in metabolic health, despite weight loss (Bhutani et 
al., 2013, Williams et al., 1998). To our knowledge, five studies have compared an intermittent 
versus continuous dietary approach for 2-12 months (Catenacci et al., 2016, Harvie et al., 2011, 
Harvie et al., 2013, Trepanowski et al., 2017, Antoni et al., 2018). These studies have shown 
that IF and DR produce similar reductions in body weight and markers of cardiovascular risk. 
However, Harvie et al reported that IF reduced body fat and fasting insulin more than DR 
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(Harvie et al., 2011). Two studies have examined insulin sensitivity by hyperinsulinaemic-
euglycaemic clamp after IF (Halberg et al., 2005, Soeters et al., 2009), but none have compared 
this with DR. Moreover, changes in metabolic parameters between fed and fasted states have 
only been examined in lean men (Halberg et al., 2005). This is important since “metabolic 
switching” between fed and fasting states, rather than weight loss, may underlie the health 
benefits of IF (Antoni et al., 2017, Anton et al., 2018).  
 
The aims of this study were to conduct a randomised, controlled trial, in women who were 
classified as overweight or obese to: 1) compare the effects of intermittent versus continuous 
food intakes at two energy levels on peripheral insulin sensitivity, weight and body 
composition, and cardio-metabolic outcomes; and 2) to explore the acute metabolic changes 
that occur when switching between a fed (i.e., after a 12h overnight fast) and fasted (24h fast) 
state.  
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3.3 Participants and Methods 
Participants 
Between 1 March 2013 and 4 September 2015, 119 women were screened following 
advertisement in local newspapers and media to participate in this single-centre, randomised 
controlled trial in Adelaide, South Australia (Fig. 3.1). A total of 88 women were enrolled in 
the study. Inclusion criteria were: aged 35-70 years; BMI 25-42 kg/m2; self-reported to be 
weight-stable (within 5% of their screening weight) for >6 months prior to study entry; non-
diabetic; non-smoker; sedentary or lightly active (i.e., <2 moderate to high-intensity exercise 
sessions per week); consumed <140 g alcohol/week; no personal history of cardiovascular 
disease, eating disorders or major psychiatric disorders (including those taking 
antidepressants); not pregnant or breastfeeding; and not taking medication that may affect study 
outcomes (e.g., phentermine, orlistat, metformin, excluding antihypertensive/lipid lowering 
medication). The Royal Adelaide Hospital Research Ethics Committee approved the study, and 
all participants provided written, informed consent prior to their inclusion. The study was 
registered with Clinicaltrials.gov (NCT01769976). 
 
Randomisation and masking 
The active trial period was 10 weeks, including a 2-week lead-in, and an 8 week intervention. 
During the lead-in, participants consumed their normal diet and maintained their weight. 
Following this, participants were randomly assigned in a 2:2:2:1 ratio to one of the four diets; 
1) IF70: intermittent fasting diet at 70% of calculated baseline energy requirements per week; 
2) IF100: intermittent fasting diet at 100% of calculated baseline energy requirements per week 
(i.e., weight maintenance); 3) DR70: continuous restriction at 70% of calculated baseline 
energy requirements daily; 4) Control: 100% of calculated baseline energy requirements daily. 
Daily energy requirements were calculated by averaging predicted daily energy expenditure 
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from two published equations, both of which use age, gender, height and weight variables 
(Institute of Medicine (U.S.). Panel on Macronutrients. and Institute of Medicine (U.S.). 
Standing Committee on the Scientific Evaluation of Dietary Reference Intakes., 2005, Redman 
et al., 2009). Block randomisation (4 or 8 participants) was performed by a research officer, 
with stratification by BMI (<=32.9 or >=33 kg/m2) and age (<=49.9 or >=50 years). Nine 
participants withdrew from the study. Seven no longer wished to participate, and two were 
withdrawn by the investigators; one for pre-existing bronchial issues unrelated to the study, 
and one due to gastrointestinal surgery that was not disclosed during the screening process 
(completers: DR70: n=24, IF70: n=22, IF100: n=22, Control: n=11).  
 
On fed days, IF70 were provided with~100%, and IF100 ~145% of energy requirements. IF 
groups consumed breakfast before 8am on fasting days (~32% of energy requirements was 
given at breakfast on fasting days to IF70, and ~37% to IF100; Appendix table 1), then 
commenced a ~24 hour “fast” until 8 am the following day, on 3 non-consecutive 
weekdays/week. During the fast, participants were allowed water and small amounts of energy-
free foods (e.g., “diet” drinks, chewing gum, mints), black coffee and/or tea, and were provided 
with 250 mL of a very low energy broth (20 kcal/250 mL, 2.0g protein, 0.1g fat, 3.0g 
carbohydrate) for lunch or dinner. All diets were matched for macronutrient composition (35% 
fat, 15% protein, 50% carbohydrate). Participants were free-living, and foods were delivered 
fortnightly to their home, excluding fresh fruit and vegetables. Portions of fruits and vegetables 
were standardised (1 ‘serve’ of fruit = 150g of fresh fruit or 30g dried fruit; 1 ‘serve’ of 
vegetables = 75g raw, steamed or boiled vegetables) and participants self-selected according 
to the number of serves specified in their individual menus.  
 




Figure 3-1: CONSORT flow diagram 
 
Adherence and perceptions of appetite 
Participants completed daily checklists to monitor adherence, and energy intake in weeks 1, 4 
and 7 was calculated from 7-day food diaries using FoodWorks (version 8, Xyris Software; 
Appendix table 1 and 2). Participants attended our clinic weekly, where they returned the 7-
day checklist from the previous week, were weighed (Fig. 3.2A), and received individual 
counselling to maintain compliance. Perceptions of appetite and symptoms (hunger, fullness, 
desire-to-eat, mental alertness, irritability and perceived difficulty adhering to the diet) were 
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To minimize the influence of the menstrual cycle, pre-menopausal women were studied in the 
follicular phase. Participants consumed a standardised diet (100% of calculated energy 
requirements, 35% fat, 15% protein, 50% carbohydrate) for 3 days, and were instructed to 
avoid exercise, alcohol, and caffeine for 24 hours prior to the first metabolic testing visit 
(“baseline”). Participants fasted for 12 hours overnight prior to the baseline and “fed” (week 
8) visits. IF groups underwent a third metabolic visit following a 24-hour fast to capture 
outcomes from fasting days. This visit occurred 2-7 days after the “fed” visit, depending on 
clinician availability (Fig.3.2). At all visits, participants arrived at 0730h, were weighed in a 
gown after voiding and waist and hip measurements were taken. Blood pressure was measured 
with the participant in a seated position, after 10-min of rest. Intravenous cannulae were placed, 
baseline samples collected and a primed 120-min hyperinsulinaemic-euglycaemic (60 
mU/m2/min) clamp commenced as previously described (Heilbronn et al., 2004b). Peripheral 
insulin sensitivity (M) was calculated as the mean glucose infusion rate (GIR) during steady-
state (last 30 min), normalised for the estimated size of fat free mass (FFM) as described by 
others (GIR /kg FFM+17.7) (DeFronzo et al., 1979, Tam et al., 2012c). Steady-state insulin 
was significantly lower after 24-hour fasts in IF70 (P=0.002), and IF100 (P=0.05), suggesting 
increased insulin clearance following a prolonged fast (Heijboer et al., 2005, Soeters et al., 
2008). We calculated insulin-adjusted GIR by dividing M by I, where I is the steady-state 
insulin concentration (mU/L),*100 (DeFronzo et al., 1979, Rebelos et al., 2011). Due to 
scheduling conflicts or technical issues on the day, 11 clamps were not conducted. Of these 11, 
5 participants did not have baseline clamps and so subsequent clamps were not scheduled, 2 
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completed baseline clamps only, and 4 completed baseline and the “fed” visit only. The 
following n were used in the completer’s analysis of the clamp data: DR70, n=22; IF70, n=17; 
IF100, n=19; Control, n=10. Homeostatic model assessment of insulin resistance (HOMA-IR) 
was calculated as (fasting serum insulin (mU/L) × fasting plasma glucose (mmol/L))/22.5. 
Total body composition was assessed by dual-energy x-ray absorptiometry (DXA; Lunar 
Prodigy; GE Healthcare, NSW, Australia). All procedures were identical on study days, 
however no DXA was performed at the “fast” visit. 
 
 
Figure 3-2: Schematic of study design 
 
Analytical methods 
Blood samples were immediately centrifuged and frozen at -80°C. Blood lipids and fasting 
blood glucose were examined by photometric assays in the laboratory of SA Pathology (South 
Australia, Australia). Serum insulin was measured by radioimmunoassay (HI-14K, Millipore; 
MA, USA). Serum non-esterified fatty acids (NEFA) were measured by enzymatic colorimetric 
assay (NEFA-HR (2), Wako Diagnostics; CA, USA). Plasma ß-hydroxybutyrate (RANBUT 
D-3 Hydroxybutyrate kit, Randox; Antrim, UK), alanine aminotransferase (ALT), aspartate 
aminotransferase (AST), and high-sensitivity c-reactive protein (HS-CRP) were measured 
using commercially available enzymatic kits (Beckman Coulter Inc.; CA, USA) on a Beckman 
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AU480 clinical analyser (Beckman Coulter Inc.; CA, USA). Samples from each subject were 
analysed within the same run to reduce instrument variation. Serum fibroblast growth factor-
21 was measured by ELISA (R & D Systems; MN, USA).  
 
Statistical analysis 
The number of participants was established from past studies (Samocha-Bonet et al., 2012, 
Heilbronn et al., 2004b, Albu et al., 2010). The primary comparison was insulin sensitivity 
normalised for fat free mass and steady-state insulin concentration (M/I; GIR/kg 
FFM+17.7/mU), between DR70 and IF70. With n=22 per group (randomised 1:1) a t-test 
would allow detection of a mean difference in M of 15µmol/kg FFM+17.7 between groups, 
based on an SD of 17, with 80% power (two-sided α=0.05). This has allowed for a 10% drop 
out rate, and thus we recruited a total of n=25 per group. For completeness we included an 
IF100 group and a non-weight loss group (Control) at half sample size. 
 
Statistical methods 
All endpoints were assessed as follows. DR70 and IF70 measured at the fed day were compared 
using linear regressions, adjusting for baseline levels. Thereafter we included the IF70 24-hour 
fast measurements and compared the three levels (DR70 vs IF70-12h vs IF70-24h) using mixed 
effects regressions, with a random intercept per individual and compound symmetry correlation 
structure. Finally, we assessed the diet comparison with and without adjusting for weight loss, 
which was included as an additional fixed effect. IF100 vs Control diets were compared in a 
similar manner using the same regression models. Finally IF70 vs IF100 were compared using 
linear mixed effects regressions using the same random effect structure as above, with baseline 
measure, time (12 hr vs 24 hr) and diet (IF70 vs IF100) as the three fixed effects. Individuals 
missing outcome data were excluded from each analysis, while those missing baseline data 
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were imputed using cohort means. After examination of residual distributions all endpoints 
measured from plasma (glucose, insulin, ketones and liver markers) except total-, HDL-, and 
LDL- cholesterol were log-transformed. Data are shown as mean ± SEM. Diet comparisons are 
pairwise with significance set at P<0.05 (two sided). Statistical analyses were performed using 
SPSS software (version 21.0; SPSS Inc., IBM, NY, USA) and R (version 3.3.3). 
 
  





A total of 88 women (mean age 50.2±0.9 years, mean BMI 32.3±0.5 kg/m2) were enrolled in 
the study. Baseline age, weight, BMI, percent body fat, fasting glucose, insulin, and blood 
lipids appeared balanced between treatment groups (Table 3.1). Women who were post-
menopausal (n=47) were older and displayed higher levels of triglycerides, ALT and AST than 
those were pre-menopause (all P<0.05).  
 









Age at enrolment (years) 49.8±2.6 51.0±1.8 49.5±2.0 50.9±1.8 
Weight (kg) 83.8±4.8 84.1±2.8 89.4±2.8 88.4±2.8 
BMI (kg/m2) 30.9±1.5 31.2±0.9 32.4±0.8 32.6±1.0 
Pre/Postmenopausal 6/6 10/15 13/12 11/14 
Body fat (%) 44.5±2.6 47.0±1.3 48.3±1.4 48.4±1.4 
Waist circumference (cm) 98.0±5.8 98.8±2.6 100.5±2.2 99.0±1.8 
Hip circumference (cm) 112.1±3.5 112.1±1.9 115.1±2.1 115.7±2.4 
Fasting glucose (mmol/L) 4.9±0.1 4.9±0.1 4.9±0.1 4.9±0.1 
Fasting insulin (mU/L) 16.8±2.2 18.6±1.5 19.5±1.5 15.5±1.3 
HOMA-IR 3.8±0.6 4.1±0.4 4.3±0.3 3.4±0.3 
Total cholesterol (mmol/L) 4.5±0.4 5.0±0.2 4.8±0.1 4.9±0.1 
HDL-C (mmol/L) 1.3±0.2 1.4±0.2 1.4±0.1 1.4±0.1 
LDL-C (mmol/L) 2.6±0.3 3.0±0.2 2.9±0.1 3.0±0.1 
Triglycerides (mmol/L) 1.4±0.3 1.5±0.1 1.2±0.1 1.3±0.1 
HS-CRP (mg/dL) 2.1±0.6 2.8±0.5 2.9±0.5 2.7±0.5 
ALT (U/L) 16.7±1.9 21.6±2.4 19.5±1.9 19.7±1.7 
AST (U/L)  19.7±1.4 21.3±1.3 20.1±1.1 19.5±1.0 
FGF-21 (mmol/L) 163.8±32.7 169.1±23.1 142.5±23.1 184.4±22.1 
DR70: continuous energy restriction at 70% of baseline energy requirements: IF70: 
intermittent fasting diet at 70% of baseline energy requirements; IF100: intermittent fasting 




diet at 100% of baseline energy requirements; Control (C): continuous food intake at 100% 
baseline energy requirements. Abbreviations: ALT: alanine transaminase; AST: aspartate 
transaminase; FGF-21: fibroblast growth factor-21; HDL-C: high-density lipoprotein 
cholesterol; HS-CRP: high-sensitivity C-reactive protein; HOMA-IR: homeostatic model 
assessment of insulin resistance; LDL-C: Low-density lipoprotein cholesterol. 
 
Data are shown as mean ± SEM. There were no significant differences between groups at 
baseline in any of the outcome measures.  
 
In addressing aim 1, total weight (P=0.03; Fig. 3.3B) and fat loss (P=0.05; Fig. 3.3C) were 
significantly greater in IF70 compared with DR70, and compared with IF100 (both P<0.01). 
Total weight and fat loss were also greater in IF100 compared with Control (both P<0.001). 
The reduction in FFM (Fig. 3.3D) was not statistically different between IF70 and DR70 
(P=0.07) and IF70 and IF100 (P=0.06), but was greater in IF100 compared with Control 
(P=0.04). The proportion of weight lost as FFM was not significantly different between IF70 
and DR70 (P=0.94), IF70 and IF100 (P=0.74) or IF100 and Control (P=0.11; Appendix table 
3). The reduction in waist circumference was greater in IF70 compared with IF100 (P=0.04; 
Appendix table 3). There were no differences between groups for change in hip circumference 
(Appendix table 3). Given the unexpected differences in weight loss between DR70 and IF70, 
and IF100 and Control, we have reported comparisons below unadjusted, and adjusted for 
weight loss. 
 





Figure 3-3: Changes in anthropometric outcomes following 8 weeks of intermittent or 
continuous intake at 70 and 100% of daily energy requirements 
(A) Weekly weights; (B) Change in body weight; (C) Change in fat mass; (D) Change in fat 
free mass. Control (C): continuous energy intake at 100% of baseline energy requirements; 
IF100: intermittent fasting diet at 100% of baseline energy requirements; IF70: intermittent 
fasting diet at 70% of baseline energy requirements; DR70: continuous energy restriction at 
70% of baseline energy requirements. 
 
Data are shown as mean ± SEM. Pairwise comparisons: *P<0.05 vs Control; ^P<0.05 vs. 
IF100; ‡P<0.05 vs. DR70.  
 
Self-reported energy intake was not significantly different from provided in Control (P=0.83) 
or DR70 (P=0.96) (Appendix table 1). The IF100 group reported consuming 240±336 
kcal/day less than provided on fed days, and the IF70 group 188±200 kcal/day less than 
provided on fed days (Appendix table 2). This resulted in an overall average weekly deficit of 
~9% and ~2% respectively. As such, energy restriction was greater in IF70 (-31±2%) compared 
with DR70 (-30±2%) (P=0.02), and in IF100 (-9±8%) compared with Control (0±5%; P=0.02). 




Perceived difficulty adhering to the diet was higher in IF100 compared with IF70 and Control 
at week 1 (both P<0.05), but not at week 6 (P=0.61 compared with IF70, P=0.08 compared 
with Control). In week 1, self-reported feelings of hunger on a fed day were lower in IF70 
compared with DR70, and higher compared with IF100. (Appendix figure 1).  
 
The change in insulin sensitivity by clamp was not significantly different between IF70 and 
DR70 (P=0.95), IF70 and IF100 (P=0.31) or IF100 and Control (P=0.65) after a fed day (Fig. 
3.4A). However, there was a trend for insulin sensitivity to be impaired after a fast day in IF70 
compared with DR70 (P=0.08). Changes in glucose (Fig. 3.4C) and insulin (Fig. 3.4D) were 
significantly greater after a fast day in IF70 compared with DR70 (both P<0.05) and after a fed 
day compared with IF100 (both P=0.02). This translated into reduced (i.e. improved) HOMA-
IR after a fast day in IF70 compared with DR70 (P=0.01; Fig. 3.4B) and increased HOMA-IR 
after a fed day in IF100 compared with IF70 after the fed day (P=0.002). Increased fasting 
insulin (P=0.05) in IF100 compared with Control after a fed day was also observed. There was 
a greater reduction in NEFA after a fed day in IF70 compared with DR70 (P=0.005), and 
greater increases after a fasting day (P=0.003) Fig. 3.4E). Adjusting for weight loss did not 
alter the outcomes for HOMA-IR or NEFA. 
 
The changes in total and LDL-cholesterol were greater in IF70 compared with DR70 (both 
P<0.01) and IF100 (both P≤0.05, Table 3.2). The change in triglycerides was significantly 
greater in IF70 compared with DR70 (P=0.05). There were no differences between diets for 
the change in HDL-cholesterol (table 2), HS-CRP, ALT (Appendix table 3), AST (Fig. 3.4F) 
or the change in systolic and diastolic blood pressure (Appendix table 3). The change in FGF-
21 was greater in IF70 compared with IF100 (P=0.008; Fig. 3.4G). After adjustment for weight 




loss, differences between IF70 and DR70 for the changes in total (P=0.01) and LDL-cholesterol 
(P=0.04) remained.  
 
 




Figure 3-4: Changes in markers of insulin sensitivity and biochemical markers following 
8 weeks of intermittent or continuous intake at 70 and 100% of daily energy requirements 
(A): Change in insulin sensitivity as assessed by hyperinsulinaemic-euglycaemic clamp; 
completers analysis (DR70 n=22; IF70 n=18; IF100 n=19; C n=10); (B): Change in HOMA-
IR; (C): Change in fasting blood glucose; (D): Change in fasting insulin; (E) Change in non-
esterified fatty acids (NEFA); (F): Change in Alanine transaminase; (G): Change in fibroblast 
growth factor-21; (H): Change in β-hydroxybutyrate. Control (C): continuous energy intake at 
100% of baseline energy requirements; IF100: intermittent fasting diet at 100% of baseline 
energy requirements; IF70: intermittent fasting diet at 70% of baseline energy requirements; 
DR70: continuous energy restriction at 70% of baseline energy requirements. Black bars: 
change from baseline to fed visit; Red bars: change from baseline to fasted visit. 
 
Data are shown as mean ± SEM. Pairwise comparisons: *P<0.05 vs Control; ^P<0.05 vs. 
IF100; ‡P<0.05 vs. DR70; All end-points (excluding insulin sensitivity) were log-transformed 
before analysis.  
 
With regards to aim 2, a 24-hour fast significantly impaired insulin sensitivity by clamp 
compared with a 12-hour fast (P=0.002; Fig. 3.4A, Appendix table 4). Contrary to this, 
HOMA-IR was improved by a 24-hour fast (P<0.0001, Fig.3.4B). Fasting glucose (Fig. 3.4C) 
and insulin (Fig. 3.4D) were reduced (both P=0.01) and plasma NEFA (Fig. 3.4E), and ketone 
(Fig. 3.4H) concentrations were increased (all P<0.001). A 24-hour fast also increased AST 
(P=0.01; Fig. 3.4G) and reduced insulin-induced suppression of NEFA (P=0.002; Appendix 
table 4). 
 
Table 3-2: Change in plasma lipids and inflammatory marker C-reactive protein 









Total cholesterol (mmol/L) -0.30±0.15 -0.37±0.15 -0.59±0.08b.c -0.24±0.10 
HDL-cholesterol (mmol/L) -0.03±0.07 -0.07±0.06 -0.10±0.03 -0.05±0.02 
LDL-cholesterol (mmol/L) -0.16±0.12 -0.16±0.13 -0.37±0.07b,c -0.13±0.08 
Triglycerides (mmol/L) -0.25±0.09 -0.28±0.12 -0.24±0.07c -0.16±0.05 
HS-CRP (mg/dL) 1.11±0.55 -0.33±0.23a -0.30±0.35 0.34±0.46 




Control (C): continuous energy intake at 100% of baseline energy requirements; IF100: 
intermittent fasting diet at 100% of baseline energy requirements; IF70: intermittent fasting 
diet at 70% of baseline energy requirements; DR70: continuous energy restriction at 70% of 
baseline energy requirements. HDL: high-density lipoprotein; LDL: Low-density lipoprotein; 
HS-CRP: high-sensitivity C-reactive protein. 
 
Data are shown as mean ± SEM. aSignificantly different from Control (P<0.05); bSignificantly 










This randomised controlled trial showed that provision of an energy restricted-IF diet led to 
greater loss of weight and fat mass, improvements in total and LDL-cholesterol and NEFA 
versus energy matched DR. There were no overall differences in insulin sensitivity by clamp 
between groups, although the 24-hour fast induced transient insulin resistance. When IF was 
prescribed in energy balance, transient increases in risk markers for type 2 diabetes were 
observed, despite modest weight loss. Taken together, these data suggest that IF with energy 
restriction improves metabolic health, while IF in energy balance does not. 
 
One study has shown that IF led to greater weight loss over eight weeks (Catenacci et al., 2016). 
However, the IF group were prescribed a lower energy intake and this, rather than the mode of 
meal delivery, was likely responsible for this outcome. Harvie et al prescribed a similar energy 
deficit between intermittent and continuous energy-restricted groups (Harvie et al., 2011). In 
that study, weight loss was not statistically different between intermittent and continuous 
groups after 6 months (-6.4 kg [95% CI -7.9 - -4.8kg] IF compared with 5.6 kg [-6.9 - -4.4 kg] 
DR). Although, self-reported energy intakes were lower in the intermittent group, the 
intermittent group consumed meal replacements on “fasting” days, whereas the continuous 
group was prescribed a conventional food-based diet, daily (Harvie et al., 2011). This study 
was repeated with conventional food based diets prescribed to both groups for three months, 
and fat mass losses were greater in the intermittent versus continuous group (Harvie et al., 
2013). In contrast, Trepanowski et al. show that weight and fat loss was not different between 
intermittent and continuous restriction groups at six months or one year (Trepanowski et al., 
2017). The authors noted that this study was underpowered to detect weight differences.  
 
In the current study, IF did not preserve fat free mass as has been reported previously (Varady 
et al., 2013, Varady et al., 2009), and resulted in significantly more weight and fat mass loss. 




Whilst participants were instructed to maintain their pre-enrolment activity levels, we 
acknowledge that undisclosed changes in activity could have contributed to this outcome. 
Analysis of self-reported diet records showed excellent adherence in the Control and DR70 
groups, and in the IF groups on fasting days, since reported food intake was not significantly 
different from prescribed. However, IF participants reported consuming less food than 
prescribed on “fed” days, resulting in an additional energy restriction of 2% in the IF70, and 
9% in the IF100 group. A degree of spontaneous energy restriction on “fed” days has been 
reported previously (Harvie et al., 2013, Trepanowski et al., 2017), and appears to be a benefit 
of IF.  
 
The mechanistic reason for this remains elusive, however the increase in plasma ketone 
concentrations may play a role. Inducing physiological ketosis reduces feelings of hunger and 
increases feelings of fullness in humans (Boden et al., 2005), and may also mitigate the 
reduction in postprandial cholecystokinin and increased ghrelin concentrations that occur in 
response to energy restriction (Sumithran et al., 2013). Fasting for 24 hours also reduces ghrelin 
concentrations (Koutkia et al., 2005). However, the impacts of IF on gut peptides are 
controversial (Heilbronn et al., 2005b, Catenacci et al., 2016). In the current study, we observed 
no differences in perceived hunger between modes of dietary restriction, but this was recorded 
at a single time point only each day. Previous studies report that perceived hunger on a fast day 
(Heilbronn et al., 2005b) or averaged across eating and fasting days (Harvie et al., 2013) was 
unchanged, while others report reduced hunger at the end of a fasting day (Klempel et al., 
2010). The effects of IF on appetite regulation deserves further investigation. 
 
There is controversy in the existing literature over whether IF is superior to DR to improve 
metabolic health, with four out of five studies reporting greater improvements in markers of 




diabetes or cardiovascular risk (Catenacci et al., 2016, Harvie et al., 2013, Harvie et al., 2011, 
Antoni et al., 2018). In this study, we observed greater reductions in total cholesterol, LDL 
cholesterol and NEFA in the IF70 compared with DR70 group, and transiently lower glucose 
and insulin levels after the fasting day. However, the additional weight loss in the IF70 group 
may underlie the greater metabolic benefits observed in this study, despite our intentions to 
match weight loss in these groups. To account for this, we adjusted for the change in body 
weight, and observed that greater reductions in NEFA, total cholesterol and LDL-cholesterol 
levels in the IF70 group occurred independent of weight loss. The reduction in NEFA likely 
reflects greater improvements in adipose tissue insulin sensitivity (Appendix figure 2) and 
stimulation of fatty acid oxidation after IF. 
 
In order to establish whether the purported health benefits of IF were attributable to weight 
loss, or the fasting pattern per se (i.e., patterns of regular feeding and fasting), as has been 
established in mice (Anson et al., 2003), we included the IF100 group. Women in this group 
were provided food at overall energy balance, which necessitated them eating at ~145% of 
energy balance for four days per week. Aside from modest weight and fat loss, there were no 
metabolic health benefits in the IF100 group. This is contrary to mouse study observations 
(Anson et al., 2003, Mattson and Wan, 2005, Varady et al., 2010). Further, transient increases 
in glucose and insulin were observed after a fed day, as we have noted previously in response 
to acute overfeeding (Samocha-Bonet et al., 2010). We speculate this intermittent 
‘overfeeding’ underlies the lack of overall benefits observed in this group. The long-term 
impacts of these transient elevations in risk markers of type 2 diabetes are unclear. However, 
Trepanowski et al. showed that LDL concentrations were elevated by IF after 12 months 
(Trepanowski et al., 2017). While we cannot directly extrapolate our findings to free-living 




individuals, both studies highlight the necessity of examining the safety of IF long-term, when 
weight loss typically slows (Ravussin et al., 2015). 
 
In our study, we observed marked elevations in blood NEFAs and ketones, and decreases in 
fasting insulin and blood glucose on fasting days, reflecting the switch towards activation of 
adipose tissue lipolysis and fatty acid oxidation. This is similar to findings by Heilbronn et al. 
who measured samples following 3 weeks of ADF (after a 10-hour overnight fast) and again 
after a 34-hour fast (Heilbronn et al., 2005a). Few studies have examined the acute changes in 
metabolic parameters between “fed” and “fasted” states. Halberg et al reported that NEFA and 
glycerol concentrations were increased, while glucose concentrations were decreased when 
measured after a 20-hr fast. They observed no change in beta-hydroxybutrate, or insulin. 
However, samples were taken immediately before breaking a 20-hour fast (at 5pm), and 
compared to samples taken after an overnight fast (8am). Thus clock differences (i.e., morning 
vs. evening) could have contributed to this result. Nonetheless, this metabolic switching has 
been postulated to result in up-regulation of mitochondrial fatty acid oxidation, and may 
underpin the benefits to metabolic health by IF (Anton et al., 2018). In support of this, we noted 
that the IF70 group displayed greater reductions in NEFA following the fed days compared 
with DR70, which was independent of the amount of weight lost.  
 
Transient insulin resistance was induced in response to a 24-hour fast in both IF groups, when 
assessed by clamp. This change was at trend level when comparing a 24-hour fast in IF70 with 
the fed day in the DR70 group. This may have been partly due to reduced steady state insulin 
concentrations, which are indicative of increased insulin clearance (Heijboer et al., 2005), 
despite adjustment. Nonetheless, this finding contrasts data obtained by HOMA (Harvie et al., 
2013, Harvie et al., 2011) and highlights that assessing insulin sensitivity by this method is 




insufficient to make inferences of “insulin sensitivity” in studies of IF. It also highlights the 
possibility that tissue-specific changes in insulin sensitivity may occur in response to IF, since 
HOMA-IR generally reflects hepatic insulin sensitivity, whilst the clamp mainly reflects 
muscle insulin sensitivity. To our knowledge, only two studies have previously investigated 
the impacts of two weeks of IF on peripheral insulin sensitivity by clamp, in lean men. In the 
study by Halberg et al, body weight was unchanged, insulin sensitivity was improved, and the 
authors reported an increase in insulin-induced suppression of adipose tissue lipolysis (Halberg 
et al., 2005). In contrast, Soeters et al performed a 2-step clamp to assess both hepatic and 
peripheral insulin sensitivity and reported no differences in either measure following 14 days 
of IF or a standard diet in weight-stable participants (Soeters et al., 2009). In both of these 
examples, insulin sensitivity was assessed solely following the “fed” day. In humans, 
prolonged fasting (>48h) induces insulin resistance; this is likely a protective mechanism to 
spare glucose for the central nervous system (Hoeks et al., 2010). Impaired glucose tolerance 
was observed after a 36-hour fast, and 3 weeks of alternate day fasting in women (Heilbronn 
et al., 2005a). Reduced insulin sensitivity has also been detected by IVGTT after a 24h fast in 
lean individuals (Salgin et al., 2009). This was mitigated by blocking lipolysis with acipimox, 
suggesting it is mediated by the increase in NEFA (Salgin et al., 2009). In light of this, further 
understanding of the overall effects of IF on NEFA, lipid metabolism and ectopic lipid 
deposition is required. 
 
This was a short-term, highly-controlled intervention conducted solely in women. As such, this 
data is not translatable beyond eight weeks or to wider populations, including men, or those 
with established metabolic disturbances, such as type 2 diabetes. Therefore, further longer-term 
highly controlled interventions and in other populations are required. This study was powered 
to detect a 15 unit difference in M with N=22/group and thus was underpowered to detect the 




primary outcome, given that we were only able to conduct clamps in N=17 from the IF70 
group. The randomisation pattern of 2:1 for IF100:Control also weakens the comparisons 
between these two groups. 
 
IF was more effective than DR for reducing body weight, and improving metabolic health, 
when prescribed with a similar energy deficit, but did not differentially impact insulin 
sensitivity assessed by hyperinsulinaemic-euglycaemic clamp. When IF was prescribed 
without energy restriction, there were transient elevations in markers of diabetes risk, and no 
overall beneficial effects on metabolic parameters, despite minor weight loss. This study 
demonstrates that IF approaches that involve repeated 24-hour fasts improve metabolic health 
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4.1 Abstract  
Background:  Increased macrophage infiltration and extracellular matrix deposition in adipose 
tissue and skeletal muscle occur in obesity, and are associated with insulin resistance. However, 
acute fasting also increases adipose tissue macrophage infiltration in mice. This study 
compared the effects of 8 weeks of daily calorie restriction (DR) versus intermittent fasting 
(IF) on markers of adipose tissue and skeletal muscle remodelling in women who were 
overweight and obese.   
 
Methods: Women who were overweight or obese (N=76, BMI 25.0-42.0kg/m2) were 
randomized to one of three diets and provided with all foods to meet 100% (IF100) or 70% 
(IF70 and DR70) of calculated energy requirements. IF groups initiated a 24-hour fast, after 
consuming breakfast, on 3 non-consecutive days/week. Weight, body composition, non-
esterified fatty acids (NEFA), circulating inflammation markers, markers of macrophages and 
extracellular matrix in adipose tissue and skeletal muscle were measured at baseline and after 
8-weeks of intervention following an overnight 12-hour fast (all groups) and a 24-hour fast (IF 
groups).  
 
Results: IF70 resulted in greater weight and fat loss versus DR70 and IF100 (P<0.05). Markers 
of inflammation in serum, subcutaneous adipose tissue and skeletal muscle were unchanged by 
DR or IF, when assessed after the overnight fast. However, serum NEFA and markers of 
classically activated M1-macrophages in adipose tissue, and alternatively activated M2- 
macrophages in muscle were increased after the 24-hour fast in both IF groups (all P<0.05), 
and the changes in NEFA and CD68 mRNA levels in adipose tissue were positively correlated 
(r=0.56, P=0.002). Matrix metalloproteinase-2 mRNA levels in adipose tissue were increased 
in IF70 and DR70, but adipose tissue collagen by histology was unchanged in any group.  





Conclusions: Intermittent fasting transiently elevated markers of macrophage infiltration, 
which may link with stimulation of lipolysis. 
 
Key words: adipose tissue, calorie restriction, extracellular matrix, intermittent fasting, 
macrophage, skeletal muscle.  





Obesity is associated with increased adipocyte size (Trayhurn et al., 1979, Salans et al., 1973), 
inflammation and fibrosis in adipose tissue (Xu et al., 2003, Weisberg et al., 2003, Khan et al., 
2009) and skeletal muscle (Fink et al., 2014, Tam et al., 2015, Martinez-Huenchullan et al., 
2017), which are linked to the development of insulin resistance (Sun et al., 2011, Martinez-
Santibanez and Lumeng, 2014, Wu and Ballantyne, 2017). In humans and animal models of 
obesity, monocytes are recruited into adipose tissue and skeletal muscle. These macrophages 
are polarised towards inflammatory M1-macrophages, which release pro-inflammatory 
cytokines including interferon-gamma (IFN-γ), lipopolysaccharide (LPS) and tumour necrosis 
factor alpha (TNFα), impairing the insulin signalling cascade (Lumeng et al., 2007a, Fink et 
al., 2014, Martinez-Santibanez and Lumeng, 2014, Wu and Ballantyne, 2017). There is also an 
increase in extracellular matrix (ECM) deposition, which provides mechanical and nutritional 
support to neighbouring cells. Excessive accumulation of the ECM has been linked with 
impairments in adipocyte expansion, and ectopic lipid accumulation in liver and skeletal 
muscle (Sun et al., 2013, Divoux et al., 2010).  
 
Daily calorie restriction (DR) promotes weight and fat loss, and reduces the risk of type 2 
diabetes and cardiovascular diseases in individuals with obesity (Barnosky et al., 2014, 
Heilbronn and Ravussin, 2003). Mouse and human studies have shown that DR reduces 
adipocyte size (Larson-Meyer et al., 2006, Zamarron et al., 2017) and macrophage infiltration 
in adipose tissue and muscle (Fabbiano et al., 2016, Capel et al., 2009, Yang et al., 2016). There 
is also some evidence that DR may result in phenotype switching of macrophages from the 
inflammatory M1- to anti-inflammatory M2-macrophage profile in adipose tissue, in mice 
(Fabbiano et al., 2016). DR down-regulates mRNA levels of collagen genes and up-regulates 




genes involved in ECM degradation in adipose tissue (Higami et al., 2006, Magkos et al., 
2016), but its effects on muscle ECM remodelling are less clear. 
 
Intermittent fasting (IF) involves intermittent periods of zero, or minimal energy intake, 
typically for 24 hours, followed by unlimited food access. IF reduces body weight, fat mass 
and improves cardiovascular and diabetes risk markers in mice and in humans (Varady et al., 
2010, Gotthardt et al., 2016, Heilbronn et al., 2006, Heilbronn et al., 2005b, Trepanowski et 
al., 2017). The impacts of intermittent fasting on markers of adipose tissue or skeletal muscle 
remodelling have not been examined in humans. This is of interest since three studies in mice 
have reported that an acute 24-hour fast increase macrophage infiltration into adipose tissue 
(Asterholm et al., 2012, Ding et al., 2016, Kosteli et al., 2010). 
 
This study compared the effects of 1) eight-week daily calorie restriction versus intermittent 
fasting on markers of adipose tissue and skeletal muscle remodelling in women with 
overweight or obesity,  and 2) the acute effects of the 24-hour fast during IF on these outcomes. 
We hypothesised that DR and IF would differently impact markers of adipose tissue and 
skeletal muscle remodelling, and particularly markers of inflammation. 
  




4.3 Research Design and Methods 
Participants and Study Design 
Eighty-eight women aged 35-70 years, with a BMI of 25-42 kg/m2, were recruited. Those who 
were smokers, taking medications known to affect appetite, body weight, diagnosed with 
diabetes, cardiovascular diseases and eating disorders, pregnant or breastfeeding, or planning 
to become pregnant, had >5% weight change in past 6 months, took part in >2 moderate to 
high-intensity exercise sessions per week, consumed >140g alcohol/week were excluded. This 
study was approved by the Royal Adelaide Hospital Research Ethics Committee, and all 
participants provided written, informed consent prior to their inclusion. The study was 
registered as a clinical trial with Clinicaltrials.gov (NCT01769976). 
 
This report excludes the control group (n=12), as biopsies were not obtained. Seventy-six 
participants were randomly assigned to one of three diets, DR70, IF70 and IF100 by BMI (<33 
or >33 kg/m2), for 8 weeks. The estimated energy requirements for each participant were 
calculated as described previously (Samocha-Bonet et al., 2010). DR70 were provided 70% of 
calculated energy requirements, daily. The IF70 group were provided foods at ~100% of energy 
requirements, and IF100 at ~145% of energy requirements on fed days. On fasting days, IF 
groups consumed breakfast before 8am (~ 32-37% of energy requirements) prior to “fasting” 
for 24-hours, until 8am the following day, every other week-day (3 fasting days per week). 
During the fasting period, participants were allowed to consume water and energy-free foods, 
black coffee and/or tea, and one very low calorie broth (250 ml, ~20 kcals). A total of night 
participants withdrew (Fig. 4.1).








Figure 4-1: Flowchart of the study 




Metabolic Testing in Participants  
Participants were required to attend the research clinic at 7:30 a.m., at baseline and after 8-
weeks following an overnight 12-hour fast. IF groups undertook an additional visit following 
a 24-hour fast. Body weight, height, waist and hip circumference were measured with the 
participant dressed in a hospital gown after voiding. Blood samples were obtained, and serum 
and plasma were separated and stored at -80°C freezer for analysis of insulin, non-esterified 
fatty acids (NEFA), TNFα, interleukin-6 (IL-6), interleukin-10 (IL-10) and monocyte 
chemoattractant protein-1 (MCP-1). Total body composition was assessed by dual-energy x-
ray absorptiometry (Lunar Prodigy; GE Healthcare, NSW, Australia) at baseline and after 8-
weeks following an overnight fast for all groups. 
 
Adipose and muscle tissue biopsies 
Subcutaneous abdominal adipose and vastus lateralis muscle samples were obtained by 
percutaneous biopsy at baseline and at week 8 after 12-hour fast (all groups) and 24-hour fast 
(IF groups only). Briefly, biopsy sites were located and cleaned. After anesthetizing the skin 
and underlying tissues with lidocaine, adipose tissue was aspirated from the periumbilical area 
and vastus lateralis samples were collected using the Bergstrom technique as previously 
described (Tam et al., 2010, Tam et al., 2017). A small piece of sample (~30mg) was fixed for 
histology, and the remainder (~150mg) frozen in liquid nitrogen and stored at -80°C. Not all 
participants consented to both adipose and skeletal muscle biopsies. Due to this, and scheduling 
conflicts, biopsy samples were obtained from a subset of participants (n=14-16/group for 
adipose tissue and n=12-16/group for muscle, Fig. 4.1). The baseline characteristics in those 
who underwent adipose tissue or skeletal muscle biopsies were not different between groups 
and were not different from that of those who completed 8 weeks of intervention. 
 




Table 4-1: Taqman primers used for gene expression analysis 
Gene symbol Gene Name Assay ID 
Housekeeper 
ACTB Actin beta Hs01060665_g1 
PPIB Peptidylprolyl isomerase B Hs00168719_m1 
LRP10 LDL receptor related protein 10 Hs01047362_m1 
Pan macrophage  
CD68 CD68 molecule Hs02836816_g1 
M1-macrophage  
CD40 CD40 molecule Hs01002913_g1 
TNF Tumor necrosis factor Hs01113624_g1 
IL6 Interleukin 6 Hs00985639_m1 
M2-macrophage 
CD163 CD163 molecule Hs00174705_m1 
IL10 Interleukin 10 Hs00961622_m1 
Macrophage recruitment  
CCL2 C-C motif chemokine ligand 2 Hs00234140_m1 
CCL3 C-C motif chemokine ligand 3 Hs00234142_m1 
Extracellular matrix  
COL6A1 Collagen type VI alpha 1 Hs01095585_m1 
MMP2 Matrix metallopeptidase 2 Hs01548727_m1 
TIMP1 TIMP metallopeptidase inhibitor 1 Hs00171558_m1 
Lipolysis   
LIPE Lipase E, hormone sensitive type Hs00193510_m1 
PLIN1 Perilipin 1 Hs00160173_m1 
lipogenesis 
FASN Fatty acid synthase Hs01005622_m1 
ACACA Acetyl-CoA carboxylase alpha Hs01046047_m1 
Adipogenesis 
CEBPb CCAAT/enhancer binding protein beta Hs00270923_s1 
SREBF1 Sterol regulatory element binding transcription factor 1 Hs01088691_m1 
 
 





Blood lipids and fasting blood glucose were examined by photometric assays in the laboratory 
of SA Pathology (Adelaide, South Australia, Australia). Serum insulin was measured by 
radioimmunoassay (HI-14K, Millipore, MA, USA). Plasma high-sensitivity C-reactive protein 
(Hs-CRP, Beckman Coulter Inc, CA, USA) was measured using commercially available 
enzymatic kits on a Beckman AU480 clinical analyser (Beckman Coulter Inc). Serum TNFα, 
IL-6 and IL-10 were analysed by multiplex bead array assays (R & D Systems, Minneapolis, 
USA) with MAGPIX Multiplex Reader (Luminex, Austin, TX, USA). Serum non-esterified 
fatty acids (NEFA) were measured by enzymatic colorimetric assay (NEFA-HR (2), Wako 
Diagnostics, CA, USA), and serum MCP-1 was measured using ELISA kit (BD, San Diego, 
CA, USA) on a VersaMax ELISA Microplate Reader (Sunnyvale, CA, USA). Samples were 
run in duplicate and samples from each participant were tested within the same run to reduce 
instrument variation. Homeostasis model of assessment-insulin resistance (HOMA-IR) was 
calculated as fasting glucose (mmol/L) × fasting insulin (mU/L)/22.5. 
 
Quantitative Real-Time PCR 
As described previously (Chen et al., 2016a), total RNA was extracted from adipose (100-
150mg) and muscle (30-50mg) samples using TRI Reagent (Sigma, St. Louis, USA) following 
manufacturer’s instructions. The concentration and purity of RNA were assessed by NanoDrop 
Lite Spectrophotometer (Thermo Fisher Scientific, CA, USA). cDNA synthesis was conducted 
using T100 Thermal Cycler (Bio-Rad, CA, USA) with 1000 ng of each RNA sample using the 
QuantiTect reverse transcription kit (Qiagen, Valencia, CA, USA) according to kit instructions. 
Quantitative real-time PCR was performed using the Taqman primers for pan-macrophage 
(CD68), inflammatory M-1 macrophage (CD40, TNF and IL6), anti-inflammatory M2-
macrophage (CD163 and IL10), macrophage recruitment (CCL2 and CCL3), extracellular 




matrix (COL6A1, MMP2 and TIMP1), lipolysis (LIPE and PLIN1), lipogenesis (ACACA and 
FASN), adipogenesis (CEBPb and SREBF1, Table 4.1) and Fast Universal PCR Master Mix 
(Applied Biosystems, Foster City, CA, USA). The samples were run in duplicate on an ABI 
7500 sequence detection system (Applied Biosystems, Foster City, CA, USA) with internal 
negative controls and a standard curve (pooled from ten participants at baseline). Relative gene 
expression was analysed using the 2−ΔCT method and normalised for the mean of ACTB and 
PPIB for adipose tissue, and the mean of ACTB and LPR10 for skeletal muscle, which were 
not different at baseline, or following the intervention. CCL3, TNF and IL6 were below 
detectable limits in adipose tissue and muscle.  
 
Histological Analysis and Immunofluorescent Staining. 
Adipose tissue biopsy samples were fixed in Bouin’s solution (Sigma-Aldrich, HT10132), 
dehydrated, paraffin embedded, sectioned at 5µm and mounted on positively-charged glass 
slides. All slides were randomly assigned numeric codes by a research officer to blind the 
investigator (BL) quantifying outcomes. Hematoxylin and eosin (H&E) staining was 
performed using a standard protocol. Digital images were acquired using a camera (U-TV1X-
2, Olympus, Tokyo, Japan) and diameters measured using cellSens Software (Olympus, Tokyo, 
Japan). Adipocyte diameter was measured in at least three fields of view at 20X. The mean 
diameter was calculated from an average of 300 cells per sample as described previously (Tam 
et al., 2010). Masson’s trichrome staining was performed using a commercial kit (Sigma, St. 
Louis, MO, USA) following manufacturer’s instructions. Slides were scanned using the 
Pannoramic 250 Flash II scanner (3DHISTECH, Budapest, Hungary) and whole sections were 
analysed using Masson’s trichrome macro in Image J (National Institutes of Health). Particular 
care was taken to exclude areas which contained blood vessels, as collagen is associated with 
vasculature (Rhodes and Simons, 2007).  




For CD40 (M1-macrophage) and CD206 (M2-macrophage) co-staining, deparaffinised and 
rehydrated slides were incubated with ELOXALL solution (SP-600, Vector) for 10min at room 
temperature to eliminate endogenous peroxidase and alkaline phosphatase. Antigen retrieval 
was achieved using modified citrate-based buffer (S1700, Dako) and incubation in a 95°C 
water bath for 20min. Slides were blocked with 5% bovine serum albumin (Sigma) in 
phosphate-buffered saline (PBS, Sigma) for 60min at room temperature before incubated with 
a mouse anti-human CD40 (1:200, MAB6321, R& D) for 90min at room temperature. Slides 
were then washed with PBS for 5min for 3 times prior to being incubated with a chicken anti-
mouse secondary antibody (1:500, A-21200, ThermoFisher) for 60min at room temperature.  
Following 5min x 3 washing, goat anti-human CD206 (1:200, AF2534, R & D) and the 
corresponding donkey anti-goat secondary antibody (1:500, A-11057, ThermoFisher) were 
applied. CD40 and CD206 co-labeled slides were counterstained with ProLong Gold Antifade 
Mountant with DAPI (P36941, ThermoFisher). Eight to ten fields at 40X were analysed using 
the camera and software mentioned above. Positive cells were expressed per 100 adipocytes as 
described previously (Aron-Wisnewsky et al., 2009) .  
 
Statistical analysis 
Data are expressed as mean ± SEM. Individuals who withdrew from the study were not 
included in the analyses. Participants completing baseline and week-8 (12-hour fast) biopsies 
were included for gene expression analyses. All statistical analyses were performed using IBM 
SPSS Statistics 24 (Armonk, New York, USA). Baseline differences between groups were 
analysed using one-way ANOVA with Bonferroni-Holm post-hoc test. A maximum likelihood 
mixed effects model was employed to examine the group differences of 8-week intervention 
following an overnight 12-hour fast, as well as the time effects within each group. The model 
included fixed effects for intervention, visit and the intervention by visit interaction, and a 




random effect for subject with an unstructured covariance matrix to account for the repeated 
visits. The effect of intervention was assessed with planned contrasts between groups in the 
change from baseline to week 8 (12-hour fast). Bonferroni-adjusted pairwise comparisons were 
also conducted within each group to assess differences over time from baseline to following a 
12-hour fast (all groups) and a 24-hour fast (IF groups only). Data were log-transformed for 
analysis if skewness in the residuals was observed. Significance was accepted as P < 0.05. 
  




4.4 Results  
Anthropometrics and metabolites at baseline 
Anthropometric and metabolic parameters of the participants at baseline are summarised in 
Table 4.2. There were no significant differences between groups with respect to any variables 
assessed at baseline. There were no significant differences between individuals completed this 
trial and those underwent biopsies or did not with regards to the variables listed in Table 4.2. 
 
Table 4-2: Anthropometric and metabolic measures of participants at baseline  
Variable DR70 IF70 IF100 P  
N 26 25 25 
 
Age (years) 50.9 ± 1.8 49.5 ± 2.0 51.0 ± 1.8 0.827 
Pre-/post- menopause  11/16 11/14 13/12 - 
Weight (kg) 88.4 ± 2.8 89.4 ± 2.8 84.1 ± 2.8 0.289 
Height (cm) 164.7 ± 1.0 166.0 ± 1.7 162.2 ± 1.5 0.158 
Waist(cm) 99.0 ± 1.8 100.5 ± 2.2 98.8 ± 2.6 0.859 
Hip(cm) 115.7 ± 2.4 115.1 ± 2.1 112.1 ± 1.9 0.433 
Waist/hip 0.86 ± 0.01 0.87 ± 0.02 0.88 ± 0.02 0.640 
BMI (kg/m2) 32.6 ± 1.0 32.4 ± 0.8 31.2 ± 0.9 0.746 
TG (mmol/l) 1.3 ± 0.1 1.2 ± 0.1 1.5 ± 0.1 0.093 
TC (mmol/l) 4.9 ± 0.1 4.8 ± 0.1 5.0 ± 0.2 0.256 
HDL-C (mmol/l) 1.4 ± 0.1 1.4 ± 0.1 1.4 ± 0.2 0.728 
LDL-C (mmol/l) 3.0 ± 0.1 2.9 ± 0.1 3.0 ± 0.2 0.726 
Glucose (mmol/l) 4.9 ± 0.1 4.9 ± 0.1 4.9 ± 0.1 0.956 
Insulin (mU/ml) 15.5 ± 1.3 19.5 ± 1.5 18.6 ± 1.5 0.116 
HOMA-IR 3.4 ± 0.3 4.3 ± 0.3 4.1 ± 0.4 0.207 
Hs-CRP (mg/l) 2.7 ± 0.5 2.9 ± 0.5 2.8 ± 0.5 0.907 
Data are presented as mean ± SEM. One-way ANOVA with Bonferroni-Holm post-hoc test. 
DR70: continuous energy restriction at 70% baseline energy requirements: IF70: intermittent 
fasting diet at 70% baseline energy requirements; IF100: intermittent fasting diet at 100% 
baseline energy requirements. BMI: body mass index; TG: triglycerides; TC: total cholesterol; 
HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; 
HOMA-IR: homeostasis model assessment of insulin resistance; Hs-CRP: high-sensitivity C-
reactive protein  




Adiposity, glucose metabolism and non-esterified fatty acids  
Body weight and fat mass were reduced in all groups (all P<0.001), with greater reductions in 
IF70 vs. DR70 and IF100 (both P<0.05, Fig. 4.2A and B). Adipocyte size was reduced in all 
groups (all P≤0.01), with no difference between groups (Fig. 4.2C and D). When measured 
following the overnight fast, NEFA levels were decreased in all groups (all P<0.05), with 
greater reductions in IF70 vs. DR70 (P=0.02, Fig. 4.2E). Fasting HOMA-IR was reduced in 
IF70 (P=0.01), and a group effect was observed between IF100 vs. IF70 and DR70 (both 
P<0.05, Fig. 4.2F). When measured following the 24-hour fast, NEFA levels were increased 
(both P<0.05, Fig. 4.2E) and HOMA-IR was reduced (both P≤0.01, Fig. 4.2F) in both IF 
groups. Since biopsies were performed in a subgroup of participants, an additional analysis 
examining the outcomes reported above was conducted. This revealed the responses to dietary 
intervention were not different between participants underwent biopsies and those did not. 
Importantly, all the within group effects reported in Fig.4.2 held. However, the between group 
difference in weight and fat mass loss did not exist. 
 
 




Figure 4-2: Adiposity, glucose metabolism, and non-esterified fatty acids following 8 
weeks of intervention  
(A): Body weight; (B): Fat mass; (C): Representative H&E staining of subcutaneous adipose 
tissue; (D): Fat cell size; (E): HOMA-IR and (F): NEFA. DR70: continuous energy restriction 
at 70% baseline energy requirements: IF70: intermittent fasting diet at 70% baseline energy 
requirements; IF100: intermittent fasting diet at 100% baseline energy requirements. Scale bar: 
100μm. 
 
Data presented as Mean±SEM. ^P<0.05 vs. DR70 in the change from baseline to week 8 
following a 12-hour fast; ‡ P<0.05 vs. IF100 in the change from baseline to week 8 following 
a 12-hour fast. *P<0.05, **P<0.01 and ***P<0.001 vs. baseline.  
 
Systemic and tissue inflammation  
When measured following the overnight fast, there were no within or between group changes 
in any inflammatory markers assessed in serum (Fig. 4.3A-D, and Appendix figure 3), adipose 
tissue (Fig. 4.3I-K and Fig. 4.3M-P) or muscle (Fig. 4.3Q-T, and Appendix figure 4 and 5), 
except for an increase in serum MCP-1 in IF100 (P=0.01, Fig. 4.3D). When measured 
following the 24-hour fast, serum MCP-1 (Fig. 4.3D), CD40 mRNA levels (Fig. 4.3M), the 
total number of M1- and pan-macrophages in adipose tissue by histology (Fig. 4.3I and K), 
CD163 mRNA levels and the CD163:CD40 ratio in muscle (Fig. 4.3R and T) were increased 
in the IF70 group (all P<0.05).  The number of M1-, M2- and pan-macrophages in adipose 
tissue (Fig. 4.3I-K), CD163 and CD68 mRNA levels and the CD163:CD40 ratio in muscle 
(Fig. 4.3R-T) were also increased after the 24-hour fast in the IF100 group (all P<0.05). When 
measured following the 24 hour fast, the change in CD68 mRNA levels in adipose tissue was 
positively correlated with the change in NEFA in both IF groups (r=0.56, P=0.002, Fig. 4.3L). 
 





Figure 4-3: Systemic and tissue inflammation following 8 weeks of intervention 
(A-D): Serum TNFα, IL-6, IL-10 and MCP-1; (E-H): Representative images of fluorescent 
staining for M1-macrophage (CD40), M2-macrophage (CD206), nuclei (DAPI) and layout; (I 
to K): Quantification of M1-, M2- and total macrophages in adipose tissue; (L): Correlation 
between changes in NEFA levels and CD68 mRNA levels in adipose tissue after a 24-hour 
fast; (M-O): mRNA levels of CD40 (M1- macrophage), CD163 (M2- macrophage) and CD68 
(pan-macrophage) in adipose tissue; (P): The ratio of CD163:CD40 in adipose tissue; (Q-S): 
mRNA levels of CD40, CD163 and CD68 in skeletal muscle and (T): The ratio of 
CD163:CD40 in muscle. DR70: continuous energy restriction at 70% baseline energy 
requirements: IF70: intermittent fasting diet at 70% baseline energy requirements; IF100: 




intermittent fasting diet at 100% baseline energy requirements. Scale bar: 20μm. AU: arbitrary 
unit. 
 
Data presented as Mean±SEM. *P<0.05 and **P<0.01 vs. baseline.  
 
Extracellular matrix remodelling in adipose tissue and muscle  
When measured following the overnight fast, there were no between group differences in the 
change in extracellular matrix markers in adipose tissue (Fig. 4.4A-C) or muscle (Fig. 4.4E-
G). However, MMP2 mRNA levels were increased in adipose tissue in DR70 and IF70 (both 
P<0.01, Fig. 4.4B). COL6A1 and MMP2 mRNA levels were increased in skeletal muscle in 
IF100 (both P≤0.05, Fig. 4.4E and F). When measured after the 24-hour fast, MMP2 mRNA 
levels remained elevated in adipose tissue in the IF70 group (P=0.002, Fig. 4.4B). However, 
the integrated density (Fig. 4.4D) or area (Appendix figure 6) of collagen in adipose tissue 




Figure 4-4: Extracellular matrix remodelling in adipose tissue and muscle following 8 
weeks of intervention 
(A-C): mRNA levels of COL6A1, MMP2 and TIMP1 in adipose tissue; (E-G): mRNA levels 
of COL6A1, MMP2 and TIMP1 in muscle; (D and H): Representative image of Masson's 
trichrome staining and quantification of the integrated density of collagen in adipose tissue. 




DR70: continuous energy restriction at 70% baseline energy requirements: IF70: intermittent 
fasting diet at 70% baseline energy requirements; IF100: intermittent fasting diet at 100% 
baseline energy requirements. Scale bar: 100μm. AU: arbitrary unit. 
 
Data presented as Mean±SEM. *P<0.05 and **P<0.01 vs. baseline. 
 
Lipid metabolism and adipogenesis markers in adipose tissue  
When measured following the overnight fast, FASN mRNA levels in adipose tissue were 
decreased in the IF70 group (P=0.02, Fig. 4.5A), and this was significantly different from the 
change in FASN mRNA levels in the IF100 group (P=0.03). ACACA mRNA levels in adipose 
tissue were tended to be reduced in the DR70 group (P=0.05, Fig. 4.5B). When measured 
following the 24-hour fast, there were no significant change in markers of lipogenesis (Fig. 
4.5A and B) or lipolysis (Fig. 4.5C and D) in either IF group. mRNA levels of CEBPb and 
SREBF1 were not altered in any group (Fig. 4.5E and F). 
 
 
Figure 4-5: Lipogenesis, lipolysis, and adipogenesis markers in adipose tissue following 8 
weeks of intervention 
(A and B) mRNA levels of lipogenesis markers ACACA and FASN; (C and D) mRNA levels 
of lipolysis markers LIPE and PLIN1; (E and F): mRNA levels of adipogenesis markers 
CEBPb and SREBF1. DR70: continuous energy restriction at 70% baseline energy 




requirements: IF70: intermittent fasting diet at 70% baseline energy requirements; IF100: 
intermittent fasting diet at 100% baseline energy requirements. AU: arbitrary unit. 
 
Data presented as Mean±SEM. ‡P<0.05 vs. IF100 in the change from baseline to week 8 
following a 12-hour fast. *P<0.05 vs. baseline. 
  




4.5 Discussion  
Obesity is associated with increased macrophage infiltration and extracellular matrix 
deposition in adipose tissue, which can be at least partially reversed following weight loss by 
DR (Weisberg et al., 2003, Xu et al., 2003, Zamarron et al., 2017, Divoux et al., 2010, Higami 
et al., 2006, Magkos et al., 2016). The effects of IF, as an alternative weight loss strategy, on 
tissue remodelling in humans are unknown. Data obtained from mouse studies suggest that 
macrophage infiltration is stimulated in response to an acute 24-hour fast (Kosteli et al., 2010, 
Ding et al., 2016, Asterholm et al., 2012). In this study, we observed an increase in markers of 
macrophage infiltration in human adipose tissue in response to the 24-hour fast imposed by the 
intermittent fasting schedule. This was associated with increases in NEFA, a marker of adipose 
tissue lipolysis, as has also been shown previously in mouse models (Kosteli et al., 2010).  
 
Macrophages are the dominant leukocyte population in adipose tissue, and can be divided into 
two subtypes based on their functional properties: M1- and M2- macrophages. M1, or 
classically activated macrophages, secrete pro-inflammatory molecules such as IFN-γ, LPS and 
TNFα, and contribute to obesity related morbidities. The M2- subtype represents alternatively 
activated anti-inflammatory macrophages (Martinez-Santibanez and Lumeng, 2014). In this 
study, DR did not impact any of the markers of macrophages or inflammation in adipose tissue, 
skeletal muscle, or systemically. This finding is in line with previous reports (Magkos et al., 
2016, Tam et al., 2012a). Tam et al reported that 24-weeks of DR led to 10% weight loss in 
individuals with obesity, but did not alter systemic inflammation or markers of macrophages 
in adipose tissue (Tam et al., 2012a). Magkos et al reported that 10-15% weight loss by DR 
partially improved systemic inflammation, without altering mRNA levels of macrophage 
markers in subcutaneous adipose tissue in humans with obesity (Magkos et al., 2016). In 
skeletal muscle, one study reported that inflammatory markers were decreased in skeletal 




muscle collected from individuals following long-term DR (3-15 yrs) versus age-matched 
sedentary individuals consuming western diet (Yang et al., 2016), but this was not observed 
after 3-months of DR (Liu et al., 2017a). 
 
Of note, a 24-hour fast increased multiple markers of inflammation in adipose tissue and 
skeletal muscle, and the increase in macrophage marker in adipose tissue was associated with 
elevated NEFA levels. In mice, a 24-hour fast significantly increased circulating NEFA levels 
and macrophage infiltration in adipose tissue (Kosteli et al., 2010). The peak of adipose tissue 
macrophage number coincided with the peak in the circulating concentration of NEFA and 
glycerol released from adipose tissue, suggesting that lipolysis drives macrophage 
accumulation in adipose tissue (Kosteli et al., 2010). Moreover, in vivo and in vitro studies 
have shown that stimulation of adipocyte lipolysis increased the uptake and storage of lipids 
by macrophages (Caspar-Bauguil et al., 2015, Kosteli et al., 2010). Elevations in NEFA are 
linked with insulin resistance in liver and muscle (Delarue and Magnan, 2007),  and thus 
macrophages may play a protective role to buffer elevated NEFA levels induced by fasting, in 
humans.  
 
The phenotype of macrophages covers a continuum of functional states from inflammatory 
M1- to anti-inflammatory M2- profiles (Mantovani et al., 2004). The polarization of 
macrophages toward M1- or M2- phenotype is through distinct pathways by external stimuli. 
For example, lipopolysaccharides and IFNγ promotes a M1- polarization, whilst interleukin 4 
and 10 yields a M2-polarization (Martinez and Gordon, 2014). Some evidence suggests 
macrophages can maintain their population by self-proliferation, and M2-macrophages can be 
transformed into M1-phenotype to promote inflammation (Zheng et al., 2013, Zamarron et al., 
2017). Previous studies in mice show that an acute 24-hour fast, and intermittent fasting, also 




promote M2-polarisation of macrophages in adipose tissue (Asterholm et al., 2012, Kim et al., 
2017). To our knowledge, the impacts of acute or intermittent fasting on muscle macrophage 
phenotype have not been reported in mice or humans. In this study, we observed IF increased 
mRNA levels of M2- macrophages in muscle. The mechanisms by which IF promotes M2-
polarization requires further study.   
 
ECM is a non-cellular component existing in all tissues, which provides structural support to 
the neighbouring cells, and influences cell morphology and function through cell-matrix 
connections (Sun et al., 2013). The homeostasis of ECM is maintained by a balance between 
synthesis and degradation. Collagens are the main proteins in ECM and are degraded by matrix 
metalloproteinases (MMPs), which are negatively regulated by tissue inhibitors of 
metalloproteinases (TIMPs) (Zamarron et al., 2017). Previous studies have shown that ECM 
accumulation in adipose tissue and skeletal muscle is linked with obesity and poor metabolic 
phenotype, such as insulin resistance (Williams et al., 2015). In this study, we found that MMP2 
mRNA expression, which contributes to the degradation of ECM, was increased in adipose 
tissue in DR and IF70 groups. This finding suggests that weight loss, rather than the mode of 
dietary restriction, increases ECM degradation in adipose tissue. This is in line with a recent 
human study, which suggests that minor weight loss (5%) upregulates genes involved in the 
degradation of ECM in subcutaneous adipose tissue (Magkos et al., 2016). We did not see a 
reduction in collagen deposition in adipose tissue by histology, but this may be the result of the 
minor weight loss achieved. Substantial weight loss by bariatric surgery also did not change 
fibrosis in subcutaneous adipose tissue in morbidly obese patients with and without Type 2 
diabetes after 6 months (Chabot et al., 2017). Interestingly, Clément’s group observed 
increased collagen deposition in subcutaneous adipose tissue 3-12 months after bariatric 
surgery (Liu et al., 2016). However, this was characterised by a decrease in cross-link of matrix 




fibres and increased degradation of the extracellular matrix, and was associated with an 
increase in M2-macrophages. This study highlights that the “structure or quality” of collagen 
should be taken into consideration when assessing adipose tissue fibrosis. Further studies are 
required to investigate the structure and quality of collagen, and the crosstalk between 
extracellular matrix and macrophages in adipose tissue and skeletal muscle following weight 
loss.  Our data also supports past studies to suggest that ECM gene expression in skeletal 
muscle is sensitive to overfeeding (Tam et al., 2017, Tam et al., 2014), as the mRNA levels of 
COL6A1 and MMP2 were transiently increased in the IF100 group after consuming~145% of 
energy requirements on the fed day. This suggests both intermittent “fasting” and “overeating” 
in an intermittent fasting regimen are signals that could impact tissue remodelling.  
 
This study was a short-term intervention that was limited to women who were overweight and 
obese. Thus, the responses in men and in individuals with normal body weight may be different. 
The long-term effects of intermittent fasting on adipose tissue and skeletal muscle require 
further study.  
 
In conclusion, weight loss by DR or IF reduced fat cell size and stimulated markers of ECM 
remodelling, but did not alter markers of inflammation, when measured after an overnight fast. 
In response to the 24-hour fast, IF transiently elevated markers of inflammation in adipose 
tissue and muscle. The change in markers of macrophage infiltration in adipose tissue 
following the 24-hour fast was associated with the change in NEFA. The long-term effects of 
these transient increases in markers of inflammation in response to intermittent fasting requires 
further investigation.   
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Background:  Intermittent fasting (IF) promotes weight loss in diet-induced obese mice, but 
its effects on adipose tissue inflammation and fibrosis are unclear.  
 
Methods: Ten-week old male C57BL/6J mice were fed a high-fat (HFD; 43% fat) or chow 
diet (18% fat) for 8-weeks ad libitum (AL), and randomised to AL or IF for an additional 8-
weeks. IF was initiated one hour before lights off (Zeitgeber time 11, lights on at ZT0) for 24-
hours, on 3 non-consecutive days per week. Body weight and energy intake were monitored 
and oral glucose tolerance (2g/kg body weight) was assessed. At the end of the study, all mice 
were sacrificed at ZT7-9, fed state or after a 22-hour fast. Plasma insulin and non-esterified 
fatty acids (NEFA) were analysed. Inguinal and gonadal fat were collected for the assessment 
of markers of inflammation and extracellular matrix. Fat cell size, macrophage numbers and 
collagen content in adipose tissue were assessed by histology. Two-way ANOVA with 
Bonferroni post-hoc test was used to assess the effects of diet (chow and HFD) and schedule 
(AL and IF) between groups. Significance was accepted as P<0.05. 
 
Results: IF decreased energy intake, body weight and fat cell size in HFD fed mice, and 
decreased fat mass and improved glucose tolerance in chow and HFD fed mice (all P<0.05). 
IF decreased mRNA levels of Lgals3, Itgax, Ccl2 and Ccl3 in inguinal and gonadal fat, and 
adipose tissue macrophages numbers in HFD fed mice only (all P<0.05). IF increased mRNA 
levels of Mmp9, but reduced mRNA levels of Col6a1 and Timp1, and fibrosis in gonadal fat in 
HFD fed mice (all P<0.05). The 22-hour fast elevated NEFA levels (all P<0.05), but did not 
alter inflammation markers in adipose tissue in either diet groups.    
 




Conclusions: Intermittent fasting improved glucose tolerance in chow and high fat diet fed 
mice, and ameliorated the adipose tissue inflammation and fibrosis in high fat diet fed mice. 
 
Key words: adipose tissue, extracellular matrix, glucose tolerance, intermittent fasting, 
macrophage 
  





Daily caloric restriction (DR) promotes weight loss, improves health, and extends lifespan in a 
variety of species. Intermittent fasting (IF) has recently gained attention as a viable alternative 
to DR. IF extends lifespan, reduces fat mass, and improves glucose tolerance with no, or 
minimal, impact on food consumption and body weight in chow fed mice (Goodrick et al., 
1990, Anson et al., 2003, Varady et al., 2008, Varady et al., 2010). The impact of IF on high-
fat diet fed mice are less clear, with only four animal studies conducted very recently (Gotthardt 
et al., 2016, Joslin et al., 2017, Li et al., 2017, Liu et al., 2017b). These studies have consistently 
reported that IF resulted in significant weight loss, but improvements in glucose tolerance are 
controversial.  
 
White adipose tissue undergoes remodelling during weight gain, including adipocyte 
hypertrophy and/or hyperplasia, increases in macrophage infiltration and extracellular matrix 
(ECM) deposition (Sun et al., 2011, Sun et al., 2013, Martinez-Santibanez and Lumeng, 2014). 
Increased accumulation of macrophages and ECM in adipose tissue has been linked to 
development of insulin resistance (Weisberg et al., 2003, Xu et al., 2003, Olefsky and Glass, 
2010, Sun et al., 2013). Macrophages may also promote ECM deposition (Spencer et al., 2010, 
Bourlier et al., 2012, Keophiphath et al., 2009), which could negatively impact adipocyte 
expansion, promote ectopic lipid deposition and impact metabolic health (Sun et al., 2013, 
Khan et al., 2009). Marked weight loss by DR reduces macrophage infiltration in adipose tissue 
(Hoevenaars et al., 2014, Zamarron et al., 2017, Kovacikova et al., 2011, Capel et al., 2009, 
Magkos et al., 2016), and may promote macrophage phenotype switching from a pro-
inflammatory M1- towards an anti-inflammatory M2- profile (Lumeng et al., 2007a, Fabbiano 
et al., 2016). There is some evidence that markers of ECM synthesis in adipose tissue decrease 
following long-term DR in mice (Higami et al., 2006).  





Paradoxically, a beneficial role of inflammation in healthy adipose tissue expansion and 
function is also reported (Wernstedt Asterholm et al., 2014). Increases in macrophage 
infiltration in adipose tissue occurs in the early phase of DR, and after 24-hours of fasting(Capel 
et al., 2009, Kosteli et al., 2010, Asterholm et al., 2012, Ding et al., 2016), and this increase 
coincides with elevated circulating non-esterified fatty acids (NEFA) (Kosteli et al., 2010). 
These studies have suggested that adipose tissue macrophages may play a positive role 
buffering lipid released from adipocytes.  
 
We examined the effects of intermittent fasting, on both fed and fast days, in mice fed a chow 
or high-fat diet, on markers of adipose tissue remodelling. We hypothesised that intermittent 
fasting will improve metabolic phenotype and reduce adipose tissue fibrosis, but may increase 
adipose tissue macrophage infiltration in chow and high-fat diet fed mice.  
 




5.3 Research Design and Methods 
Ethical approval 
All experimental protocols for the animal study were approved by the animal ethics committee 
of the South Australian Health and Medical Research Institute (SAHMRI) and the University 
of Adelaide, and were performed in accordance with the Australian Code of Practice for the 
Care and Use of Animals for Scientific Purposes. 
 
Animals and diets 
Forty-eight male C57BL/6J mice (Bioresources, SAHMRI, Adelaide, Australia) were housed 
four per cage under a 12:12h light/dark cycle, with lights on at 0700h (Zeitgeber time 0). At 
ten-week old, mice were fed either a lard based high-fat diet (HFD) comprising 43%, 21%, 36% 
of energy from fat, protein, and carbohydrate respectively (SF04-001, Specialty Feeds, WA, 
Australia) or a standard chow diet (Chow) comprising 18%, 24%, 58% of energy from fat, 
protein, and carbohydrate respectively (2018SX, Specialty Feeds, WA, Australia) for eight 
weeks. Mice on each diet were then randomized into ad libitum feeding (AL, n=8) or 
intermittent fasting (IF, n=16) for another eight weeks. Intermittent fasting was initiated at 
ZT11 (1-hour prior to lights off) for 24-hours for 3 non-consecutive days/week (Fig. 5.1A). 
Mice, cardboard tunnels and chew blocks were transferred daily between cages with or without 
food. Ad libitum fed mice were also transferred between feeding cages at the same time to 
standardize handling. All mice had free access to water throughout the study. Body weight and 
food intake were monitored at ZT11 weekly before IF was introduced, and daily after IF was 
implemented. At 28-week old, all mice were sacrificed at ZT7-9 with mice in IF group culled 
in the fed state or following a 22-hour fast. Whole blood was collected via cardiac puncture 
following isoflurane anaesthesia. Following cervical dislocation, inguinal and gonadal adipose 
tissue were collected and weighed. Another group of 10-week old male C57BL/6J mice (n=24) 




were fed chow or HFD ad libitum for eight weeks and culled at ZT7-ZT9 in the fed state or 
after a 22-hour fast.  
 
Glucose tolerance test 
At twenty-four weeks of age and after 6 weeks of IF or AL feeding, mice were fasted from ZT1 
for 6-hours and then challenged with an oral gavaging of glucose (2 g/kg body weight). Glucose 
was assessed at 0, 15, 30, 60, 90, and 120 minutes via tail vein bleeding by a glucometer 
(AccuChek Performa Monitor, Roche Diagnostics, Indianapolis, USA), and insulin was 
assessed at 0, 15, 30, and 60 minutes.  
 
Plasma analysis 
Insulin was measured using ultra-sensitive ELISA kit (Cat: 10-1249-01, Mercodia, Sweden) 
and Non-esterified fatty acids (NEFAs) by enzymatic colorimetric assay (NEFA-HR (2), Wako 
Diagnostics, CA, USA) on a VersaMax ELISA Microplate Reader (Sunnyvale, CA, USA). 
 
Quantitative Real-Time PCR 
As described previously (Chen et al., 2016a), Total RNA were extracted from gonadal and 
inguinal adipose tissue (100-150 mg) using TRI Reagent (T9424, Sigma, St. Louis, USA) 
following the manufacturer’s instructions. The concentration and purity of RNA were assessed 
by NanoDrop Lite Spectrophotometer (Thermo Fisher Scientific, CA, USA). cDNA synthesis 
was conducted using T100 Thermal Cycler (Bio-Rad, CA, USA) with 1000 ng of each RNA 
sample using the QuantiTect reverse transcription kit (Qiagen, Valencia, CA, USA) according 
to kit instructions. Standard control (25ng/ul) samples were pooled from each sample. 
Quantitative real-time PCR was performed using Taqman primers and Fast Universal PCR 
Master Mix (Applied Biosystems, Foster City, CA, USA). Genes for pan macrophage (Adgre1 




and Lgals3), inflammatory M1-macrophage (Itgax and Cd38), anti-inflammatory M2-
macrophage (Arg1 and Mrc1), macrophage recruitment (Ccl2 and Ccl3), ECM synthesis 
(Col3a1 and Col6a1), ECM degradation (Mmp2, Mmp9 and Timp1) were assessed using 
Taqman primers (Table 5.1). The samples were run in duplicate on an ABI 7500 sequence 
detection system (Applied Biosystems, Foster City, CA, USA) with internal negative controls 
and a standard curve. Six reference genes including Rn18s, Actb, Gapdh, Hprt, Ppia and B2m 
were examined, and the combination of Actb and B2m was determined as the best housekeeper 
using the NormFinder program as described previously (Chen et al., 2014). The relative gene 
expression was determined using the 2−ΔCT method, where ΔCT = (CTtarget gene–CTreference gene). 
 
Histological Analysis and Immunohistochemical staining 
Briefly, adipose tissue samples were fixed with Bouin’s solution (HT10132, Sigma, St. Louis, 
MO, USA), dehydrated, paraffin embedded, and sectioned at 5μm. Hematoxylin and eosin 
(H&E) staining was performed using a standard protocol, and Masson’s Trichrome staining 
with a commercial kit (HT15, Sigma, St. Louis, MO, USA). For immunohistochemistry, we 
used F4/80 targeting to pan-macrophages and slides were counterstained with Mayer's 
hematoxylin. Slides were scanned using the Pannoramic 250 Flash II scanner (3DHISTECH, 
Budapest, Hungary). At least one thousand adipocytes were analysed for adipocyte size and 
collagen content using Image J built-in macros (National Institutes of Health). Crown-like 
structures and F4/80 positive cells were counted in ten randomly chosen areas at ×40 
magnification and adjusted by adipocyte numbers as described previously (Cancello et al., 
2005). Reagents used for histology are listed in Table 5.2. 
  
  




Table 5-1: Taqman primers used for gene expression analysis 
Gene symbol Gene Name Assay ID 
Housekeeper 
Actb Actin, beta Mm00607939_s1 
18s Eukaryotic 18S rRNA Mm03928990_g1 
Ppia Peptidylprolyl isomerase A Mm02342430_g1 
Hprt Hypoxanthine guanine phosphoribosyl transferase Mm01545399_m1 
Gapdh Glyceraldehyde-3-phosphate dehydrogenase Mm99999915_g1 
B2m Beta-2 microglobulin Mm00437762_m1 
Pan-macrophage 
Adgre1 (F4/80) Adhesion G Protein-Coupled Receptor E1 Mm00802529_m1  
Lgals3 (Mac2) Lectin, Galactoside-Binding, Soluble, 3 Mm00802901_m1 
M1-macrophage 
Itgax (Cd11c) Integrin subunit alpha X Mm00498701_m1 
Cd38 Cluster of differentiation 3 Mm01220906_m1  
M2-macrophage 
Arg1 Arginase, liver Mm00475988_m1 
Mrc1 Mannose receptor, C type 1 Mm01329362_m1 
Macrophage recruitment 
Ccl2 Chemokine (C-C motif) ligand 2 Mm00441242_m1 
Ccl3 Chemokine (C-C motif) ligand 3 Mm00441259_g1 
Extracellular matrix 
Col3a1 Collagen, type III, alpha 1 Mm01254476_m1 
Col6a1 Collagen, type VI, alpha 1 Mm00487160_m1 
Mmp2 Matrix metallopeptidase 2 Mm00439498_m1 
Mmp9 Matrix metallopeptidase 9 Mm00442991_m1 








Table 5-2: Reagents used for immunohistochemical staining 
Reagent  Source Identifier  
Rat anti mouse F4/80 (1:200) Abcam  Ab6640 
Goat Anti-Rabbit HRP (IgG H&L)  (1:500) Abcam Ab6721 
Goat sera Gibco 16210064 
Endogenous Peroxidase and Alkaline 
Phosphatase Blocking Solution 
Vector  SP-6000 
DAB Vector SK-4105 
Bovine serum albumin (BSA) Sigma-Aldrich A7030-10G 
PBS Sigma-Aldrich P4417-100TAB 




All data are expressed as mean ± the standard error of the mean. Data were analysed statistically 
with SPSS 24 (IBM, Chicago, IL, USA) and log-transformed for analysis if not normally 
distributed. For insulin in the fasted mice, undetectable samples (Figure 5.3) were input with 
the minimum values. Area under the curve (AUC) for glucose and insulin was calculated as 
mentioned previously (Matthews et al., 1990, Allison et al., 1995). Single comparisons were 
performed using two-way ANOVA with diet (Chow and HFD) and schedule (AL and IF) as 
between group factors, Bonferroni post hoc tests were performed when diet*schedule effects 
were present. P<0.05 was considered as statistically significant. 
 
Table 5-3: Mice with insulin undetectable after the fasting day 
 Eight-week intermittent fasting Acute one day fasting 
Diet  Chow HFD Chow HFD 
Number 3/8 3/8 4/8 0/8 





IF differentially impacted on energy intake and adiposity in chow and HFD fed mice  
Cumulative energy intake and final body weight was not different between chow-IF vs. chow-
AL groups (Fig. 5.1B-E). In contrast, HFD-IF displayed reduced energy intake (-28.0%) vs. 
HFD-AL group and significant weight loss (-20.9%, both P<0.001). Weight loss plateaued after 
5 weeks of IF in the HFD-IF group, and the final body weight was not different to the chow 
fed groups. Gonadal and inguinal fat mass was reduced as a result of IF in chow and HFD 
groups, but fat pad weights remained higher in HFD-IF vs. chow-IF (all P<0.05, Fig. 5.1F and 
1G). Fat cell size was decreased by IF in HFD fed mice only (all P<0.001, Fig. 5.1H to 1M).  
 
 




Figure 5-1: IF differentially impacted on energy intake and adiposity in chow and HFD 
fed mice 
(A): Schematic outline of the intermittent fasting regimen used in this study. (B and C): 
Cumulative energy intake during diet-induced obesity and intermittent fasting, results were 
calculated based on 4 mice/cage. (D and E): Body weight during diet-induced obesity and 
intermittent fasting. (F and G): Gonadal and inguinal fat mass. (L and M): Gonadal and 
inguinal fat cell size. (H to K): Representative H & E staining of gonadal fat. Scale bar: 100μm.  
 
Data presented as Mean±SEM. n=8 in AL and 16 in IF per diet in A-D; n=7-8/group in D-G; 
n=5-6 in H and I. Two-way ANOVA with Bonferroni post hoc test. Post hoc test: *P<0.05, 
**P<0.01, and ***P<0.001; ^P<0.01 vs. Chow-IF-Fed and #P<0.01 vs. Chow-IF-Fast. 
 
IF improved glucose tolerance in chow and HFD fed mice  
IF improved glucose tolerance as assessed by glucose AUC in both diet groups (all P<0.05, 
Fig. 5.2A and 2B). Insulin AUC was reduced by IF in HFD fed mice only (P<0.001, Fig. 5.2D 
and 2E). We additionally measured glucose tolerance in the HFD-IF group after a 20-hour fast, 
but this was not different from HFD-IF group that were fasted for 6-hours (Fig. 5.2C). In the 
fed state, IF reduced terminal blood glucose in both diet groups (schedule effect, P<0.01, Fig. 
5.2F), but reduced insulin and HOMA-IR in HFD fed mice only (both P<0.05, Fig. 5.2G and 
2H). Fasting glucose, insulin and HOMA-IR was also reduced in fasted vs. fed state in IF 
groups (all P<0.01, Fig. 5.2F to 2H).  
 




Figure 5-2: IF improved glucose tolerance in chow and HFD fed mice 
(A to C): Glucose and area of glucose under the curve during OGTT. (D and E): Plasma insulin 
and area of insulin under the curve during GTT. (F and G): Terminal glucose and insulin. (H): 
HOMA-IR calculated from terminal glucose and insulin. AU: arbitrary unit.  
 
Data presented as Mean±SEM, n=7-8/group. Two-way ANOVA with Bonferroni post hoc test. 
Diet effect: ^^P<0.01. Schedule effect: $P<0.01 vs. AL and &P<0.001 vs. IF-Fed. Post hoc test: 
*P<0.05, **P<0.01, and ***P<0.001; #P<0.05 vs. Chow-IF.   
 
IF reduced adipose tissue inflammation in HFD fed mice 
Markers of adipose tissue inflammation were increased in both gonadal and inguinal fat in 
HFD-AL vs. Chow-AL group (Fig. 5.3A to 3G). IF decreased mRNA levels of Lgals3, Itgax, 
and Ccl2 in both gonadal and inguinal fat, and decreased crown-like structure and pan-
macrophage numbers in gonadal fat in HFD fed mice (all P<0.05, Fig. 5.3B, 3D, 3E, 3G, 3M, 
3O, 3S and 3T). IF did not alter any markers of inflammation in chow fed mice, except for 
decreased Lgals3 mRNA levels in gonadal fat (P<0.05, Fig. 5.3B).  
 
Adgre1, Mrc1, Arg1 and Ccl2 mRNA levels were lower in fasted vs. fed states in gonadal fat 
in IF groups (P<0.01, Fig. 5.3A, 3I, 3J and 3M). Crown-like structure and pan-macrophage 
numbers were not different between fed vs. fasted states in both diets (Fig. 5.3S and 3T). NEFA 
levels were increased in fasted vs. fed state in both diets (both P<0.05, Fig. 5.3P), but there 
was no relationships between the changes in NEFA and any marker of inflammation. 





Figure 5-3: IF reduced adipose tissue inflammation HFD fed mice 
(A to D): mRNA levels of pan-macrophage marker Adgre1 and Lgals3. (E to H): mRNA levels 
of M1-macrophage marker Itgax and Cd38. (I to L): mRNA levels of M2-macrophage marker 
Mrc1 and Arg1. (M and N): mRNA levels of macrophage recruitment marker Ccl2 and Ccl3 
in gonadal fat. (O): mRNA levels of macrophage recruitment marker Ccl2 ininguinal fat, Ccl3 
was undetectable in inguinal fat. (P): Plasma NEFA. (Q and R): Representative images of 
immunohistochemical staining for F4/80 (pan-macrophage) in gonadal fat in chow and HFD 
ad libitum fed mice. (S and T): Quantification of Crown-like structures and F4/80 positive cells 
in gonadal fat, results were adjusted adipocyte numbers. Scale bar: 100μm. AU: arbitrary unit.  





Data presented as Mean±SEM. n=7-8/group for A to P, n=5/group for S and T. Two-way 
ANOVA with Bonferroni post hoc test. Diet effect: ^P<0.05, ^^P<0.01 and ^^^P<0.001 vs. chow. 
Schedule effect: $P<0.05 vs. AL and #P<0.05 vs. IF-Fed. Post hoc test: *P<0.05, **P<0.01 and 
***P<0.001; &P<0.05 vs. Chow-IF-Fed.  
 
IF reduced fibrosis in gonadal adipose tissue in HFD fed mice 
IF increased Col3a1 mRNA levels in gonadal and inguinal fat (schedule effect, both P<0.05, 
Fig. 5.4A and 4C), but decreased Col6a1 mRNA levels in gonadal fat (schedule effect, P<0.01, 
Fig. 5.4B). IF increased Mmp9 mRNA levels and decreased Timp1 mRNA levels in gonadal 
fat in HFD fed mice only (all P<0.001, Fig. 5.4F and 4I). Collagen deposition assessed by 
histology was reduced in gonadal fat in HFD-IF vs. HFD-AL group (P=0.05, Fig. 5.4K and 
4L), but was increased in inguinal fat in Chow-IF vs. Chow-AL group (P<0.001, Fig. 5.4M 
and 4N). Decreased Col3a1mRNA levels, but increased Col6a1 and Mmp2 mRNA levels in 
gonadal fat were observed in the fasted vs. the fed state in both IF groups (schedule effect, all 
P<0.05, Fig. 5.4A, 4B and 4E).  
 
Responses to a single acute fast in chow and HFD fed mice 
Recent studies have shown that acute fasting for 24-hours increased markers of inflammation 
in adipose tissue (Kosteli et al., 2010, Ding et al., 2016, Asterholm et al., 2012). We did not 
detect this in response to IF, but habituation to fasting may have occurred. Thus, a group of 
mice were examined after the first exposure to an intermittent fasting diet. In response to one 
acute 22-hour fast, blood levels of NEFA were increased and insulin levels were decreased in 
both diet groups (schedule effect, all P<0.001, Fig. 5.5A and 5B). Fasting did not increase the 
mRNA levels of any inflammation markers examined in gonadal fat or inguinal fat (Fig. 5.5C 
to 5J, inguinal fat data not shown). These results were confirmed by histology (Fig. 5.5K and 




5L). Col6a1 and Timp1 mRNA levels were decreased after one acute fast (schedule effect, all 
P<0.05, Fig. 5.5N and 5Q). 
 
 
Figure 5-4: IF reduced fibrosis in gonadal fat in HFD fed mice 
(A to D): mRNA levels of ECM synthesis marker Col3a1 and Col6a1. (E to J): mRNA levels 
of ECM degradation marker Mmp2, Mmp9 and Timp1. (K and M): Representative images of 
Masson’s trichrome staining for gonadal and inguinal fat. (L and N): Quantification of collagen 
integrated density in gonadal and inguinal fat. Scar bar: 100μm. AU: arbitrary unit.  
 
Data presented as Mean±SEM. n=7-8/group for A to J and n=5-6/group for L and N. Two-way 
ANOVA with Bonferroni post hoc test. Diet effect: ^P<0.05, ^^P<0.01 and ^^^P<0.001 vs. chow. 
Schedule effect: $P<0.05, $$p<0.01 and $$$P<0.001 vs. AL; #P<0.05, ##P<0.01 and ###P<0.001 
vs. IF-Fed. Post hoc test: ***P<0.001.  
 





Figure 5-5: Responses to a single acute fast in chow and HFD fed mice 
(A and B): Plasma insulin and NEFA levels. (C and D): mRNA levels of pan-macrophage 
marker Adgre1 and Lgals3. (E and F): mRNA levels of M1-macrophage marker Itgax and 
Cd38. (G to H): mRNA levels of M2-macrophage marker Mrc1 and Arg1. (I and J): mRNA 
levels of macrophage recruitment marker Ccl2 and Ccl3. (K and L): Crown-like structures and 
F4/80 positive cells, results adjusted adipocyte numbers. (M and N): mRNA levels of ECM 
synthesis marker Col3a1 and Col6a1.  (O to Q): mRNA levels of ECM degradation marker 
Mmp2, Mmp9 and Timp1. AU: arbitrary unit.  
 




Data presented as Mean±SEM. n=6/group. Two-way ANOVA with Bonferroni post hoc test. 
Diet effect: ^P<0.05, ^^P<0.01 and ^^^P<0.001 vs. chow. Schedule effect: $P<0.05 and 











Inflammation and fibrosis of adipose tissue occurs in obese animals, and in humans, and is 
associated with impaired glucose tolerance and insulin resistance (Weisberg et al., 2003, Xu et 
al., 2003, Lumeng et al., 2007a, Sun et al., 2013, Pasarica et al., 2009a). Caloric restriction 
improves this phenotype (Zamarron et al., 2017, Higami et al., 2006, Anson et al., 2003, 
Argentino et al., 2005). IF promotes weight loss and may improve glucose tolerance in diet-
induced obese mice (Joslin et al., 2017, Li et al., 2017, Liu et al., 2017b). However, the effects 
of IF on adipose tissue remodelling is unclear. Our results suggest that IF improves glucose 
tolerance in both lean and obese mice, and reduced adipose tissue inflammation and fibrosis in 
obese mice.  
 
In this study, chow fed mice were able to consume sufficient energy during feeding days to 
compensate for the fasting days, and maintain body weight. However, mice that were fed a 
high-fat diet were unable to compensate entirely, resulting in weight loss. This is consistent 
with recent studies (Liu et al., 2017b, Joslin et al., 2017). In our study, HFD-IF mice presented 
with greater inguinal and gonadal fat mass compared to chow-IF mice. This is in agreement 
with previous studies which showed formerly diet-induced obese mice retained greater 
adiposity compared to lean controls (Wang et al., 2011, Guo et al., 2009). Gonadal and inguinal 
fat pad weight was also lower in chow-IF versus chow-AL mice, although these mice did not 
display overall weight differences. This could indicate increased lean mass after IF. Indeed, 
increased lean mass was reported in diet-induced obese mice subjected to chow diet with IF 
(Gotthardt et al., 2016). Preservation of lean mass was also observed in humans who underwent 
a modified IF intervention, where they were allowed to consume 25% of energy requirement 
on each fasting day (Klempel et al., 2013b), but was not observed in a recent study by our 




group whom consumed ~30% of requirements at breakfast prior to initiating a 24-hour fast 
(Chapter 3)  
  
In this study, we observed that oral glucose tolerance was improved by IF in both diet groups. 
In diet-induced obese mice, this finding is controversial. Gotthardt et al (Gotthardt et al., 2016) 
observed no change in oral glucose tolerance using the same dose applied in this study. 
However, glucose tolerance was improved in diet-induced obese mice when given at 1g/kg 
orally or by intraperitoneal injection (Liu et al., 2017b, Joslin et al., 2017, Kim et al., 2017). 
There is also some evidence that glucose tolerance is impaired on fasted vs. fed days in IF mice 
that were fed a HFD (Joslin et al., 2017). We have also shown transient insulin resistance by 
clamp following a fasting day in humans with obesity after 8 weeks of IF (Chapter 3). In our 
hands, fasting did not alter oral glucose tolerance in mice fed a high-fat diet. Since a group of 
mice that were paired-fed to the HFD-IF group was not included, and thus results cannot be 
distinguished between caloric restriction and weight loss, and IF per se. In mouse studies, 
insulin sensitivity is reported to be improved (Kim et al., 2017, Gotthardt et al., 2016) and 
unchanged (Liu et al., 2017b) when it was assessed by insulin tolerance test (Liu et al., 2017b, 
Kim et al., 2017, Gotthardt et al., 2016). No studies have examined measures of insulin 
sensitivity by tracers, or hyperinsulinaemic-euglycaemic clamp in response to intermittent 
fasting.  
 
Obesity is a low-grade inflammatory state with increased macrophage accumulation in white 
adipose tissue (Xu et al., 2003, Weisberg et al., 2003). In mice, a large body of evidence has 
suggested that weight loss reduces adipose tissue macrophages and improves insulin sensitivity 
(Hoevenaars et al., 2014, Zamarron et al., 2017, Kovacikova et al., 2011, Magkos et al., 2016). 
Weight loss may also promote the phenotype switching of macrophages from inflammatory 




M1- to anti-inflammatory M-2 profile (Lumeng et al., 2007a, Cancello et al., 2005, Fabbiano 
et al., 2016). In this study, HFD increased markers of adipose tissue macrophages and 
inflammation, which was rescued by IF. This is in agreement with a recent study by Kim et al 
(Kim et al., 2017), which showed that a modified IF regimen (which was comprised of 2 
feeding days followed by 1 fasting day) reduced inflammation-related genes in gonadal fat in 
HFD fed mice (Kim et al., 2017).  However, we did not observe M2-polarisation of 
macrophages following IF as reported by Kim et al (Kim et al., 2017). Of note, there was no 
change in markers of macrophages in IF mice that were fed a chow diet, despite improvements 
in glucose tolerance.  
 
Increased macrophage accumulation in adipose tissue has also been reported during the early 
stage of weight loss by calorie restriction, and after a 24-hour fast (Kosteli et al., 2010, Ding et 
al., 2016, Asterholm et al., 2012, Ebke et al., 2014). Further studies show that adipose tissue 
macrophages take up and store lipids (Caspar-Bauguil et al., 2015, Kosteli et al., 2010). 
Contrary to studies that have reported increased macrophage infiltration in response to an acute 
24-hour fast(Kosteli et al., 2010, Asterholm et al., 2012, Ding et al., 2016), there was no change 
in adipose tissue macrophages in either IF group, after the fasting day, despite marked elevation 
in NEFA. We theorized this could be due to habituation to intermittent fasting and therefore 
examined the response to the first day of IF in a separate group of mice fed chow or HFD. 
Under these conditions, fasting did not alter the mRNA levels of any inflammatory genes or 
macrophage numbers as assessed by histology. This discrepancy could be due to differences in 
the mice strains, ages or diet composition, or the clock time that the tissues were collected. 
Indeed, in one study (Kosteli et al., 2010), the time they collected tissue from fasted mice was 
at ZT2, which was 7-8 hours earlier than the time tissue was collected in our study. This could 
be of importance, since macrophages and cytokines levels are under circadian control (Keller 




et al., 2009). We should also consider that mice were fasted for 22 hours rather than 24 hours, 
and that the “fed mice” in our study had likely not eaten since lights on at ZT0, potentially 
elevating the baseline comparison level. However, the single reference gene used to normalized 
gene expression results in previous studies (Kosteli et al., 2010, Ding et al., 2016) was reduced 
by acute fasting in our hands. Additionally, that study adjusted the macrophage count by total 
nuclei, or white blood cells, in adipose tissue. Fasting reduces white blood cells, and monocyte 
counts in blood in mice and humans (Walrand et al., 2001, Brandhorst et al., 2015, Cheng et 
al., 2014, Choi et al., 2016), which if occurring in adipose tissue, could artificially elevate the 
number of macrophages detected.  
 
Increased fibrosis in adipose tissue is linked with inflammation and insulin resistance (Sun et 
al., 2013, Guglielmi et al., 2015). The homeostasis of ECM is a balance between collagen 
synthesis, and degradation by matrix metalloproteinases (MMPs), and tissue inhibitor of 
metalloproteinases (TIMPs) that negatively regulate the enzyme activity of matrix 
metalloproteinase, to avoid excessive degradation of the ECM (Bonnans et al., 2014, Sun et al., 
2013, Martinez-Santibanez and Lumeng, 2014). Our results show that IF reduced ECM 
synthesis and promoted ECM degradation in gonadal fat in mice that were fed a high-fat diet. 
This result was supported by histology. In contrast, mRNA levels of collagen, and collagen 
content, were increased in inguinal adipose tissue by IF. This could be due to the different 
nature of collagen in gonadal and inguinal fat. In gonadal fat, collagen presents a peri-adipocyte 
property, surrounding adipocytes and dominantly locating in crown-like structures area (Sun 
et al., 2013, Zamarron et al., 2017). In inguinal fat, however, large fibre bundles are frequently 
presented in adipose tissue through which subcutaneous fat pads attach to the skin. We 
speculate that IF promotes fat pad loss, but may have less impact on large fibre bundles than 
peri-cellular collagens. This highlights that not only the “quantity” but also the “structure or 




quality” of collagen may be important when assessing tissue fibrosis. Further studies are 
required to investigate the structure or stiffness or adipose tissue following IF. 
 
In conclusion, IF promoted fat mass loss and improved glucose tolerance in mice fed a chow 
or high-fat diet. Adipose tissue inflammation and fibrosis was also improved as a result of 
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6.1 Abstract  
Background: Intermittent fasting (IF) may limit metabolic adaptations that reduce energy 
expenditure, potentially by stimulating white adipose tissue browning. This study examined 
the effects of 8 weeks of intermittent fasting on energy metabolism and markers of white 
adipose tissue browning in lean and diet-induced obese mice and in women who were 
overweight or obese. 
 
Methods: Ten-week old male C57BL/6J mice were fed a high-fat (43% fat) or chow diet (18% 
fat) for 8 weeks ad libitum, then randomized to ad libitum or IF for 8 weeks. A 24-hour fast 
was initiated one hour before lights off, on 3 non-consecutive days per week (Mon, Wed, Fri). 
At 27 weeks of age, meal size and number, energy intake and energy expenditure were 
measured for 3 days in a metabolic cage (2 fed and one fast day), followed by collection of 
inguinal and gonadal fat pads in the fed state, or after a 22-hour fast (IF mice only). Uncoupling 
protein 1 (UCP1) in fat was assessed by qPCR and immunohistochemistry in mice. UCP1 
mRNA levels were also examined in subcutaneous adipose tissue at baseline, and after 8-weeks 
of IF (in the fed state, and after a 24-hour fast), in women who were overweight or obese (BMI 
25.0-42.0kg/m2, aged 35-70 years).  
 
Results: IF reduced body weight and energy intake in high-fat, but not chow diet, fed mice. 
Gonadal and inguinal fat pad weights were reduced by IF in both diet groups (all P<0.05). 
Energy expenditure and meal numbers were increased in both IF diet groups on fed days 
(P<0.05). IF increased Ucp1 mRNA levels in both inguinal and gonadal fat depots, and UCP1 
protein in inguinal fat (schedule effect, all P<0.05). In women, IF reduced body weight and fat 
mass (-4.0±0.4kg and -3.1±0.3kg [Mean± SEM], respectively, both P<0.001), but had no effect 




on UCP1 mRNA levels in subcutaneous adipose tissue, irrespective of whether it was sampled 
in the fed or fasted state. 
 
Conclusions: Intermittent fasting increased energy expenditure and promoted white adipose 
tissue browning in chow and high-fat diet fed mice. However, IF did not alter UCP1 mRNA 
levels in subcutaneous adipose tissue in women.      
 
Key words: adipose tissue, browning, energy expenditure, intermittent fasting 
  





Intermittent fasting (IF) is a dietary intervention that involves periods of minimal or no caloric 
intake followed by periods, typically 24-hours, of unrestricted eating. IF is effective to extend 
lifespan (Arum et al., 2009, Xie et al., 2017, Goodrick et al., 1990), reduce fat mass (Gotthardt 
et al., 2016, Barquissau et al., 2018, Li et al., 2017), improve glucose tolerance and insulin 
sensitivity (Anson et al., 2003, Gotthardt et al., 2016, Joslin et al., 2017), and reduce the risk 
for cardiovascular diseases (Krizova and Simek, 1996, Wan et al., 2003) and cancer (Xie et al., 
2017, Chen et al., 2016b) in chow fed rodents. However, few studies have investigated the 
response in obese animals (Gotthardt et al., 2016, Joslin et al., 2017, Liu et al., 2017b, Li et al., 
2017, Kim et al., 2017). In humans, most studies of IF have been conducted in individuals who 
are overweight or obese. In these studies, IF promotes weight and fat mass loss (Heilbronn et 
al., 2005b, Klempel et al., 2013b, Trepanowski et al., 2017, Byrne et al., 2018), reduces total 
cholesterol, low-density lipoprotein cholesterol, triglycerides, systolic blood pressure (Varady 
et al., 2009, Trepanowski et al., 2017), and improves markers of insulin sensitivity (Heilbronn 
et al., 2005b). 
 
Brown adipose tissue plays a critical role in energy homeostasis and thermogenesis (Sidossis 
and Kajimura, 2015). In addition to the classical brown adipocytes residing in brown fat, 
brown-like adipocytes located within white adipose tissue also have thermogenic properties 
(Sidossis and Kajimura, 2015). A range of external cues, such as cold exposure (Barbatelli et 
al., 2010, Lim et al., 2012, Fisher et al., 2012), exercise (Bostrom et al., 2012, Xu et al., 2011, 
Stanford et al., 2015) and pharmaceutical treatment (Wu et al., 2013, Cypess et al., 2015), 
promote the development of beige adipocytes in white adipose tissue in mice. This is known 
as “browning” of white adipose tissue. Recently, three animal studies have shown that both 
daily calorie restriction and IF promote white adipose tissue browning (Fabbiano et al., 2016, 




Li et al., 2017, Kim et al., 2017), and suggest this could be linked with the alternative activation 
of macrophages (Kim et al., 2017, Li et al., 2017).  
 
The aim of this study was to examine the effects of intermittent fasting on food intake and 
energy expenditure and adipose tissue browning in mice fed chow or high-fat diet in the fed 
and fasted state. We also assessed the effects of IF on expression of uncoupling protein 1 
(UCP1) in subcutaneous adipose tissue in women who were overweight or obese.  
  




6.3 Research Design and Methods 
Animals and diets 
This study was approved by the animal ethics committees of the South Australian Health and 
Medical Research Institute (SAHMRI) and the University of Adelaide, and was performed in 
accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific 
Purposes. Mice used in this study were the same as the mice used in Chapter 5. Briefly, ten-
week old male C57BL/6J mice (Bioresources, SAHMRI, Australia) were housed four per cage 
in the Bioresources Facility at SAHMRI  under a 12:12h light/dark cycle, with lights on at 7am 
(Zeitgeber time 0, ZT0) and temperature at 21±3°C. Mice were fed either a lard based high-fat 
diet (HFD, 43% fat, SF04-001, Specialty Feeds, Australia) or a chow diet (chow, 18% fat, 
2018SX, Envigo, United States) ad libitum for eight weeks prior to randomizing mice on each 
diet into ad libitum feeding (AL, n=8) or intermittent fasting (IF, n=16) for another eight weeks. 
Intermittent fasting was initiated at ZT11 for 24-hours for 3 non-consecutive days/week. Food 
access was controlled by transferring mice daily between cages with or without food. Mice fed 
ad libitum were also transferred between feeding cages at the same time to standardize handling. 
All mice had free access to water throughout the study. Body weight and food intake were 
monitored at ZT11 weekly before IF was introduced, and daily after IF was implemented. At 
28-weeks old, all mice were sacrificed at ZT7-ZT9 with mice in IF groups culled after feeding 
or 22-hours fasting (n=7-8/group). Inguinal and gonadal adipose tissue were collected.  
 
At twenty-seven weeks of age, indirect calorimetry (n=7-8/group) was assessed. Mice were 
acclimated to the metabolic cages for 24-hours prior to data collection (Promethium, Sable 
Systems, Las Vegas, NV). Three days of data were collected after acclimation. This was two 
consecutive feeding days, followed by a fasting day. Food access for mice in IF groups was 
controlled using gates connected to the food hoppers. Food spilled by mice and dropped into 




bedding was carefully removed using forceps before the commencement of data recording, and 
prior to the fasting day, to improve the accuracy of food consumption monitoring. Four mice 
in each HFD group dragged food from the hopper during monitoring periods, this data was not 
included in the analysis and an additional 4 mice were measured to repeat metabolic monitoring. 
However, this behaviour was repeated in some mice and finally n=4-7/group were included for 
the analysis of food related parameters including meal size, meal number and energy intake. 
Data analysis of oxygen consumption (VO2), carbon dioxide expired (VCO2), respiratory 
quotient (RQ), energy expenditure (EE) and activity was performed in n=7-8/group. VO2 and 
VCO2 were measured at 5 minutes intervals for 1 minute to calculate RQ and EE as described 
previously (Kaiyala et al., 2012). VO2, VCO2 and EE were adjusted by a modified body mass 
which was determined by subtracting collected inguinal and gonadal fat mass from body mass, 
lessening the weight bias from this metabolically less active tissue (Tschop et al., 2011). We 
also normalized EE by other ways including body weight, body weight raised to the power 2/3 
or 3/4, or analysis of covariance as mentioned previously (Tschop et al., 2011). For ambulatory 
activity, consecutive adjacent infrared beam breaks in x-, y- and z-axes as an activity count 
were recorded every 5 min as previously described (Kaiyala et al., 2012). Data acquisition and 
food access control were coordinated by MetaScreen v.2.3.4 and raw data were extracted using 
ExpeData v.1.6.4 (Sable Systems) with built-in macros. All metabolic data were expressed in 
two ways: hourly and daily. Hourly value was calculated by the real-time output in one hour.  
Daily value was determined by the sum of hourly value on each day. Weekly values for energy 
intake and energy expenditure were calculated using (Day 1+ Day 2+ Day 3)/3*7 for AL groups, 
and (Day 1 *3+Day 2+Day3*3) for IF groups.  
 
Quantitative real-time PCR 




The extraction of total RNA, the determination of RNA concentration and purity, and the 
synthesis of cDNA from RNA were performed as previously reported (Chen et al., 2014). 
Quantitative real-time PCR was performed using the Taqman Ucp1 primer 
(Mm01244861_m1), and Fast Universal PCR Master Mix (Cat: 4352042, Applied Biosystems, 
Foster City, CA, USA). The samples were run in duplicate on an ABI 7500 sequence detection 
system (Applied Biosystems, Foster City, CA, USA) with corresponding internal negative 
controls and standard curve (pooled from ten participants at baseline, and from individual 
mouse, respectively). Relative gene expression was analysed using the 2−ΔCT method, where 
ΔCT = (CTtarget gene – CTreference gene). Actb (Mm00607939_s1) and B2m (Mm00437762_m1) 
were selected out from 6 housekeepers (18s, Actb, Gapdh, Hprt, Ppia and B2m) using 
NormFinder as the most stable reference for mice.  
 
Immunohistochemistry 
Inguinal adipose tissue from mice (n=6/group) were fixed in Bouin’s solution (HT10132, 
Sigma-Aldrich), dehydrated, paraffin embedded, sectioned at 5um and mounted on positively-
charged glass slides. De paraffinised and rehydrated slides were incubated with ELOXALL 
solution (SP-600, Vector) for 10 minutes at room temperature to eliminate endogenous 
peroxidase and alkaline phosphatase. Antigen retrieval was achieved using modified citrate-
based buffer (S1700, Dako) and incubation in a 95°C water bath for 20 minutes. Slides were 
incubated with a rabbit anti-UCP1 (1:400, Ab10983, Abcam) overnight and then goat anti-
rabbit secondary antibody (1:500, Ab6721, Abcam) for 1-hour at room temperature. 
Immunohistochemical detection was performed using 3, 3′-diaminobenzidine (DAB, SK-4105, 
Vector) and slides were counterstained with Mayer's haematoxylin, followed by dehydrating 
and mounting. All slides were randomly assigned numeric codes by a research officer to blind 
the investigator (BL) quantifying outcomes. Slides were scanned using the Pannoramic 250 




Flash II scanner (3DHISTECH, Budapest, Hungary). UCP1 positive areas was analysed in 10 
randomly selected fields at 40X using Image J built-in macros (National Institutes of Health).  
 
Human study 
This human study was registered as a clinical trial with Clinicaltrials.gov (NCT0176997) and 
approved by the Research Ethics Committee of the Royal Adelaide Hospital and the University 
of Adelaide. All participants provided written, informed consent prior to their inclusion. The 
design of the human study and baseline characteristics of the participants have been reported 
in Chapter 3. Briefly, fifty healthy women who were overweight and obese, aged 35-70 years, 
BMI 25.0-42.0 kg/m2 were randomly assigned to one of two IF groups for 8 weeks.  
Participants were provided with ~30% of their daily energy requirements for breakfast, and 
then initiated a 24-hours fast on 3 non-consecutive days/week. On fed days, one group was 
provided foods at ~100% of energy requirements, to achieve an overall 30% energy deficit 
(IF70). The other group was provided foods at ~145% of their daily energy requirements on 
fed days, without overall energy restriction (IF100). Periumbilical subcutaneous adipose was 
obtained by percutaneous biopsy at baseline and after 8 weeks of the intervention diet, after a 
12-hour overnight fast and 24-hour fast as described previously (Chen et al., 2016a). Twenty-
two participants in each group completed the intervention. Due to the unwillingness of some 
participants to undergo biopsies and scheduling conflicts, biopsy samples were obtained from 
all 3 visits from only fourteen individuals in each group. For the purpose of this study, the two 
IF groups were combined together to assess UCP1 mRNA levels in subcutaneous adipose 
tissue. UCP1 mRNA levels (Hs00222453_m1) in human subcutaneous adipose tissue were 
normalized by ACTB (Hs01060665_g1) and PPIB (Hs00168719_m1), which was not different 
at baseline and following the intervention. 
 





Data are shown as mean ± SEM. All statistical analysis was performed using IBM SPSS 
Statistics 24 (Armonk, New York, USA). The normality of data distribution was assessed by 
Shapiro-Wilk test, and data were log10 transformed if not normally distributed. Single 
comparisons in mouse study were performed using two-way ANOVA with diet (chow and 
HFD) and schedule (AL and IF) as between group factors, Bonferroni post-hoc tests were 
performed when diet by schedule effects were presented. Time effects within group in mouse 
and human studies were examined by repeated measures ANOVA with Bonferroni post-hoc 
test or paired t test (for energy intake and meal numbers in IF mice on two consecutive feeding 
days only). Significance was accepted as P < 0.05.   





As reported in Chapter 5, final body weight was increased in HFD-AL (43.0±0.8g) vs. HFD-
IF (32.9±0.8g), chow-AL (34.7±1.0g) and chow-IF (32.2±0.5g, all P<0.05), and was not 
different between Chow-AL, Chow-IF and HFD-IF groups. Gonadal and inguinal fat mass was 
reduced by IF in both diet groups, but was greater in HFD-IF vs. chow-IF groups (all P<0.05).  
 
 




Figure 6-1: Energy intake, meal size and meal number in metabolic cages 
(A-C): hourly, daily and calculated weekly food intake. (D-E): hourly and daily meal numbers. 
(F-G): hourly and daily meal size. Day 1 and 2 were two consecutive feeding days, followed 
by a fasting day (day 3). Effects of diet and schedule on each day or in a week (energy intake 
only) were analysed by two-way ANOVA with Bonferroni post hoc tests. Within group effects 
over days were analysed using repeated measures ANOVA with Boferroni post hoc test (AL 
groups) or paired t test (IF groups).  
 
Data presented as Mean±SEM. N=4-7/group. Diet effect: #P<0.05 vs. chow on day 1, day 2 
and day 3. Schedule effect: $P<0.05 vs. AL on day 1 and day 2. Post hoc test: *P<0.05. 
 
There were significant diet and schedule effects observed for energy intake measured in the 
metabolic chamber on two refeeding days, with increased energy intake in HFD vs. chow fed 
mice, and in IF vs. AL mice (all P<0.05, Fig. 6.1A and 1B). Meal number was increased by IF 
on refeeding days (schedule effect, both P<0.05, Fig. 6.1D and 1E). Of note, chow-IF mice 
maintained similar energy intake and meal numbers on both refeeding days (both P>0.05). 
However, HFD-IF mice displayed decreased energy intake and meal number on the second vs. 
first refeeding day (both P<0.05). Mathematical extrapolation of this to a weekly value 
suggested that overall energy intake was not different in chow-IF vs. chow-AL mice (-1.4%, 
P=0.94), but was 25% lower in HFD-IF vs. HFD-AL mice (P<0.05, Fig. 6.1C). This data 
supports the weighed food intake data that we reported in Chapter 5. Meal size was not altered 
by IF, but was smaller in HFD vs. chow fed mice (all P<0.05, Fig. 6.1F and 1G).  
 





Figure 6-2: Energy expenditure, respiratory quotient and activity  
(A-C): Hourly, daily and calculated weekly energy expenditure. (D-E): Hourly and daily RQ. 
(F-G): Hourly and daily activity. Day 1 and 2 were two consecutive feeding days, followed by 
a fasting day (day 3). Effects of diet and schedule on each day, or in a week (energy expenditure 
only) were analysed by two-way ANOVA with Bonferroni post hoc tests. Within group effects 
over three days were analysed using repeated measures ANOVA with Boferroni post hoc test.  
 
Data presented as Mean±SEM. N=7-8/group. Schedule effect: $P<0.05 vs. AL on day 1 and 









There were significant schedule effects for energy expenditure on the two refeeding days, with 
increased energy expenditure in IF vs. AL mice (schedule effect, both P<0.001, Fig. 6.2A and 
2B). Energy expenditure on a fasting day was not different between IF and AL mice, but was 
lower versus a fed day (schedule effect, P<0.05, Fig. 6.2B). Mathematical extrapolation of this 
showed that calculated weekly energy expenditure was higher in IF vs. AL mice (schedule 
effect, P<0.001, Fig. 6.2C). This result held when energy expenditure was normalized against 
modified body mass, raw body weight, or body weight raised to the power 2/3 or 3/4, or by 
analysis of covariance with body weight as the covariate (Tschop et al., 2011). There were 
significant diet by schedule effects for averaged RQ on the two refeeding days (all P<0.01, Fig. 
6.2D and 2E). RQ was increased in chow-IF vs. chow-AL and HFD-IF mice on both refeeding 
days (all P<0.05), but was increased in HFD-IF vs. HFD-AL mice on the first refeeding day 
only (P<0.05). As expected, RQ was lower on fasted vs. fed days in IF groups (schedule effect, 
P<0.001), and vs. AL mice (both P<0.05). There were significant diet by schedule effects for 
activity, with reduced activity in HFD-AL vs. chow-AL and HFD-IF mice (all P<0.05, Fig. 
6.2F and 2G). There was no difference in activity between fed and fasted days in IF mice. 
 
Ucp1 mRNA levels in gonadal fat were higher in HFD vs. chow fed mice (diet effect, P<0.05, 
Fig. 6.3A). After a fed day, Ucp1 mRNA levels in inguinal and gonadal fat and UCP1 protein 
in inguinal fat were increased in IF vs. AL mice (schedule effect, all P<0.05, Fig. 6.3A to 3E). 
Ucp1 mRNA levels in both fat pads were lower on a fasted vs. fed day in both IF groups 
(schedule effect, both P<0.05), but was not different from AL mice.  





Figure 6-3: IF promoted white adipose tissue browning in mice but not in humans 
(A and B): Ucp1 mRNA levels in gonadal and inguinal fat in mice. (C): UCP1 positive area in 
inguinal fat in mice. (D and E): Representative images of immunohistochemical staining of 
Ucp1 in chow-AL (D) and chow-IF mice (E). (F): UCP1 mRNA levels in human subcutaneous 
adipose tissue. Effects of diet and schedule (Figure 3A-3C) were analysed using two-way 
ANOVA with Bonferroni post hoc test. Time effects within group (Figure 3F) were analysed 
using repeated measures ANOVA with Bonferroni post hoc test. Scale bar: 100μm. AU: 
arbitrary unit. 
 
Data presented as Mean±SEM. N=7-8/group for Figure 3A and 3B, N=6/group for Figure 3C. 
N=28 for Figure 3F. Diet effect: #P<0.05 vs. chow; Schedule effect: $P<0.05 vs. AL and 
^P<0.05 vs. IF-Fast.  
 
In humans, 8-weeks of intermittent fasting reduced body weight and fat mass (-4.0±0.4kg and 
3.1±0.3kg, respectively, both P<0.001). UCP1 mRNA levels in subcutaneous adipose tissue 
were detectable in 19 out of 28 participants who consented to biopsy (IF100/IF70=10/9). There 
was no difference with regards to any assessed baseline characteristics in participants with 
UCP1 mRNA detectable or undetectable. There were no changes in the UCP1 mRNA levels 
following 8-weeks of IF, either when measured in the morning following a 12-hour overnight 
fast (after a fed day), or after a 24-hour fast (Fig. 6.3F). The change in UCP1 mRNA levels 
following intermittent fasting was not associated with any clinical outcomes reported in 
Chapter 3 and 4.   




6.5 Discussion  
Intermittent fasting reduces adiposity, improves glucose tolerance and markers of insulin 
sensitivity in rodent models (Varady et al., 2010, Gotthardt et al., 2016, Anson et al., 2003, 
Joslin et al., 2017, Heilbronn et al., 2005b, Harvie et al., 2011). Recent evidence suggests that 
browning of white adipose tissue may contribute to this phenotype (Kim et al., 2017, Li et al., 
2017). Our study confirms and extends this, showing that IF promoted visceral and 
subcutaneous adipose tissue browning in chow and HFD fed mice. However, UCP1 mRNA 
level was not altered in subcutaneous adipose tissue in women with overweight or obesity who 
underwent intermittent fasting for 8-weeks.   
 
Total daily energy expenditure consists of resting energy expenditure and thermoregulation, 
food-induced thermogenesis, and physical activity (Speakman, 2013), and increasing this is 
one approach to tackle obesity (Hill et al., 2012). In this study, energy expenditure was 
increased by intermittent fasting.  In chow fed mice, this was observed without a change in 
activity. Whilst increases in food-induced thermogenesis on refeeding days may have partially 
contributed to increased EE, energy expenditure was not different when measured on a fasting 
day between chow-IF and chow-AL groups. Physical activity was lower in mice fed a high-fat 
diet ad libitum, and likely contributed to some of the difference in energy expenditure between 
HFD groups. These results support recent findings that intermittent fasting increases energy 
expenditure in mice (Kim et al., 2017, Li et al., 2017). Similar to previous studies (Goodrick et 
al., 1990, Anson et al., 2003, Gotthardt et al., 2016, Liu et al., 2017b, Kim et al., 2017), our 
study confirmed that chow-IF mice compensate for intermittent food deprivation by overeating 
on refeeding days, and do not lose weight. This is in contrast to IF mice fed a high-fat diet, 
where calculated food intake was lower and activity and energy expenditure was higher, 
resulting in weight loss. Further analysis using metabolic cage revealed that upon refeeding, 




chow-IF started to consume food as soon as food was provided even prior to dark phase, but 
HFD-IF mice fasted for an additional hour and initiated eating in the dark phase. Additionally, 
chow-IF mice displayed hyperphagia on two consecutive refeeding days, but HFD-IF mice lost 
hyperphagia after 24-h refeeding consuming similar food as HFD-AL mice. However, the 
signal that is preventing overconsumption on a HFD is unclear. 
 
Intermittent fasting increased adipose tissue browning in inguinal and subcutaneous adipose 
tissue. This is consistent with two recent reports (Kim et al., 2017, Li et al., 2017). We further 
show that the increases in Ucp1 mRNA levels in both inguinal and gonadal adipose tissue were 
higher after the refeeding day. This data suggests that “intermittent overfeeding”, rather than 
“intermittent fasting” promotes white adipose tissue browning. Acute fasting (24-48 hours) 
decreases Ucp1 expression in both brown and white adipose tissue (Tang et al., 2017, Ding et 
al., 2016, Sivitz et al., 1999, Champigny and Ricquier, 1990), whilst refeeding increased Ucp1 
expression (Li et al., 2017, Champigny and Ricquier, 1990). Further, Ding et al. demonstrated 
that an acute 24-hour fasting suppressed white adipose tissue browning via microRNA 149-3p 
and PR domain containing 16 pathway (Ding et al., 2016). Interestingly, recent work by 
Fabbiano et al suggested that daily calorie restriction (-40%) also led to white adipose tissue 
browning in both subcutaneous and visceral adipose tissue. This was mediated by increased 
eosinophil infiltration, type 2 cytokine signalling and alternative activation of macrophage in 
fat (Fabbiano et al., 2016). In our hands, intermittent fasting did not promote alternate 
activation of macrophages in white adipose tissue in mice, or in humans who underwent 8-
weeks of IF (Chapter 3 and 4) 
 
In humans, white adipose tissue browning occurs following burn injury, and administration of 
β3- adrenergic receptor agonists (Cypess et al., 2015, Sidossis et al., 2015, Patsouris et al., 




2015). However, mild to moderate external stimuli such as cold exposure, exercise and daily 
calorie restriction that promote visceral and subcutaneous adipose tissue browning in mice 
(Barbatelli et al., 2010, Lim et al., 2012, Fisher et al., 2012, Bostrom et al., 2012, Xu et al., 
2011, Stanford et al., 2015, Fabbiano et al., 2016), do not induce subcutaneous adipose tissue 
browning in humans (van der Lans et al., 2013, Nakhuda et al., 2016, Norheim et al., 2014, 
Barquissau et al., 2018). We did not see changes in UCP1 mRNA levels in subcutaneous 
adipose tissue following IF. This is in line with a previous study which suggested diet-induced 
weight and fat mass loss is independent of subcutaneous adipose tissue browning in people 
with obesity (Barquissau et al., 2018). It should also be noted that while brown-like adipocytes 
are found in both visceral and subcutaneous adipose tissue (Zuriaga et al., 2017), their 
distribution patterns are different in mice and humans. As shown in our study, and previously, 
mice have higher levels of brown-like adipocytes in subcutaneous adipose tissue, whereas these 
are higher in visceral fat depots in humans (Zuriaga et al., 2017). This indicates there is likely 
to be a greater potential for visceral than subcutaneous adipose tissue to brown in response to 
external stimuli in humans. However, it was not possible to obtain visceral fat samples in this 
study. 
 
The clock time that food is withdrawn and introduced during IF is likely important in the overall 
phenotype (Albrecht, 2017, Damiola et al., 2000). In this study, we returned food at ZT11, half 
an hour before the twilight when mice start to become active. This is different from most of the 
previous studies where the time to start fasting/feeding was set 2-7 hours after lights on (9am 
to 1pm), which could have induced circadian desynchrony (Goodrick et al., 1990, Varady et 
al., 2010, Anson et al., 2003, Gotthardt et al., 2016, Liu et al., 2017b, Xie et al., 2017). Further 
studies are necessary to examine the importance of this in mice and in humans.  
 




In this study, only male mice were examined, and we recruited females in the human study, 
and gender rather than species differences could explain the discrepancy in results. There is 
one study examined the effect of IF in chow and HFD fed female mice. Unlike male mice, 
these female mice were resistant to HFD-induced weight gain and IF-induced weight loss (Liu 
et al., 2017b). Secondly, both trials were of short duration, limiting interpretation.  
 
In conclusion, IF increased energy expenditure and promoted white adipose tissue browning in 
both chow and HFD fed mice, but did not alter UCP1 mRNA levels in human subcutaneous 
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Background: Adipose tissue and skeletal muscle undergo remodelling in obesity characterised 
by increased macrophage and extracellular matrix accumulation. The aim of this study was to 
examine the acute effects of 3 days of overfeeding on markers of adipose tissue and skeletal 
muscle remodelling in young adults, and the association with insulin sensitivity. 
 
Methods: Thirty-four young healthy adults (24 women and 10 men; age: 18-27 yrs; BMI: 17.1-
35.1 kg/m2) were recruited. Metabolic assessments were performed  at baseline after 3 days 
energy balanced diet (30% fat), and 3 days after overfeeding (+1,250 kcal/day, 45% fat) 
including body weight, fasting glucose, insulin, serum C-reactive protein (CRP), monocyte 
chemoattractant protein 1 (MCP-1) and insulin sensitivity by a hyperinsulinaemic-euglycaemic 
clamp (80mU/m2/min). Adipose tissue and skeletal muscle biopsies were obtained from a 
subgroup of participants at baseline and after overfeeding to assess mRNA levels of makers of 
macrophage, extracellular matrix, adipogenesis and angiogenesis.  
 
Results: Overfeeding increased body weight (1.1±0.2%), fasting glucose and insulin (all 
P<0.05)), but did not alter peripheral insulin sensitivity assessed by clamp, or serum CRP or 
MCP-1. In adipose tissue, mRNA levels of markers involved in extracellular matrix synthesis 
(COL1A1,  COL3A1) and adipogenesis (SREBF1) were increased (all P<0.01), but macrophage 
and angiogenesis markers were not altered. There were no changes in any of the markers 
assessed in muscle.  
 
Conclusion: Extracellular matrix remodelling in adipose tissue occurs rapidly in response to 
acute over-nutrition and weight gain in young adults. 
 




Key words: adipose tissue, extracellular matrix, inflammation, overfeeding, skeletal muscle, 
young adults 
  





Adipose tissue and skeletal muscle are key organs involved in development of insulin 
resistance, and undergo marked alterations in response to obesity (Wu and Ballantyne, 2017, 
Sun et al., 2011, Petersen et al., 2007). In animals, this includes increases in adipose tissue 
mass through enlargement in fat cell size (hypertrophy) and generating new adipocytes 
(hyperplasia) (Sun et al., 2011, Strissel et al., 2007). This is associated with an increase in 
macrophages (Weisberg et al., 2003, Xu et al., 2003, Lumeng et al., 2007a, Fink et al., 2014, 
Wu and Ballantyne, 2017) and deposition of  extracellular matrix muscle (Sun et al., 2013, 
Kang et al., 2011), which provides mechanical and nutritional support to neighbouring cells, in 
adipose tissue and skeletal muscle (Sun et al., 2013, Kang et al., 2011). Lastly, there is an 
increase in new blood vessel formation (angiogenesis) (Cao, 2010, Silvennoinen et al., 2013), 
as an adaptive response to meet expanded tissue requirements.  
 
In humans, increased markers of inflammation, extracellular matrix and angiogenesis have 
been reported in adipose tissue and skeletal muscle in individuals with obesity (Xu et al., 2003, 
Weisberg et al., 2003, Wu and Ballantyne, 2017, Sun et al., 2013, Martinez-Huenchullan et al., 
2017, Cao, 2010), and were observed in some short-term (28-56 days) overfeeding studies 
(Tam et al., 2014, Tam et al., 2017, Alligier et al., 2012). Since these studies also observed an 
impairment in insulin sensitivity assessed by hyperinsulinaemic-euglycaemic clamp (Tam et 
al., 2014, Tam et al., 2017, Alligier et al., 2012), but whether the remodelling occurring in 
adipose tissue and muscle in response to overfeeding are a cause to or consequence of insulin 
resistance is unclear. 
 
In this study, we examined adipose tissue and skeletal muscle remodelling in response to 3 
days of overfeeding in young adults. We hypothesised that markers involved in macrophage, 




extracellular matrix, adipogenesis and angiogenesis in adipose tissue and muscle would be 
sensitive to acute changes in energy intake, and that this would be associated with changes in 
markers of insulin sensitivity. 
  




7.3 Research design and methods  
Ethics  
The study was approved by the Research Ethics Committee of the Royal Adelaide Hospital 
and the Human Research and Ethics Committee of the University of Adelaide, and was 
registered as a clinical trial at clinicaltrials.gov, registration number NCT01230632. All 
participants provided written, informed consent prior to the commencement of the study. 
 
Study design and participants 
The study design and protocol have been described previously (Chen et al., 2016a, Chen et al., 
2014). Briefly, 34 young adults with age from 18 to 27 yrs and BMI from 17.1 to 35.1 kg/m2 
were recruited. Thirty-one individuals (10 men and 21 women) completed the study and were 
used for the data analysis. Individuals were excluded if they were born premature (<37 weeks) 
or with low birthweight (<2500g), displayed any significant medical conditions, took 
medications affecting glucose or lipid metabolism, smoked cigarettes or drank alcohol 
(>140g/week), and had first-degree relatives with type 2 diabetes or cardiovascular disease. 
Female participants were tested in their follicular phase of menstrual cycle.  
 
Participants were provided with a standardised diet calculated as previously described (Chen 
et al., 2014) (100% of calculated energy requirements, 35% fat, 15% protein, 50% 
carbohydrate) for 3 days prior to the metabolic testing (Fig. 7.1). After baseline assessment, 
individuals were instructed with an overfeeding diet (+1,250 kcal/day, 45% fat, 15% protein, 
and 40% carbohydrates) for 3 days before metabolic assessments were repeated. Participants 
were provided with all foods and completed daily food checklists.  
 





Figure 7-1: Scheduling of the overfeeding study 
 
Participants attended the clinic at 8am after a 12-hour overnight fast at baseline and after 3-
days of overfeeding. The tests at two visits were identical except that body composition was 
measured at baseline only using dual energy X-ray absorptiometry (Lunar DPX-Lunar 
Radiation, Madison, Wis., USA). Weight and height were measured in a hospital gown after 
voiding. Intravenous cannulae were inserted and fasting blood samples were collected. 
Following this, a 2-hour hyperinsulinaemic-euglycaemic clamp (80 mU/m2 body surface/min) 
was performed. Glucose was infused at a variable rate to maintain its level at 5.0 mmol/L. 
Peripheral insulin sensitivity was calculated as the glucose infusion rate during steady-stage 
(90-120min), and normalised to fat-free mass as described previously (Chen et al., 2016a).  
 
Adipose tissue and muscle biopsies 
Subcutaneous abdominal adipose tissue and vastus lateralis muscle tissue were obtained by 
percutaneous biopsy as mentioned previously (Tam et al., 2017, Tam et al., 2010) before clamp 
was conducted. Briefly, biopsy sites were located and cleaned. After anesthetising the skin and 
underlying tissues with lidocaine, adipose tissue (~150mg) and vastus lateralis (~100mg) 
samples were collected using the biopsy needles, and were snap frozen in liquid nitrogen and 




stored at -80°C for future analysis.  Adipose tissue and muscle biopsies were available from 15 
patients at baseline, and 12 and 8 individuals, respectively, after overfeeding.  
 
Table 7-1: Taqman primers used for gene expression analysis 
Category  Gene name Assay ID 
Macrophage   
CD68 CD68 molecule Hs02836816_g1 
CD40 CD40 molecule Hs01002913_g1 
CD163 CD163 molecule Hs00174705_m1 
Macrophage recruitment  
CCL2 C-C motif chemokine ligand 2 Hs00234140_m1 
CCL3 C-C motif chemokine ligand 3 Hs00234142_m1 
Extracellular matrix 
COL1A1 Collagen type I alpha 1 chain  Hs00164004_m1 
COL3A1 Collagen type III alpha 1 chain Hs00943809_m1 
MMP2 Matrix metallopeptidase 2 Hs01548727_m1 
MMP9 Matrix metallopeptidase 9 Hs00234579_m1 
TIMP1 TIMP metallopeptidase inhibitor 1 Hs00171558_m1 
Adipogenesis 
CEBPa CCAAT/enhancer binding protein alpha Hs00269972_s1 
SREBGF1 Sterol regulatory element binding transcription factor 1 Hs01088691_m1 
Angiogenesis 
VEGFa Vascular endothelial growth factor A Hs00900055_m1  
ANGPT2 Angiopoietin 2 Hs01048042_m1  
Housekeeper 
ACTB Actin beta Hs01060665_g1 
 
Quantitative real-time PCR 
As described previously (Chen et al., 2016a), total RNA was extracted from adipose tissue 
(100-150 mg) and skeletal muscle (~30mg) using Trizol (Invitrogen, USA) following 




manufacturer’s instructions. The concentration and purity of RNA were determined by 
NanoDrop Lite Spectrophotometer (Thermo Fisher Scientific, CA, USA). cDNA synthesis was 
conducted using T100 Thermal Cycler (Bio-Rad, CA, USA) with 800 ng of each RNA sample 
using the QuantiTect reverse transcription kit (Qiagen, Valencia, CA, USA) consistent with 
the manufacturer’s protocol. Quantitative real-time PCR of genes involved in macrophage 
(CD68, CD40 and CD163), macrophage recruitment (CCL2 and CCL3), extracellular matrix 
(COL3A1, COL6A1, MMP2, MMP9 and TIMP1), adipogenesis (CEBPα and SREBF1) and 
angiogenesis (VEGFa and ANGPT2) was performed using Taqman primers (Table 7.1) and 
Fast Universal PCR Master Mix on an ABI 7500 sequence detection system (all from Applied 
Biosystems, Foster City, CA). Samples were run in duplicate with internal negative control and 
a standard curve for which standard samples were pooled from ten participants at baseline. 
Relative gene expression was analysed using the 2−ΔCT method, and normalised by ACTB which 
was not different before and after overfeeding. 
 
Biochemical analysis  
Glucose was analysed using a glucose dehydrogenase method (YSI Life Sciences, Ohio, USA), 
and serum insulin by radioimmunoassay (Millipore, St Charles, MO, USA). Homeostasis 
model of assessment - insulin resistance (HOMA-IR) was calculated as fasting glucose 
(mmol/l) x fasting insulin (mU/L)/22.5. Plasma monocyte chemotactic protein-1 (MCP-1) and 
C-reactive protein (CRP) were assessed by Quantikine® ELISA (R&D Systems Europe, Ltd., 
Abingdon, UK) on a Beckman AU480 clinical analyser (Beckman Coulter Inc), with intra- and 
inter-assay CVs of MCP-1 <8% and <7%, and CRP <9% and <8%, respectively.    
 
Statistics 




Data are shown as mean ± SEM. All statistical analyses were performed using IBM SPSS 
Statistics 24 (SPSS, Chicago, IL, USA). Data were log10 transformed if not normally 
distributed. Response to overfeeding was analysed using paired t-test. Correlations were 
calculated using Pearson Correlation Coefficients. Significance was accepted as P < 0.05. 
 
  




7.4 Results  
Clinical characteristics of participants at baseline and 3-day after overfeeding are summarised 
in Table 7.2. Fat mass was positively correlated with HOMA-IR (r=0.43, P=0.01), CRP 
(r=0.40, P=0.02), and mRNA levels of CD68 (r=0.58, P=0.01) in adipose tissue. Clinical 
characteristics of the participants who completed 3 days of overfeeding were not different from 
that of those underwent adipose tissue or skeletal muscle biopsies. However, the baseline 
correlations between fat mass, HOMA-IR and CRP did not exist when this was analysed using 
the subgroup of participants underwent biopsies. 
 
Table 7-2: Clinical characteristics and metabolic measures before and after 3 days of 
overfeeding 
Variable  Baseline Overfeeding P value 
Number  10/21 (M/F) 10/21(M/F)  
Age, years 21.0±0.5 -  
Waist/hip Ratio 0.81±0.01 Not assessed  
Fat mass, % 35.6±2.0 Not assessed  
Weight, kg 67.5±2.5 68.2±2.5 <0.001 
BMI 23.0±0.8 23.2±0.8 <0.001 
Fasting glucose,  mmol/L 4.13±0.05 4.23±0.04 0.006 
Fasting insulin, µU/mL 12.44±0.78 13.52±0.86 0.017 
HOMA-IR, AU 2.33±0.17 2.55±0.18 0.008 
GIR, umol/kg FFM/min 99.35±4.24 96.79±4.05 0.306 
MCP-1, ng/L 144.43±10.60 145.48±12.81 0.912 
CRP, mg/L 1.36±0.33 1.43±0.39 0.751 
BMI: body mass index; HOMA-IR: homeostasis model of assessment-insulin resistance; GIR: 
glucose infusion rate; FFM: fat free mass; MCP-1: monocyte chemotactic protein-1; CRP: C-
reactive protein. 
 
Data presented as Mean ± SEM; Statistics were performed by paired t test. 
  




As reported previously (Chen et al., 2016a), 3-days of overfeeding resulted in increased body 
weight (1.1±0.2%), fasting glucose and insulin, and thus HOMA-IR. However, peripheral 
insulin sensitivity assessed by clamp was not changed by acute overfeeding (P=0.3) and there 
was no significant changes in serum levels of MCP-1 and CRP. These results held when the 
analysis was performed in those who underwent adipose tissue or skeletal muscle biopsies 
(Table 7.3). 
 
Table 7-3: Comparison of clinical outcomes between participants completed overfeeding 
and underwent adipose tissue or skeletal muscle biopsies 
Parameters Completers Fat  biopsies  Muscle biopsies  
N 31 12 8 
Body weight ↑    P<0.001 ↑      P<0.001 ↑      P<0.001 
Fasting glucose ↑    P=0.006 ↑      P=0.037 ↑      P=0.044 
Fasting insulin ↑    P=0.017 ↑      P=0.050 ↑      P=0.050 
HOMA-IR ↑    P=0.014 ↑      P=0.045 ↑      P=0.042 
GIR ↔  P=0.306 ↔    P=0.586 ↔    P=0.596 
MCP-1 ↔  P=0.912 ↔    P=0.409 ↔    P=0.350 
CRP ↔  P=0.751 ↔    P=0.520 ↔    P=0.712 
↑: increased vs. baseline; ↓: decreased vs. baseline and ↔ no change vs. baseline. 
 
In adipose tissue, mRNA levels of COL1A1,  COL3A1 and SREBF1 were increased by 
overfeeding (all P<0.01, Fig. 7.2), while CD68, CD40, CD163, CCL2, CCL3, VEGFa, 
ANGPT2, MMP2, MMP9, TIMP1, and the ratio of MMPs to TIMP1(not shown) which 
represents the activity of extracellular matrix degradation were not changed. We did not 
observe any changes in the mRNA levels of these genes in skeletal muscle. The change in 
CD40 expression in adipose tissue was positively associated with fasting glucose (r=0.67, 








Figure 7-2: Tissue remodelling genes in adipose tissue and skeletal muscle before and 
after 3 days of overfeeding.  
(A and B): mRNA levels of macrophage (CD68, CD40 and CD163) and macrophage 
recruitment (CCL2 and CCL3) in adipose tissue and muscle. (C and D): mRNA levels of 
extracellular matrix genes (COL3A1, COL6A1, MMP2, MMP9 and TIMP1) in adipose tissue 
and muscle. (E and F): mRNA levels of adipogenesis (SREBF1 and CEBPa) and angiogenesis 
(VEGFa and ANGPT2) genes in adipose tissue and muscle. SREBF1 and CEBPa were not 
assessed in muscle.  
 
Data presented as mean ± SEM, N=12 for adipose tissue and n=8 for muscle. Relative mRNA 









Figure 7-3: Correlation between the change in fasting glucose and CD40 mRNA levels in 
adipose tissue 








7.5 Discussion  
Adipose tissue and skeletal muscle undergo remodelling in obesity which is linked with 
impaired insulin sensitivity (Sun et al., 2011, Wu and Ballantyne, 2017, Petersen et al., 2007). 
However, it is not clear whether adipose tissue and/or skeletal muscle remodelling is an early 
contributor to, or a consequence of, insulin resistance in obesity. Our results show that changes 
in the extracellular matrix in adipose tissue is an early event in response to acute over-nutrition 
and may contribute to the onset of insulin resistance during overfeeding. 
 
As we have previously reported (Chen et al., 2016a), 3 days of overfeeding increased body 
weight (~1.1%). Since body composition was not assessed after overfeeding and it is likely that 
minor change in fat mass after 3 days of overfeeding cannot be differeciated by a DEXA, it is 
not clear that the weight gain achieved is attributed to increased fat mass or glycogen synthesis 
or both. That 3 days of overfeeding increased fasting glucose, insulin and thus HOMA-IR is 
consistent with previous studies of short-term overfeeding (3-day) by our group and others 
(Samocha-Bonet et al., 2010, Tam et al., 2017, Jordy et al., 2014), which likely represents 
induction of hepatic insulin resistance (Singh and Saxena, 2010). Of note, peripheral insulin 
sensitivity as assessed by hyperinsulinaemic-euglycaemic clamp, a gold-standard technique, 
was unchanged. The clamp reflects whole body glucose disposal, and primarily skeletal muscle 
since  >80% of the glucose infused during clamp is taken up by skeletal muscle (DeFronzo and 
Tripathy, 2009). This result is in line with a previous study that observed elevated HOMA-IR 
index in the absence of impaired insulin sensitivity assessed by clamp following 5 days of 
overfeeding (Brons et al., 2009).  
 
Compared to normal weight, people with obesity exhibit chronic low-grade inflammation 
including increases in circulating pro-inflammatory mediators, such as tumour necrosis factor 




α (TNFα), interleukin 6 (IL-6), CRP and MCP-1 etc. (Rodriguez-Hernandez et al., 2013), 
which directly inhibit the insulin signalling cascade (Shoelson et al., 2006). In this study, we 
did not see changes in CRP and MCP-1 levels following short-term 3 days overfeeding, which 
is in agreement with a previous work by Adochio and colleagues (Adochio et al., 2009). 
However, our past work did show a significant increase in CRP levels after 3 days of 
overfeeding (Tam et al., 2010). This discrepancy could be because the participants recruited in 
that cohort were more overweight (BMI: 26.0 vs. 23.0 kg/m2), older (age: 37 vs. 21 yrs) or 
since that cohort was enriched for people with a familial risk of type 2 diabetes (Tam et al., 
2010). We also saw no change in the mRNA levels of macrophage and macrophage-
recruitment genes in adipose tissue and skeletal muscle after 3 days of overfeeding. These data 
are in line with previous studies by our group and others (Tam et al., 2017, Tam et al., 2014, 
Tam et al., 2010, Alligier et al., 2012). Previous studies by our group have also reported that 
28 days of overfeeding did not alter markers of adipose tissue and muscle inflammation, despite 
inducing insulin resistance (Tam et al., 2010, Tam et al., 2017). Similarly, moderate weight 
loss of 5-10% improves insulin sensitivity without altering adipose tissue inflammation 
(Magkos et al., 2016). Our work contributes to growing body of evidence highlighting that 
adipose tissue and skeletal muscle inflammation is a consequence of insulin resistance in obese 
state.  
 
Excessive collagen deposition, a hallmark of fibrosis, in adipose tissue and skeletal muscle also 
occurs in obesity and insulin resistance (Sun et al., 2013, Williams et al., 2015). Collagens are 
the main structural proteins in extracellular matrix, which are cleaved by matrix 
metalloproteinases (MMPs) (Bonnans et al., 2014). The enzyme activity of MMPs is negatively 
regulated by tissue inhibitor of metalloproteinases (TIMPs) to avoid excessive degradation of 
extracellular matrix. Herein, we observed increased mRNA levels of COL1A1 and COL3A1 in 




adipose tissue after 3 days of overfeeding, which encode fibrillary collagens. We did not see 
changes in mRNA levels of MMP2, MMP9, TIMP1, or the ratio of MMPs to TIMP1, which 
may suggest an increase in extracellular matrix accumulation in adipose tissue. These results 
are supported by previous longer term overfeeding studies (28-56 days) which showed that a 
range of collagen markers including COL1A1, COL3A1, and COL6A3 were increased in 
adipose tissue (Pasarica et al., 2009a, Tam et al., 2014, Alligier et al., 2012), and extend these 
studies by showing this process is a very early event.  
 
Up-regulation of extracellular matrix genes including COL1A1, COL3A1, COL4A1, COL5A1, 
COL6A1, COL6A3 and SPARC have also been reported in skeletal muscle in men after 56 days 
of overfeeding (Tam et al., 2014). In this study, we did not see changes in mRNA levels of 
extracellular matrix genes in skeletal muscle after 3 days of overfeeding. This result is in 
agreement with a recent study by our group where detectable changes in extracellular matrix 
markers appeared at day 28 of overfeeding with no change at day 3 (Tam et al., 2017). 
Together, these data suggest that extracellular matrix in adipose tissue is sensitive to over-
nutrition, but more substantial weight gain is required to trigger extracellular matrix 
remodelling in skeletal muscle. 
 
The formation of mature adipocyte from its precursor cells is finely regulated by a group of 
transcriptional factors including CCAAT/enhancer-binding proteins (CEBP) and sterol 
regulatory element-binding transcription factors (SREBF) (Tang and Lane, 2012). Whether 
nutrient manipulations alters adipocyte turnover, particularly in humans, is debated. 
Approximately 10% of adipocytes are renewal annually in adults (Rosen and MacDougald, 
2006, Spalding et al., 2008). Some evidence suggests that adipocyte death or generation rates 
are not changed in adults with obesity (Spalding et al., 2008). However, increased adipocyte 




numbers are observed in rodent models of obesity, occurring when adipocytes reach a crucial 
cell size (Cleary et al., 1979, Johnson and Hirsch, 1972, Strissel et al., 2007). In this study, 
SREBF1 mRNA levels were increased in adipose tissue after 3 days of overfeeding, suggesting 
a possibility of increased adipogenesis. However, further studies are required to address 
whether nutritional changes impacts adipogenesis, particularly in humans. 
 
Angiogenesis is the physiological process of the formation of new capillaries from pre-existing 
blood vessels, and plays an important roles in tissue growth, expansion and repair (Cao, 2010). 
Tissue angiogenesis is regulated by multiple factors such as vascular endothelial growth factor 
(VEGF), fibroblast growth factor (FGF), transforming growth factor (TGF) and angiopoietins 
(Angs) (Cao, 2007). In adipose tissue, the rapid expansion of fat mass through hypertrophy 
and/or hyperplasia during energy excess depends on an increase in vascular perfusion to 
provide oxygen and nutrients (Cao, 2010). However, this is controversial, with some studies 
suggesting that compensatory angiogenesis in adipose tissue is insufficient (Ye et al., 2007), 
but others showing adipose tissue hypoxia is not present in individuals with obesity (Vink et 
al., 2017). In skeletal muscle, one animal study suggests obesity increases angiogenesis makers 
and capillary density in skeletal muscle (Silvennoinen et al., 2013). We investigated markers 
of this in both tissues, but observed no changes in response to acute overfeeding.  
 
In conclusion, our study shows that 3 days of overfeeding did not alter insulin sensitivity or 
inflammation in adipose tissue and skeletal muscle, however, increased markers of 
extracellular matrix synthesis in adipose tissue. This highlights that extracellular matrix 
remodelling in adipose tissue is an early event in response to over nutrition, and occurs prior 
to altered insulin sensitivity. 
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Chapter 8:  Conclusions and Future Directions 
  




8.1 Conclusions  
The mouse study highlighted that IF reduced energy intake, body and fat mass, visceral adipose 
tissue inflammation and fibrosis in high fat diet fed mice only, but improved glucose tolerance 
in both chow and high fat diet fed mice. Results in mice demonstrate that improved glucose 
tolerance by IF in chow fed mice was independent of weight loss, since they fully compensated 
for food deprivation by overeating on refeeding days. The mice work further reveals that IF 
increased energy expenditure and promoted white adipose tissue browning in both chow and 
high fat diet fed mice. This could be one mechanism to explain the improved metabolic 
phenotype in chow and high fat diet fed mice. 
 
The clinical study is the first randomised controlled trail to compare the effects of intermittent 
versus continuous food intakes at two energy levels (at energy balance, or 30% energy 
restriction). This study demonstrates that provision of an energy restricted IF led to greater loss 
of weight and fat mass, improvements in homeostasis model assessment of insulin resistance, 
total cholesterol and non-esterified fatty acids versus provision of a matched continuous energy 
restriction diet. However, there were no overall differences in insulin sensitivity by clamp. 
When IF was prescribed in energy balance, transient increases in risk markers for type 2 
diabetes were observed, despite modest weight loss. Taken together, these data suggest that 
energy restriction is required for beneficial effects on markers of metabolic health in humans.  
 
My results show that intermittent fasting promotes different responses in adipose tissue and in 
muscle collected from humans and mice. The human study demonstrated that a prolonged 24-
hour fast increased circulating, adipose tissue and muscle inflammation. Moreover, increased 
macrophages in adipose tissue after a 24-hour fast were positively correlated with serum non-
esterified fatty acids levels. This data suggests that infiltrated macrophages in adipose tissue 




could play a physiological role to buffer the excessive release of non-esterified fatty acids. 
However, results from the animal study do not support these findings. Despite increases in the 
blood non-esterified fatty acids levels, prolonged fasting did not increase markers of 
subcutaneous and visceral adipose tissue inflammation in chow and high fat diet fed mice. My 
results also show that intermittent fasting did not alter collagen content in subcutaneous adipose 
tissue in humans, however, this was increased in subcutaneous adipose tissue in mice and 
reduced in visceral fat fibrosis in high fat diet fed mice. Lastly, intermittent fasting promoted 
white adipose tissue browning in mice, but this does not appear to occur in humans at least in 
subcutaneous adipose tissue. My work highlights the limited translation that may be made from 
mouse studies. 
 
My work also supports previous human studies that weight change by calorie restriction or 
short-term overfeeding did not alter adipose tissue and skeletal muscle inflammation, but 
markers of extracellular matrix in adipose tissue were sensitive to short-term over-nutrition.  
 
In conclusion, this research highlights that energy restricted intermittent fasting may lead to 
additional health benefits compared to calorie restriction in humans. This study also suggests 
intermittent fasting results in distinct tissue adaptations versus daily calorie restriction in 
humans, and special attention should be paid to the species difference in the study of obesity 
(Table 8.1). 







Table 8-1: Summary of the thesis 
Dietary intervention IF DR 
Animals/humans  Male mice Women Women 
Diet  Status Chow HFD IF100 IF70 DR70 
Energy intake Fed ↔ ↓↓ ↓ ↓↓ ↓↓ 
Body weight Fed ↔ ↓↓ ↓ ↓↓ ↓ 
Fat mass Fed ↓ ↓↓ ↓ ↓↓ ↓ 
Glucose tolerance Fed ↑ ↑↑ NA NA NA 
Fasted NA ↑↑ NA NA NA 
HOMA-IR Fed ↔ ↓↓ ↔ ↓ ↔ 
Fasted ↓↓ ↓↓↓ ↓ ↓↓ NA 
GIR Fed NA NA ↔ ↔ ↔ 
Fasted NA NA ↓ ↓ NA 
Fat cell size  Fed ↓ ↓↓ ↓ ↓ ↓ 
Fasted ↓ ↓↓ ↓ ↓ ↓ 
Adipose tissue inflammation  Fed ↔ ↓ ↔ ↔ ↔ 
Fasted ↔ ↓ ↑ ↑ ↔ 
Adipose tissue fibrosis Fed ↔ ↓ ↔ ↔ ↔ 
Fasted ↔ ↓ ↔ ↔ ↔ 
Adipose tissue browning  Fed ↑↑ ↑↑ ↔ ↔ ↔ 
Fasted ↑↑ ↑↑ ↔ ↔ ↔ 
IF: intermittent fasting; DR: daily calorie restriction; HFD: high-fat diet; IF100: intermittent fasting diet at 100% of baseline energy requirements; 
IF70: intermittent fasting diet at 70% of baseline energy requirements; DR70: continuous energy restriction at 70% of baseline energy 







requirements; HOMA-IR: homeostatic model assessment of insulin resistance; GIR: glucose infusion rate during hyperinsulinaemic-euglycaemic 
clamp; NA: not assessed.
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8.2 Future directions 
What are the long-term effects of IF in humans? 
IF is effective to improve health markers and prolong lifespan in rats and mice (Goodrick et 
al., 1982, Goodrick et al., 1983a, Goodrick et al., 1990, Xie et al., 2017). So far, the longest IF 
study in humans is one year duration. This study suggests IF was as effective for weight loss, 
weight maintenance, and cardio-protection as daily calorie restriction (Trepanowski et al., 
2017). Whether IF alters key molecules implicated in longevity in humans is unknown.    
 
Does gender differentially impact the response to IF? 
Male mice are more susceptible to diet induced obesity and alterations in glucose metabolism 
(Hwang et al., 2010). It is possible that males and females may display different responses to 
intermittent fasting. In humans, we observed increased adipose tissue macrophages after 24-
hour fast which was linked with elevated non-esterified fatty acids, but this was not supported 
by mice study. Similarly, the browning phenomenon was detected in mice but not in humans. 
Since only women were recruited for the clinical study, and male mice were used for the animal 
work. It is currently unclear whether the discrepancy in these results is gender or species 
dependent. A study including both genders would help clarify this point.  
 
Does the increased macrophages after a fast in human adipose tissue buffer excess lipids 
released from adipocytes? 
Acute 24-hour fast increased macrophage infiltration in adipose tissue which was positively 
associated with elevated NEFA levels in mice (Kosteli et al., 2010). In vitro and in vivo studies 
suggest macrophages store excess lipids releases from adipocytes (Caspar-Bauguil et al., 
2015). We observed increased macrophages filtration in adipose tissue after a 24-hour fast 
along with elevated non-esterified fatty acids, but whether these macrophages are responsible 
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for the uptake of the released lipids from lipolysis by a fast in humans was not tested, as there 
was insufficient sample. An in vitro study treating macrophage cell line by fatty acids or serum 
collected from the participants may help test this hypothesis. 
 
Does IF affect appetite regulation? 
Recent evidence suggests that individuals following an IF regimen are not able to compensate 
the deprived food on fasting days by overeating on feeding days in a free-living environment 
(Catenacci et al., 2016, Trepanowski et al., 2017). Our human study also highlights that 
participants in the IF groups did not consume all prescribed food on fed days. From metabolic 
cage data, we observed delayed food uptake when food was returned and a significant 
reductions in cumulative energy intake in high fat diet fed mice. Therefore, the sense of hunger 
and satiety may be altered by IF. The effect of IF on appetite regulation requires further 
investigation, and is subject of a new study being run in our laboratory in 2018. 
 
Does IF improve insulin sensitivity in mice? 
A number of animal studies have assessed insulin sensitivity in chow and high fat diet fed mice 
by insulin tolerance test (Gotthardt et al., 2016, Kim et al., 2017), but the results are 
controversial. Peripheral insulin sensitivity by gold standard hyperinsulinaemic-euglycaemic 
clamp has not been reported. Further, as reported by our group and others that prolonged fasting 
impairs peripheral insulin sensitivity (van der Crabben et al., 2008, Vendelbo et al., 2012). It 
is unclear how IF affect insulin sensitivity by clamp and whether insulin sensitivity alters 
between the fed and fasted states in mice. 
 
Does IF impact the circadian rhythm? 
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The physical and behaviour activities of mammals display circadian rhythm which are 
coordinated by internal clock genes. These genes are finely regulated by the light and dark 
cycle as well as the pattern of feeding and fasting playing important roles in the maintenance 
of homeostasis(Manoogian and Panda, 2017). Synchronising the eating activity with the 
internal clock such as restricting the time window for eating to a certain period promotes weight 
loss and improves health in rodents and in humans (Chaix et al., 2014, Hatori et al., 2012, Gill 
and Panda, 2015). It’s unclear whether IF impacts circadian rhythm in mice and humans. 
Additionally, since internal clock has been found in macrophages (Keller et al., 2009). Whether 
the responses of peripheral macrophages to IF display circadian rhythm is unknown.  
 
What mechanism triggers adipose tissue browning following IF in mice? 
We, and others, have shown that IF promotes white adipose tissue browning (Kim et al., 2017, 
Li et al., 2017). By comparing the responses between the fed and fasted states, our data 
highlight that the Ucp1 mRNA levels in both visceral and subcutaneous adipose tissue mirrored 
the food access during intermittent fasting, suggesting intermittent overfeeding is the trigger 
for this to occur. Recent works demonstrated that brown-like adipocytes in adipose tissue were 
derived from their precursor cells as well as existing mature white adipocytes. This process is 
regulated by both transcriptional and post-transcriptional factors, such as AMP-activated 
protein kinase, co-regulator PR domain containing 16, DNA and histone methylation, histone 
acetylation and non-coding RNAs (Sambeat et al., 2017, Kajimura et al., 2015, Mottillo et al., 
2016). Our future work will focus on AMP-activated protein kinase and histone acetylation 
pathway, since its activity is regulated by fasting and feeding (Drazic et al., 2016, Lage et al., 
2008). 
 
Does intermittent fasting affect skeletal muscle inflammation?  
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Obesity is characterised by macrophage infiltration into adipose tissue and weight loss partially 
reverses this phenotype. This has been documented in both humans and animals (Xu et al., 
2003, Weisberg et al., 2003, Zamarron et al., 2017, Lumeng et al., 2007a, Aron-Wisnewsky et 
al., 2009). Whether this phenomenon exists in skeletal muscle, a key organ involved in energy 
metabolism, remains unclear. In our hands, intermittent fasting appears to trigger distinct 
polarisation of macrophages in adipose tissue and skeletal muscle in humans in which a 24-
hour fast shifts the macrophage population towards a classically activated M1-phenotype in fat 
while alternatively activated M2-phenotype in muscle. Additionally, the response to 
intermittent fasting could be of difference in skeletal muscle from mouse to human, since a 
~24-hour fast failed to provoke a M1- phenotype in both gonadal and inguinal adipose tissue 
in mice. Further studies are required to examine the population and polarisation of 
macrophages in skeletal muscle in response to intermittent fasting. 
 
Is skeletal muscle involved in white adipose tissue browning in mice following 
intermittent fasting? 
Skeletal muscle and brown adipocytes have been closely linked, not only because of the 
detection of ectopic brown adipocytes in skeletal muscle but the crosstalk (Almind et al., 2007, 
Rodríguez et al., 2017). Brown adipose tissue has been shown to regulate skeletal muscle 
function such as exercise capacity via the secretion of factor myostatin, and vice versa (Kong 
et al., 2018, Shan et al., 2013). Myokines such as interleukin 6 and irisin that are released during 
exercise have been reported to promote the browning of white adipose tissue in animals (Kim 
and Plutzky, 2016). A recent study suggests that intermittent fasting increased lean mass in 
mice (Gotthardt et al., 2016), whether this is linked to the browning of white adipose tissue 
could be an interesting direction in the future.

















Appendix table 1: Calculated energy and macronutrient intakes based on self-reported diet checklists 






































Control 2357±98 2363±82 102±4  91±4 29±1 258±9 2338±84 104±4 90±4 29±1 257±9 2377±87 106±4 92±4 30±1 257±9 
IF100 2366±66 2131±68d,e 86±3 82±3 27±1 243±8 2139±76d,e 88±3 83±4 28±1 242±9 2111±67d,e 87±2 82±3 28±1 239±8 
IF70 1702±49 1657±62d,f 72±3 58±2 20±1 193±8 1602±64d,f 69±3 56±3 19±1 189±8 1630±61d,f 71±2 58±2 19±1 187±8 
DR70 1725±44 1694±134 92±2 66±2 22±1 208±7 1748±136 95±2 68±2 23±1 211±7 1699±134 102±7 67±2 23±1 201±5 
Data are mean ±SEM. DR70: continuous energy restriction at 70% of baseline energy requirements: IF70: intermittent fasting diet at 70% of baseline 
energy requirements; IF100: intermittent fasting diet at 100% of baseline energy requirements; Control (C): continuous energy intake at 100% of 
baseline energy requirements. dP<0.05 compared with kcal provided. eP<0.05 compared with Control. fP<0.05 compared with DR70. 
 
 
Appendix table 2: Calculated energy intakes on fed and fasted days, and averaged in intermittent fasting groups based on self-reported 
diet checklists 
  Week 1 Week 4 Week 7 





























IF100 2366±56 2131±68 873±34 3074±105 2139±76 882±34 3082±114 2111±67 859±31 2863±93 
IF70 1702±49 1657±62 697±22 2345±93 1602±64 732±33 2246±95 1630±31 680±24 2316±93 
Data are mean ±SEM. DR70: continuous energy restriction at 70% of baseline energy requirements: IF70: intermittent fasting diet at 70% of baseline 
energy requirements; IF100: intermittent fasting diet at 100% of baseline energy requirements; Control (C): continuous energy intake at 100% of 
baseline energy requirements.  













C vs IF100 
IF70 
(n=22) 
P value  




IF70 vs DR70 
Weight (kg) 0.4±0.4 -2.7±0.5c 0.000 -5.4±0.5d,e 0.000 -3.9±0.4 0.03 
Fat mass (kg) -0.2±0.5 -2.3±0.4c 0.001 -3.9±0.4d,e 0.004 -2.8±0.4 0.05 
Fat free mass (kg) -0.4±0.4 -0.5±0.3 0.07 -1.4±0.3 0.06 -0.6±0.3 0.07 
% of weight lost as fat free mass 72±45 14±13 0.11 19±7 0.74 19±6 0.94 
Waist circumference (cm) -1.4±1.7 -4.3±1.0 0.19 -7.6±1.2d 0.04 -5.2±1.0 0.14 
Hip circumference (cm) -0.3±1.3 -3.6±0.7 0.07 -5.3±0.8 0.11 -4.4±1.0 0.45 
M/I (μmol/min/FFM+17.7 kg/mU) -2.4±3.7 -1.5±2.9 0.65 3.7±5.5 0.31 3.5±2.1 0.95 
HOMA-IR -0.1±0.5 0.8±0.3 0.08 -0.9±0.3d 0.002 -0.4±0.3 0.38 
Fasting glucose (mmol/L) 0.01±0.1 0.1±0.1 0.37 -0.2±0.1d 0.02 0.1±0.1 0.22 
Fasting insulin (mU/L) -0.4±1.9 2.9±1.4c 0.05 -3.6±1.0d 0.02 -1.2±1.1 0.70 
Fasting NEFA (mmol/L) -0.08±0.07 -0.16±0.06 0.22 -0.26±0.03e 0.38 -0.10±0.04 0.005 
Total cholesterol (mmol/L) -0.30±0.15 -0.37±0.15 0.88 -0.59±0.08d.e 0.05 -0.24±0.10 0.005 
HDL-cholesterol (mmol/L) -0.03±0.07 -0.07±0.06 0.35 -0.10±0.03 0.30 -0.05±0.02 0.20 
LDL-cholesterol (mmol/L) -0.16±0.12 -0.16±0.13 0.88 -0.37±0.07d,e 0.03 -0.13±0.08 0.001 
Triglycerides (mmol/L) -0.25±0.09 -0.28±0.12 0.62 -0.24±0.07e 0.32 -0.16±0.05 0.05 
HS-CRP (mg/dL) 1.11±0.55 -0.33±0.23c 0.008 -0.30±0.35 0.17 0.34±0.46 0.53 
ALT (mmol/L) 1.5±2.2 -1.3±1.6 0.60 -3.4±1.6 0.26 -3.0±1.7 0.39 
AST (mmol/L) 1.2±1.5 -2.9±1.5 0.23 -1.6±1.0 0.55 1.0±1.3 0.81 
FGF-21 (mmol/L) 10.8±26.3 3.2±22.2 0.66 29.2±18.7d 0.008 13.7±17.9 0.42 
β-hydroxybutyrate (mmol/L) -0.02±0.02 -0.01±0.01 0.42 0.03±0.02d 0.001 -0.00±0.01 0.25 
Systolic blood pressure (mmHg) 1.5±1.7 -5.6±3.4 0.14 -0.6±3.2 0.23 -4.2±2.9 0.34 







Diastolic blood pressure(mmHg) -1.5±2.0 -2.5±1.4 0.68 -0.4±1.0` 0.23 -0.1±1.5 0.87 
aControl (C): continuous energy intake at 100% of baseline energy requirements; IF100: intermittent fasting diet at 100% of baseline energy 
requirements; IF70: intermittent fasting diet at 70% of baseline energy requirements; DR70: continuous energy restriction at 70% of baseline 
energy requirements. bPairwise comparisons between intermittent and continuous energy intakes at each energy level (i.e., IF100 vs control, DR70 
vs IF70), and between fasting diets (IF100 vs IF70), measured after a fed day. Data are shown as mean ± SEM. cSignificantly different from control 
(P<0.05); dSignificantly different from IF100 (P<0.05); eSignificantly different from DR70 (P<0.05). HDL: high-density lipoprotein; LDL: Low-
density lipoprotein; HS-CRP: high-sensitivity C-reactive protein. 
  







Appendix table 4: Changes in outcome parameters after a fed day (Control or DR70) or fasted day (IF70 and IF100), following 8 weeks 
of intermittent fastinga,b 
 Control IF100 IF70 DR70 
   Fed Fasted Fasted Fed 
M/I (μmol/min/FFM+17.7 kg/mU) -2.4±3.7 -7.6±2.2 -2.5±5.9f 3.5±2.1 
HOMA-IR -0.1±0.5 -0.7±0.3 -1.5±0.3e -0.4±0.3 
Fasting glucose (mmol/L) 0.01±0.1 -0.1±0.1 -0.3±0.1e 0.1±0.1 
Fasting insulin (mU/L) -0.4±1.9 -2.6±1.5 -5.9±1.2e -1.2±1.1 
Fasting NEFA (mmol/L) 0.08±0.07 0.13±0.04c 0.16±0.05d,e 0.10±0.04 
Fasting triglycerides (mmol/L) -0.25±0.09 -0.25±0.08 -0.16±0.06 -0.16±0.05 
HS-CRP (mg/dL) 1.11±0.55 -0.02±0.34 0.08±0.37 0.34±0.46 
ALT (mmol/L) 1.5±2.2 -4.2±3.0 0.8±0.3 -3.0±1.7 
AST (mmol/L) 1.2±1.5 -2.0±0.9 0.1±0.1 1.0±1.3 
FGF-21 (mmol/L) 10.8±26.3 11.0±10.1 48.3±10.6f 13.7±17.9 
β-hydroxybutyrate (mmol/L) -0.02±0.02 0.12±0.03c 0.27±0.05d,e -0.00±0.01 
aControl (C): continuous energy intake at 100% of baseline energy requirements; IF100: intermittent fasting diet at 100% of baseline energy 
requirements; IF70: intermittent fasting diet at 70% of baseline energy requirements; DR70: continuous energy restriction at 70% of baseline 
energy requirements. bPairwise comparisons between intermittent and continuous energy intakes at each energy level (i.e., IF100 vs control, DR70 
vs IF70), and between fasting diets (IF100 vs IF70). Data are shown as mean ± SEM. HS-CRP: high-sensitivity C-reactive protein, NEFA: non-
esterified fatty acids. cSignificantly different from control (P<0.05) dSignificantly different from IF100 (P<0.05).eSignificantly different from 









Appendix figure 1: Ratings of perceived hunger following 1 and 6 weeks of intervention  
Control (C): continuous energy intake at 100% of baseline energy requirements; IF100: 
intermittent fasting diet at 100% of baseline energy requirements; IF70: intermittent fasting 
diet at 70% of baseline energy requirements; DR70: continuous energy restriction at 70% of 
baseline energy requirements. 
 
(A) ratings of hunger in week 1; black bars denote fed days, striped bars denote fasted days in 
IF groups; (B) ratings of hunger in week 6; black bars denote fed days, striped bars denote 
fasted days in IF groups; Pairwise comparisons: * P<0.05 vs control; ^ P<0.05 vs. IF100; ‡ 





Appendix figure 2:  Adipose tissue insulin resistance following 8 weeks of intervention 
Control (C): continuous energy intake at 100% of baseline energy requirements; IF100: 
intermittent fasting diet at 100% of baseline energy requirements; IF70: intermittent fasting 
diet at 70% of baseline energy requirements; DR70: continuous energy restriction at 70% of 
baseline energy requirements. 
 
Data presented as Mean±SEM. ^P<0.05 vs. DR70 in the change from baseline to week 8 
following a 12-hour fast; ‡ P<0.05 vs. IF100 in the change from baseline to week 8 following 








Appendix figure 3: High sensitive C-reactive protein following 8 weeks of intervention 
DR70: continuous energy restriction at 70% baseline energy requirements: IF70: intermittent 
fasting diet at 70% baseline energy requirements; IF100: intermittent fasting diet at 100% 




Appendix figure 4: mRNA levels of CCL2 in adipose tissue and skeletal muscle after 8 
weeks of intervention  
DR70: continuous energy restriction at 70% baseline energy requirements: IF70: intermittent 
fasting diet at 70% baseline energy requirements; IF100: intermittent fasting diet at 100% 
baseline energy requirements.  
 
  




Appendix figure 5: Crown-like structure numbers in adipose tissue after 8 weeks of 
intervention in women 
DR70: continuous energy restriction at 70% baseline energy requirements: IF70: intermittent 
fasting diet at 70% baseline energy requirements; IF100: intermittent fasting diet at 100% 




Appendix figure 6: Quantification of the collagen area in adipose tissue  
DR70: continuous energy restriction at 70% baseline energy requirements: IF70: intermittent 
fasting diet at 70% baseline energy requirements; IF100: intermittent fasting diet at 100% 
baseline energy requirements.  
  




Appendix figure 7: Water consumption of mice measured by metabolic cages 





Appendix figure 8: VCO2 and VO2 of mice measured by metabolic cages 
(A and B): Hourly and daily VCO2 and (C and D): Hourly and daily VO2. 
 
Mean±SEM, n=7-8/group. Effects of diet and schedule on each day were analysed by two-way 
ANOVA with Bonferroni post-hoc tests. Within group effects over three days were analysed 
using repeated measures ANOVA with Boferroni post-hoc test. Day 1 and 2 were two 
consecutive feeding days, followed by a fasting day (day 3). Diet effect: #P<0.05 on each day. 
*P<0.05; **P<0.01 and ***P<0.001; ^P<0.05 vs. chow-AL on day 3; &P<0.05 vs. chow-IF on 
day 1.  
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